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END-STAGE HEART FAILURE 
 
Chronic heart failure is one of the major healthcare problems in the world both in terms 
of patient numbers, hospitalizations, and economic costs. In the United States, 4 to 5 
million people have chronic heart failure, which leads to more than 2 million 
hospitalizations each year.1,2 Recently, the Rotterdam study showed an overall incidence 
of chronic heart failure of 1.4% in the Netherlands with an overall prevalence of 7.0%.3 
Despite optimal medical therapy (β-blockers, angiotensin-converting enzyme inhibitors, 
spironolactone), many patients develop end-stage heart failure and remain severely 
symptomatic. 
In these patients, cardiac transplantation remains the most effective surgical therapy 
with 1-, 5- and 10-year survival rates of 94, 78, and 46 percent, respectively.4,5 
Although effective, heart transplantation is hindered by donor shortage and its limited 
applicability. The International Society of Heart and Lung Transplantation has reported 
a progressive worldwide decline of cardiac transplantation.6 
Given the limitations of medical therapy and cardiac transplantation, several alternative 
therapies for end-stage heart failure have been adopted in the last decade. Most 
prominent is cardiac resynchronization therapy (CRT), after the first implant in 1995, 
large multi-center trials have been performed indicating improved symptoms, exercise 
tolerance and quality of life.7 A recent study shows an additional survival benefit in 
patients treated by CRT and pharmacological therapy above patients treated with only 
pharmacological therapy.8 In addition, new surgical therapies such as restrictive mitral 
annuloplasty and surgical ventricular restoration have evolved and are currently widely 
performed in patients with end-stage heart failure.9,10 These therapies aim to correct 
frequently observed end-stage complications as mitral regurgitation and left ventricular 
(LV) aneurysm. If not treated, these complications have important adverse effects on 
long-term survival.11-13 
The long-term survival rates of patients with end-stage heart failure treated with several 
therapies are summarized in table 1. Obviously, comparison is hampered by the fact that 
the etiology of heart failure is different in the various subgroups. 
Other alternative therapies in patients with end-stage heart failure involve the use of LV 
devices. Heerdt et al. showed that chronic unloading by LV assist devices reverses 
contractile dysfunction and alters gene expression in patients with end-stage heart 
failure.14 Recently, the cardiac support device (Acorn device) was introduced, which 
seems to reverse LV dilatation and improves functional capacity of heart failure 
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patients.15 However, long-term studies with these devices implanted in more patients 
should be awaited. Finally, preliminary data suggest that cell transplantation or stem 
cell therapy may be applied for repairing damaged myocardium.16-18 These therapies are 
currently under clinical investigation and future data should define their clinical 
efficacy. 
 
Table 1. Survival in patients with NYHA III/IV heart failure after different treatments  
 Follow-up (years) 
Therapy (ref) 1-year 5-year 10-year 
Medical 3,19 63% 35% 9% 
HTX 4,5,20 94% 78% 46% 
CRT 8,21 86% 75% - 
RMA 22-25 84% 50% - 
SVR 26 88% 69% - 
Ref: references; HTX: cardiac transplantation; CRT: cardiac resynchronization therapy; RMA: 
restrictive mitral annuloplasty; SVR: surgical ventricular restoration 
 
 
PHARMACOLOGICAL THERAPIES 
 
Currently, angiotensin-converting-enzym inhibitors and beta-blockers  constitute the 
most important pharmacological therapies for heart failure and large trials have shown 
their capacity to improve survival and to lower morbidity.27-32 Aldosterone antagonists 
and angiotensin receptor blockers may provide additional benefit.33-35,36,37 However, the 
sustained benefit of medical treatment appears relatively short-lived.38 Non-
pharmacological therapies such as heart transplantation and implantable assist devices 
are only considered in the late stage of the disease and access to such therapies is 
limited.39 Alternative non-pharmacological treatments for the failing heart such as CRT, 
mitral valve repair and surgical ventricular restoration are currently widely performed. 
 
 
NON-PHARMACOLOGICAL THERAPIES 
 
Cardiac resynchronization therapy 
LV mechanical dyssynchrony in patients with end-stage heart failure is related to 
electrical, structural, and morphological features.40,41 Mechanical dyssynchrony is 
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present in the normal heart, but becomes more apparent in pathological conditions such 
as heart failure. 42,43 In patients with heart failure, LV electrical dyssynchrony typically 
results from left bundle-branch block. Notably, left bundle-branch block changes LV 
contraction patterns, leading to early and late contraction.44,45 This, in turn, impairs 
systolic function, reduces cardiac output, and increases end-systolic volume and LV 
wall stress.40 
CRT is a novel treatment option in symptomatic patients with end-stage heart failure 
and LV mechanical dyssynchrony. Current indications for CRT in patients with drug-
refractory end-stage heart failure are NYHA class III/IV symptoms, LV ejection 
fraction below 35 percent, QRS duration above 120 ms and left bundle branch block 
configuration. Large randomized placebo controlled studies have demonstrated the 
beneficial effects of CRT on symptoms, exercise capacity, and quality of life.46,47 In 
addition, a recent prospective randomized study showed that CRT substantially reduced 
the risk of complications and death among patients with heart failure and cardiac 
dyssynchrony.8 In this study, a total of 404 patients were assigned to receive medical 
therapy alone and 409 patients to receive medical therapy plus cardiac 
resynchronization therapy and all patients were evaluated in a mean follow-up period of 
29 months. The mortality rate in the medical-therapy group was 13% at one year and 
25% at two years, as compared with 10% and 18%, respectively, in the CRT group. 
This study therefore concluded that implantation of CRT should routinely be considered 
in patients with moderate to severe heart failure and cardiac dyssynchrony. Several 
studies have demonstrated that CRT has beneficial effects on LV hemodynamics 
including reverse LV remodeling.48-50 Recently, Yu et al. demonstrated that LV reverse 
remodeling is a strong predictor of lower long-term mortality and heart failure events.51 
In addition, CRT is associated with reduced sympathetic nervous activity, suggesting 
potentially favourable neurohormonal effects.40 These benefits are pacing dependent, 
because discontinuation of pacing resulted in a rapid loss of cardiac improvement. 
Penicka et al. have recently demonstrated that the degree of baseline LV dyssynchrony 
is the main predictive factor for LV functional recovery and reversed remodeling after 
CRT.52 Therefore, LV dyssynchrony assessed by tissue Doppler imaging may be an 
important additional selection criterium for CRT.53 Bax et al. have recently shown that 
patients with septal to lateral delay above 65 ms will respond to CRT and will have an 
excellent prognosis after CRT. Furthermore, CRT also has beneficial effects on mitral 
regurgitation.54,55 Improved coordinated timing of mechanical activation of papillary 
muscle insertion sites appears to be a mechanistic contributor to immediate reduction of 
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mitral regurgitation by CRT in patients with heart failure. Despite the clear clinical 
benefit, accurate hemodynamic data, i.e. effects on systolic and diastolic LV function, 
remain largely limited to the acute effects of CRT. Long-term effects are reported 
mainly in terms of ejection fraction and reversed remodeling. More detailed 
hemodynamic studies would provide potentially important insight in the working 
mechanisms of long-term CRT. 
 
Restrictive mitral annuloplasty 
Patients with chronic heart failure due to LV systolic dysfunction frequently develop 
mitral regurgitation.56 Several studies have shown that coaptation failure arises in these 
patients as a consequence of geometric alterations, which affects mitral annular size and 
the geometric position of the subvalvular apparatus.57,58 Previously, surgical treatment 
of mitral regurgitation was avoided in patients with heart failure owing to concerns 
about operative risk and peri-operative complications.59 However, patients with mitral 
regurgitation have a significantly decreased survival at 2 years follow-up versus patients 
without mitral regurgitation.11 More recently, with improvements in surgical techniques, 
surgical mitral annuloplasty for mitral regurgitation in the setting of heart failure has 
become a more popular treatment option. Bolling et al. have demonstrated the 
feasibility of mitral valve repair in patients with heart failure by downsizing the annulus 
using a flexible ring.23 Their initial results in 48 patients who underwent restrictive 
mitral annuloplasty showed an early mortality rate of approximately 5% with 1- and 2-
year survival rates of 82% and 71% respectively. Several recent studies have confirmed 
that early mortality is low (between 5 and 7%), heart failure symptoms are ameliorated, 
LV size and ejection fraction improve, and intermediate outcome is favorable.24,25 
However, several studies in patients treated with mitral annuloplasty demonstrated a 
high recurrence rate (30%) of mitral regurgitation after six months follow-up.60,61 In 
contrast to these results, Bax et al. reported no recurrences of mitral regurgitation in 51 
patients with ischemic LV dysfunction at 2-years follow-up.22 Similarly, Szalay et al. 
reported in 121 patients with end-stage heart failure a recurrent rate of 3% with a mean 
mitral regurgitation grade 0.6 at 1-year follow-up.25 The low recurrence rates in these 
latter studies may be associated with a more truly restrictive annuloplasty performed in 
these patients. 
The effects of restrictive mitral annuloplasty on systolic and diastolic LV performance 
are relatively unknown. Bolling and coworkers hypothesized that restrictive mitral 
annuloplasty leads to LV systolic improvement by acute remodeling of the base of the 
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heart and re-establishing the ellipsoid shape.62,63 Recent data from Bax et al. reported 
that 50% of patients showed significant reduction in LV end-systolic diameter over 
time.22 Of note, a substantial percentage (60%) of patients in this study especially those 
with a preoperative LV end-diastolic diameter and LV end-systolic diameter of 65 mm 
and 51 mm, respectively, showed reverse remodeling at late follow-up. These findings 
indicate that the process of reverse remodeling may need substantial time in some 
patients. These issues are clinically relevant, since a reduction of LV dimensions and an 
increase in LV ejection fraction are associated with a favorable prognosis.64,65 However, 
until now there is no randomized clinical trial that demonstrates that surgical correction 
of mitral regurgitation by mitral annuloplasty improves survival or leads to reverse LV 
remodeling. Wu and colleagues have recently demonstrated that there is no clearly 
demonstrable survival benefit conferred by mitral annuloplasty for significant mitral 
regurgitation in patients with chronic heart failure.66 In addition, Enomoto et al. 
demonstrated in an animal model that mitral regurgitation might not contribute 
significantly to adverse remodeling suggesting that it is likely a manifestation rather 
than an important impetus for post-infarction remodeling.67 
In summary, current data demonstrates that restrictive mitral annuloplasty is safe in 
patients with heart failure. Still, data about long-term survival benefits, recurrent mitral 
regurgitation, and LV reverse remodeling is inconclusive. Future prospective 
randomized controlled trials should answer these questions. In addition, hemodynamic 
studies may provide insight in the effects of restrictive mitral annuloplasty on LV 
systolic and diastolic function. 
 
Surgical ventricular restoration 
In patients with ischemic heart failure, structural changes like LV aneurysm, may 
contribute to substantial mechanical LV dyssynchrony. At least 88% of dyskinetic LV 
aneurysms result from anterior-septal infarctions, while the remainder follow after 
inferior infarction.68 The LV nonuniformity of contraction and relaxation reduces 
mechanical efficiency of LV filling and ejection and contributes to diastolic and systolic 
dysfunction.42,69 Furthermore, scarring and LV dilatation associated with aneurysm 
formation may provide a substrate for LV arrhythmias. Surgical ventricular restoration 
is increasingly applied in patients with heart failure and LV aneurysm. Controversy still 
exists regarding the question whether similar techniques may also be useful in treating 
patients with dilated ventricles and scarred regions of the heart when the shape is not 
seriously distorted by an LV aneurysm. Dor et al. described the endoventricular circular 
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patch plasty for LV reconstruction and demonstrated that the results of this technique 
were just as good in patients with akinetic regions as in patients with dyskinetic 
regions.70 Several studies further advocated the use of the endoventricular circular patch 
technique above the simple linear technique in patients with LV aneurysm.71,72 
Although surgical ventricular restoration is increasingly performed, it has not yet found 
general acceptance. Possible reasons include a lack of evidence that demonstrates 
improvement in morbidity and mortality with this technique in patients with ischemic 
heart failure. A recent retrospective analysis has demonstrated that the outcome was 
significantly better in patients who received CABG plus surgical ventricular restoration 
compared to patients who received CABG alone.73 In most studies, operative mortality 
ranges between 0 and 20% and the reported 1- and 5-year survival hovers around 85% 
and 70%, respectively.74-76 Patients in these studies had a subjective clinical benefit, as 
indicated by a significant improvement of their NYHA classification (from III-IV to I-
III) with significant improvement of LV ejection fraction and reduction in end-diastolic 
and end-systolic volumes. However, none of these studies has been conducted in a 
prospective, randomized manner with an acceptable number of patients. 
Initial results with surgical ventricular restoration have recently been published in a 3-
year observational study by the RESTORE group.26 The surgeons in this international 
group performed the surgical ventricular restoration in 662 patients who mainly had 
akinetic defects of the anterior wall. The results have been promising, although any 
conclusions on the incremental efficacy of surgical ventricular restoration relative to 
CABG must be made with caution because of the absence of a control group in the 
RESTORE registry. LV ejection fraction was improved on an average of 10% and all 
patients had significant improvement of NYHA classification. Despite these promising 
data, Elefteriades et al. demonstrated a similar improvement in contractile function in a 
small and selected group of patients who underwent isolated CABG.77 Therefore, 
controversy remains regarding the question whether surgical ventricular restoration or 
CABG alone provide additional benefit above medical therapy. These questions will not 
be answered unless they are investigated in a prospective randomized fashion. The 
STICH (Surgical Treatment for IschemiC Heart failure) trial is the first prospective 
randomized study in the history of coronary artery surgery to specifically assess the 
potential benefit of CABG in patients with ischemic heart failure. This trial is designed 
and powered to answer fundamental clinical questions regarding the ischemic heart 
failure population. The trial tests two hypotheses: (1) CABG combined with intensive 
medical therapy improves long-term survival compared with medical therapy alone and 
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(2) surgical ventricular restoration combined with CABG and medical therapy improves 
survival free of cardiac events compared to CABG and medical therapy without surgical 
ventricular restoration. 
Several studies demonstrated beneficial hemodynamic effects of surgical ventricular 
restoration in patients with ischemic heart failure. These studies reported acute 
improvements in contractile state, energy efficiency, and relaxation, together with a 
decrease in LV mechanical dyssynchrony in patients with heart failure.78,79 Buckberg et 
al. emphasized the importance of considering size, shape and LV fiber orientation in 
patients with heart failure.80-82 It has been proposed that surgical ventricular restoration 
of the dilated LV will restore myofibers in the diseased ventricle to a normal, oblique 
orientation.83 However, this issue remains still controversial and data supporting these 
claims are lacking.84,85 
 
In conclusion, despite the promising results of these alternative therapies in patients 
with end-stage heart failure, the working mechanisms and effects on LV function are 
relatively poorly defined. 
 
 
AIM AND OUTLINE OF THE THESIS 
 
The aim of this thesis was to study the hemodynamic effects of CRT, surgical 
ventricular restoration and restrictive mitral annuloplasty in patients with end-stage 
heart failure by use of pressure-volume loops derived by the conductance catheter. An 
important rational for this approach is that pressure-volume derived indices reflect 
intrinsic systolic and diastolic LV function in a relative load-independent fashion, 
whereas conventional methods are importantly influenced by changes in loading 
conditions. This may be particular relevant during cardiac procedures such as valve 
surgery and surgical ventricular restoration where loading conditions may change 
substantially. Moreover, it is increasingly recognized that mechanical dyssynchrony, 
importantly influence LV function and that benefit of CRT and surgical therapies may 
be partly explained by reduced mechanical dyssynchrony. The ability of the 
conductance catheter to quantify mechanical dyssynchrony in an objective and on-line 
fashion may therefore add to the diagnostic power of this methodology. 
The quantification of effects of these therapies on global and intrinsic LV systolic and 
diastolic function and mechanical dyssynchrony may provide further insight in the 
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working mechanisms of these therapies. This may help to explain improved survival, 
functional status and exercise tolerance in heart failure patients treated with these 
therapies. In this thesis, acute effects of surgical therapies on LV function were assessed 
by peri-operative measurements by the conductance catheter in the operating room, 
whereas chronic effects of CRT and surgical therapies were assessed in the 
catheterization laboratory at baseline and at 6 months follow-up. 
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ABSTRACT 
 
Interpretation of peri-operative measurements of cardiac function during cardiac surgery 
is complicated by changes in loading conditions induced by anesthesia, 
cardiopulmonary bypass (CPB) and the surgical procedure itself. Quantification of left 
ventricular (LV) function by pressure-volume relations as obtained by the conductance 
catheter would be advantageous because load-independent indices can be determined. 
Accordingly, we evaluated methodological aspects of the conductance catheter 
technique and documented LV function pre- and post-CPB in 8 patients undergoing 
CABG. LV pressure-volume loops by TEE-guided trans-aortic application of the 
conductance catheter were obtained at steady state and during preload reduction by 
temporary occlusion of the inferior caval vein. All patients remained hemodynamically 
stable and no complications occurred. Complete data were acquired within 15 minutes 
pre- and post-CPB. Cardiac output (5.2±1.3 to 6.0±1.4 L/min) and LV ejection fraction 
(46±17 to 48±19%) did not change, but end-diastolic pressure increased significantly 
post-CPB (8±2 to 16±7mmHg, p<0.05). Load-independent systolic indices remained 
constant (end-systolic elastance: 1.31±1.20 to 1.13±0.59mmHg/mL). Diastolic function 
changed significantly post-CPB, as Tau decreased from 64±6 to 52±5ms (p<0.05) and 
the chamber stiffness constant increased from 0.016±0.014 to 0.038±0.016/mL 
(p<0.05). We conclude that the conductance catheter method provides detailed data on 
peri-operative myocardial function. Therefore, the conductance catheter method may be 
used to evaluate the effects of new surgical and anesthetic procedures for which the 
present data may serve as reference data. 
 
 
INTRODUCTION 
 
Recently, several new approaches were introduced in cardiac surgery such as restrictive 
mitral annuloplasty, endoventricular circular patch plasty, and off-pump CABG. 
Generally, the efficacy of new techniques is assessed by long-term follow-up of 
patients. However, the acute effects on left ventricular (LV) function of these 
procedures are not well documented and may be predictive for long-term outcome. Peri-
operative assessment of LV function may allow better evaluation of new surgical 
procedures and may help post-operative management by providing insight in the cardiac 
pathophysiology. During cardiac surgery cardiac output, aortic pressure, central venous 
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pressure and the pulmonary arterial wedge pressure usually assess hemodynamic status. 
In addition, transesophageal echocardiography (TEE) is used to assess regional 
contractile function. However, interpretation of all these parameters is complicated by 
their load-dependency. Therefore, given the substantial changes in loading conditions 
that may occur during the operation, these parameters may not reflect intrinsic 
myocardial function. Pressure-volume relations as obtained by the conductance catheter, 
have been shown to provide load-independent indices of systolic and diastolic 
function.1,2 Accordingly, the aim of present study was twofold. Firstly, we described 
and evaluated the application of the conductance technique in the operating room 
including catheter placement, calibration procedures and heart rate-controlled 
measurement of systolic and diastolic pressure-volume relations. Secondly, we 
compared various indices of LV function before and after CPB in patients undergoing 
CABG. These data obtained in patients with relatively normal LV function may provide 
reference data for future studies in which more complex cardiac surgical procedures are 
evaluated. 
 
 
METHODS 
 
The study protocol was approved by the Local Ethics Committee and all patients gave 
informed consent. Eight patients with multivessel coronary artery disease elected for 
CABG were included. Patients with severely depressed LV function (LVEF < 35%), 
unstable angina or atrial fibrillation were excluded. 
 
Anesthesia 
After 2mg lorazepam as sublingual premedication two hours before surgery, all patients 
received total intravenous anesthesia with target-controlled infusion of propofol, 
remifentanil and sufentanil.3-5 Hypnotic state was monitored with a Bispectral Index 
(BIS) monitor (Aspect medical systems, Newton, MA). Induction of anesthesia was 
started with targeted concentration of 1.5μg/ml propofol and 3ng/ml remifentanil. 
Before intubation the remifentanil-targeted concentration was increased to 9ng/ml and 
the targeted propofol concentration to 2μg/ml. A single dose of pancuronium bromide 
(0.1mg/kg) was given to facilitate intubation. During surgery the propofol concentration 
was adjusted between 1.5μg/ml and 2.0μg/ml to maintain a BIS value below 60. 
Remifentanil was titrated between 5 and 10ng/ml in response to the patient's 
Chapter 2 
 26
hemodynamic reaction on surgical stimuli. Sufentanil was started at a targeted 
concentration of 0.1ng/ml after start of surgery to allow smooth transition of the patient 
analgesic state from the operating room to the ICU. The patients were ventilated with an 
oxygen/air mixture (FiO2=40%) at a ventilatory rate of 12-15/min and ventilatory 
volume was adjusted to maintain PaCO2 between 4.5 and 5.5kPa (34-41mmHg). A 
thermal filament catheter was placed in the pulmonary artery via the right internal 
jugular vein for semi-continuous cardiac output measurements (Edwards Lifesciences, 
Uden, The Netherlands). To monitor cardiac function and facilitate positioning of the 
conductance catheter peri-operatively a multiplane TEE-probe was inserted. 
 
Conductance catheter technique 
We used a 7F integrated pressure-conductance catheter (CD-Leycom, Zoetermeer, The 
Netherlands) incorporating a solid-state pressure sensor and 12 electrodes with an inter-
electrode spacing of 10mm. A pigtail facilitates placement through the aortic valve and 
positioning within the LV apex (Figure 1). 
 
  
Figure 1. Left: The optimal position of the conductance catheter along the long-axis of the left ventricle. 
Right: the conductance catheter viewed by long-axis view by TEE peri-operatively 
 
The catheter is connected to a Leycom Cardiac Function Lab (CFL) signal-processor. 
Between the two most proximal and two most distal electrodes a dual electric field 
(20kHz, 30μA) is generated.6 The remaining 8 electrodes are used to measure 5 
segmental volume signals. The user may select from three settings the best match with 
the LV long axis: by skipping electrodes one or two 1-cm segments may be converted to 
2-cm segments thereby extending the effective length of the catheter. The optimal 
setting is selected based on inspection of the segmental volume signals. An aortic 
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volume signal is easily distinguished from a ventricular signal because it resembles an 
aortic pressure signal and is out-of-phase with the ventricular volume signals. The 
segmental conductance’s are summed to yield total conductance G(t) and, taking into 
account the specific resistivity of blood and the electrode spacing, converted to a time-
varying volume signal, V(t), which follows through the equation: 
 
V(t) = (1/α)⋅(rho⋅L²)⋅(G(t)-GP) 
 
where α is a slope factor, L is the inter-electrode spacing, rho is the specific resistivity 
of blood measured from a 5ml blood sample using a special 4-electrode cuvette 
connected to the CFL, and GP is the parallel conductance. G(t) is the sum of the 
conductance of the blood in the LV and GP. The latter results from the conductance of 
the ventricular wall, other cardiac chambers and to some extent all electrically 
conductive structures outside the LV cavity. Baan et al. devised a method to determine 
GP by injecting a small bolus (7ml) of hypertonic saline solution (10%) in the distal port 
of the pulmonary artery catheter.1 The highly conductive saline transiently changes 
blood conductivity, which is measured only in the LV. By analyzing the conductance 
signal registered during passage of the bolus through the LV, GP can be determined.1 
The correction volume (Vc) corresponding to GP equals: 
 
Vc = (rho⋅L²)⋅GP 
 
After correction for GP the volume signal is directly proportional to actual ventricular 
volume, but generally underestimates true volume by a fixed factor. There are two main 
causes for this underestimation. First, there may be a mismatch between the measured 
segments and the LV long-axis. Secondly, the conversion of conductance to volume 
assumes that the electric field is homogeneous within the cavity. In reality this is not 
entirely the case resulting in underestimation. The development of dual field excitation 
has substantially improved electric field homogeneity, but some underestimation 
remains especially in large hearts.6 To correct for this underestimation the factor α was 
introduced, which is obtained by comparing conductance-derived stroke volume (SV) 
with an independent measure of SV. In most studies α is calculated by dividing SV of 
the conductance catheter by SV obtained by thermodilution: α = 
SVconductance/SVthermodilution. In the present study we used the 'stat' cardiac output 
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measurements recorded from a Vigilance® Continuous Cardiac Output Monitoring 
System (Edwards Lifesciences, Uden, The Netherlands). 
 
Instrumentation and surgical technique 
After harvesting bypass material, the pericardium was opened and epicardial pacemaker 
leads were placed on the right atrium. A caval tourniquet was applied around the 
inferior caval vein to perform temporary preload reductions by caval vein occlusion. 
After systemic heparinization, a sheath (F8, Cordis, Roden, The Netherlands) was 
introduced in the ascending aorta for placement of the conductance catheter. 
Subsequently the conductance catheter was inserted into the LV and positioned along 
the long axis toward the LV apex. Catheter introduction and positioning was guided and 
verified by TEE and inspection of the segmental conductance signals. Positioning was 
aimed at locating the pigtail in the apex while the most proximal electrodes should be 
located just above the aortic valve. Measurements were started if 5 segmental LV 
volume signals were obtained. 
 
Measurement protocol and data acquisition 
The protocol included measurements at a paced heart rate of 80bpm pre- and post-CPB. 
If intrinsic rate was above 80bpm the pacemaker was set slightly above the intrinsic 
rate. Pressure-volume loops were measured at steady state and during transient caval 
vein occlusion (typical pressure drop of 20mmHg within 5-10s) in order to obtain 
systolic and diastolic pressure-volume relationships. The ventilator was turned off to 
exclude the effects of respiration. Rho was measured just before data acquisition, both 
before and after CPB. Additional acquisitions (before and after CPB) were done for 
determination of GP after injection of 7ml 10% hypertonic saline solution through the 
distal port of the pulmonary artery catheter. Independent cardiac output measurements 
by thermodilution were obtained during steady state. The thermodilution catheter 
provides update measurements approximately every minute indicating average cardiac 
output over the preceding period. An analog signal reflecting the 'stat' signal was 
recorded simultaneously with the pressure-volume signals for off-line calculation of α. 
 
Data analysis 
Baseline hemodynamic data were calculated from steady state pressure-volume loops: 
heart rate (HR), end-systolic volume (ESV), end-diastolic volume (EDV), end-systolic 
pressure (ESP), end-diastolic pressure (EDP), cardiac output (CO), stroke volume (SV), 
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stroke work (SW), maximal and minimal rate of LV pressure change (dP/dtMAX, 
dP/dtMIN), ejection fraction (EF) and the relaxation time constant (Tau). Tau, reflecting 
the early active relaxation process, was calculated as the time constant of mono-
exponential pressure decay during isovolumic relaxation. The isovolumic period was 
defined as the period between the time-point of dP/dtMIN and the time-point at which 
dP/dt reached 10% of the dP/dtMIN value. From pressure-volume loops during caval vein 
occlusion indices of systolic and diastolic function were derived. For systolic function, 
the end-systolic pressure-volume relation (ESPVR), the dP/dtMAX-EDV relation and the 
preload recruitable stroke work relation (PRSW: SW versus EDV) were determined as 
for diastolic function the chamber stiffness constant (CS) was determined. The systolic 
relationships were characterized by their slope and volume intercept. The slope of the 
ESPVR (Ees) as well as its volume intercept, at a fixed systolic pressure of 75mmHg 
(V75) have been shown to be indices of contractility, largely independent of loading 
conditions.7,8 The ESPVR was determined by linear regression of end-systolic pressure-
volume points obtained during caval vein occlusion. Similarly, the PRSW slope (S-
PRSW) was determined by plotting SW against EDV and the same was done for the 
slope of the dP/dtMAX-EDV relation (S-dP/dt). The slopes of these two relationships 
have also been shown to reflect contractility.9,10 The chamber stiffness constant (CS) 
was determined by exponential regression of the end-diastolic pressure-volume relation 
(EDPVR) by means of the following equation: 
EDP = yo+A⋅eCS·EDV 
where yo is the pressure asymptote and A is a constant.  
 
Statistical analysis 
Pre- and post-CPB data were compared with paired t-tests. Statistical significance was 
assumed at p<0.05. All data are presented as the mean±SD. 
 
 
RESULTS 
 
Patients 
Patient characteristics are shown in table 1. All patients underwent normothermic CPB 
and received intermittently antegrade warm oxygenated blood cardioplegia. The 
surgical procedure and postoperative intensive care stay were uncomplicated. Peri-
operative and post-operative ECGs did not show signs of ischemia. Furthermore 
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troponin T levels were measured at least up to 12 hours post-surgery and did not exceed 
0.6 μg/L at any time point indicating that in none of the patients peri-operative 
myocardial infarction occurred.11 
 
Table 1. Patient-characteristics  
Variable Mean ± SD Range 
Age (yr.) 63 ± 11 42-75 
Male sex (%) 88 - 
EF (%) 58 ± 9 40-68 
CPB-time (min) 100 ± 31 60-162 
Aox-time (min) 70 ± 22 49-80 
Duration of surgery (min) 301 ± 72 200-381 
Grafts (number) 4 ± 1 2-5 
EF = Ejection fraction; CPB = Cardiopulmonary bypass; Aox = Aortic cross clamp 
 
Technical considerations 
In all patients complete pressure-volume data were acquired before and after CPB. 
Preparation of the pacemaker wires, application of the caval tourniquet and introduction 
of the sheath were uncomplicated. The introduction of the conductance catheter through 
the aortic valve and catheter placement required careful monitoring by use of TEE 
(figure 1) to reduce the risks of perforation and to obtain an optimal catheter position.  
The optimal transesophageal long-axis view was obtained with the multiplane TEE-
probe from the midesophageal transducer position with the array at 135 º of rotation. 
Occasionally, placement of the catheter within the apex caused ventricular extrasystolic 
beats, but a stable catheter position without arrhythmias could always be obtained. After 
the pre-CPB measurements the conductance catheter was withdrawn, rinsed with 
normal saline, and placed on a sterile table to be re-used post-CPB. During the CPB, the 
introducer sheath on the ascending aorta was used to infuse cardioplegia. Catheter 
placement and measurements before and after CPB were completed within 
approximately 15 minutes. 
 
Calibration of the conductance measurements 
Rho measurements, assessment of Vc and α were performed in each patient before and 
after CPB. Results are summarized in table 2. Rho decreased significantly post-CPB as 
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expected due to hemodilution. On the average, Vc and α were not significantly altered 
post-CPB but showed a substantial interindividual variability. 
 
Table 2. Conductance catheter calibration factor, hemoglobin and hematocrit, pre- and post CPB  
Variable Pre-CPB Post-CPB P 
Vc (ml) 129 ± 54 139 ± 50 0.696 
α 0.54 ± 0.24 0.67 ± 0.21 0.267 
Rho (ohm⋅cm) 129 ± 23 105 ± 9 0.015 
Hemoglobin (mmol/L) 7.5 ± 1.1 5.3 ± 0.7 <0.001 
Hematocrit (%) 0.40 ± 0.05 0.26 ± 0.03 <0.001 
VC = Parallel conductance correction volume; α = slope factor; rho = blood resistivity 
 
Hemodynamic data 
Measurements were obtained in each patient before and after CPB. Figure 2 shows 
typical steady state volume, pressure and dP/dt signals and pressure-volume loops.  
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Figure 2. Typical steady state volume, pressure and dP/dt signals, and corresponding pressure-volume 
loops before (PRE: thick lines) and after (POST: thin lines) cardiopulmonary bypass (CPB). As shown by 
the open and closed circles marking the end-systolic pressure-volume points on the pressure-volume 
loops, ESP increased and ESV decreased after CPB indicating increased systolic function. Diastolic 
function, however, appears decreased since diastolic pressure is higher at any given diastolic volume. 
However, while the average values for the whole group showed the same trend, the changes in ESV and 
ESP did not reach statistical significance 
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Systolic and diastolic pressure-volume relations (ESPVR, EDPVR, PRSW and 
dP/dtMAX-EDV) in the same patient derived from pressure-volume loops during caval 
vein occlusion are shown in Figure 3.  
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Figure 3. Example of pressure-volume relations derived by caval vein occlusion before and after CPB. 
The ESPVRs (left panel) show the increased contractile performance after CPB in this patient: although 
Ees is slightly decreased, the position of all end-systolic P-V points to the left and above the pre-CPB 
ESPVR suggests higher contractility. The dotted lines indicate the position of the ESPVR at 75-mmHg 
(V75). The same holds for the PRSW relation (upper-right panel) and the dP/dtMAX-EDV relation (lower-
right panel) although the differences are much less pronounced. The EDPVRs (left panel) provide clear 
evidence for substantial increase in chamber stiffness after CPB, as observed in all patients. As shown in 
table 3, the average position and slope of the ESPVR were not significantly altered after CPB in this 
group of patients 
 
All patients had sinus rhythm and were paced at 80-90bpm during measurements. 
Hemodynamic data are summarized in table 3: Only EDP, Tau and CS changed 
significantly post-CPB 
 
 
DISCUSSION 
 
Assessment of peri-operative ventricular function during cardiac surgery is complicated 
by the fact that substantial changes in loading conditions may occur. Therefore the 
quantification of systolic and diastolic function requires load-independent indices, 
which can be determined from ventricular pressure-volume relations as obtained by the 
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conductance catheter. Accordingly, the purpose of this study was twofold: we evaluated 
methodological aspects of peri-operative application of the conductance catheter and 
documented changes of various indices of LV function pre- and post-CPB in patients 
undergoing CABG. 
 
Table 3. Hemodynamic measurements before and after CPB 
Variable  PRE-CPB POST-CPB t-test 
  Mean ± SD Mean ± SD p 
HR bpm 82 ± 3 85 ± 4 0.024 
CO L/min 5.2 ± 1.3 6.0 ± 1.4 0.293 
EF % 46 ± 17 48 ± 19 0.521 
SV mL 64 ± 14 72 ± 18 0.402 
SW mmHg⋅L 4.5 ± 0.9 5.1 ± 1.4 0.364 
ESV mL 109 ± 93 99 ± 57 0.625 
EDV mL 169 ± 104 164 ± 51 0.845 
ESP mmHg 73 ± 9 83 ± 15 0.198 
EDP mmHg 8 ± 2 16 ± 7 0.004 
dP/dtMAX mmHg/s 926 ± 224 1016 ± 183 0.226 
dP/dtMIN mmHg/s -825 ± 127 -958 ± 147 0.093 
Tau ms 64 ± 6 52 ± 5 0.001 
V75 mL 104 ± 10 87 ± 13 0.216 
Ees mmHg/mL 1.31 ± 1.20 1.13 ± 0.59 0.496 
S-dP/dt mmHg/s/mL 6.9 ± 3.7 6.3 ± 3.7 0.524 
S-PRSW mmHg 62 ± 35 59 ± 24 0.822 
CS 1/mL 0.016 ± 0.014 0.038 ± 0.016 0.017 
CO: cardiac output; EF: ejection fraction; SV: stroke volume; SW: stroke work; ESV: end-systolic 
volume (mL); EDV: end-diastolic volume (mL); ESP: end-systolic pressure; EDP: end-diastolic pressure 
(mmHg); Tau: relaxation time constant, V75: ESPVR volume intercept (at ESP=75 mmHg); Ees: end-
systolic elastance; S-dP/dt: slope of dP/dtMAX – EDV relation; slope of the PRSW relation; CS: chamber 
stiffness constant 
 
Methodological aspects 
Previous studies have extensively shown that the conductance catheter can be applied to 
obtain pressure-volume relationships. Although most patient studies were performed in 
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the catheterization laboratory, several groups have demonstrated feasibility of the 
technique in the operating room under various conditions.12-14 Consistent with these 
previous studies, our study demonstrates that peri-operative pressure-volume 
measurements by the conductance catheter can be used to quantify detailed intrinsic 
systolic and diastolic function within an acceptable time-window. Measurements were 
uncomplicated and no technical difficulties during instrumentation; catheter placement 
and loading interventions were encountered. New technical aspects of our study were 
the use of retrograde insertion of the conductance catheter using TEE guidance 
compared to the trans-mitral approach used in previous studies in the operating room. 
Both approaches may have theoretical advantages and disadvantages: The trans-aortic 
approach provides a better match of the catheter position with the LV long axis. 
Compared with the anterograde placement this gives a better registration especially of 
the volume changes in the basal segments. In contrast anterograde placement through 
the mitral valve may complicate interpretation of segmental volume signals because of 
changes in the mitral valve plane during ejection and filling. On the other hand with 
retrograde placement eccentric (antero-medial) displacement of the catheter at the base 
of the heart may occur but the electric field is such that the measurement electrodes will 
move approximately parallel to the equipotential planes field and thus the eccentric 
movement is unlikely to strongly influence the conductance signal. Another reason for 
using the trans-aortic approach is that we aim to apply this methodology in future 
studies to evaluate the effects of mitral valve surgery, in which case placement through 
the aortic valve is clearly preferable. Furthermore we analyzed the changes in the 
calibration factors. As a disadvantage, substantial between-patient variability was found 
for calibration factors (rho, α and Vc) indicating the need for careful assessment of these 
factors in each individual patient. In addition, after CPB calibration factors rho and, to a 
lesser extent α and Vc, were changed due to reduced hematocrit, fluid shifts and 
possibly altered catheter position with re-insertion. Although the average α and Vc were 
not significantly changed, substantial differences were present in individual patients 
indicating that re-assessment is required at the various stages of surgery. Besides 
influencing between and within-patient variability, the calibration factors importantly 
determine the absolute accuracy of the conductance-derived volumes. Calibration 
factors α and Vc are both obtained by means of indicator-dilution methods: 
thermodilution and, respectively, saline dilution. Thermodilution is widely used in the 
surgical setting and the accuracy is generally found to be acceptable.15 In the present 
study we used 'stat' continuous cardiac output measurements using a thermal filament 
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catheter which has been shown to have accuracy comparable to the bolus injection 
method.16,17 The saline dilution method has been used extensively to obtain parallel 
conductance and was found to be accurate with a slight tendency to underestimate 
parallel conductance obtained by alternative methods.18 An important advantage of 
these indicator-dilution methods compared to imaging modalities such as TEE is that 
they do not require assumptions regarding the geometry of the ventricle. This may be 
relevant especially when comparing conditions in which geometrical changes would be 
anticipated such as after ventricular reconstruction or mitral valve surgery. Furthermore 
the inter- and intra-observer variability of indicator-dilution methods is very limited. 
 
Physiological aspects 
Our main physiological findings were that systolic function was unchanged after CPB 
in these patients undergoing CABG, whereas early relaxation was improved and 
diastolic stiffness was increased. Previous pressure-volume studies comparing pre- and 
post-CPB cardiac function in patients undergoing CABG have shown conflicting data. 
Schreuder et al. reported unchanged systolic function and increased diastolic stiffness, 
while Wallace et al. found a decrease in systolic function, but no changes in relaxation 
or diastolic stiffness.13,14 Both studies used cold cardioplegia whereas our study was 
performed with warm blood cardioplegic arrest, which may explain the preserved 
systolic function in our study as compared to the decrease found by Wallace et al. The 
unchanged systolic function found by Schreuder et al. may be explained by the fact that 
during their pre-CPB measurement the temperature was lowered below 35OC, which 
according to a recent study significantly reduces Ees by approximately 50%. 19 Since 
the post-CPB measurements in Schreuder's study were done at 37OC this may have 
masked an actual reduction in systolic function. With regard to diastolic function all 
studies report an increase in diastolic stiffness although in Wallace's study this effect did 
not reach statistical significance.14 Also in Schreuder's study the increase was less 
pronounced as compared to our study (39% increase vs. 138%).13 However, Schreuder 
et al. described the end-diastolic pressure-volume relation as linear, whereas we derived 
the diastolic stiffness constant from an exponential relation. The increase is most likely 
due to myocardial edema post-CPB as myocardial lymph flow has been shown to 
almost cease during cardioplegic arrest.20 De Hert et al. have shown that a more rapid 
normalization of diastolic stiffness may be obtained by optimizing preload conditions 
prior to weaning from CPB.21 Furthermore, Allen et al. demonstrated that increasing 
contractility by dobutamine infusion enhanced myocardial lymphatic function, thus 
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speeding edema removal post-CPB.22 Thus, for patients who are difficult to wean from 
CPB due to increased diastolic stiffness, inotropic support could be considered. 
However it should be used with caution because it may adversely affect energetics, raise 
heart rate, and induce ischemia.23 In addition several pharmacological substances added 
to the cardioplegia composition have been shown to be associated with reduced edema 
formation.24-26 Remarkably, although diastolic stiffness was increased, early relaxation 
was improved in our study as shown by the significantly reduced Tau. After 
revascularization, enhanced oxygen dependent re-uptake of calcium into the 
sarcoplasmic reticulum would indeed be expected to improve active relaxation.27 Our 
findings are consistent with the results of Humphrey et al. who demonstrated a reduced 
Tau post-CPB in patients undergoing CABG.28 In contrast, De Hert et al. found an 
increased Tau in a similar patient group.21 Differences may be due to the applied 
anesthetic and cardioplegic protocol which influence post-CPB relaxation directly or 
indirectly via changes in contractility or loading, which are tightly coupled with 
relaxation.23,29 Thus unchanged or even increased Tau as found in some studies may be 
related to post-CPB changes in systolic function and/or loading conditions. In our study 
EDV, ESP, dP/dtMAX and Ees were not significantly altered after CPB, whereas De Hert 
et al. report a reduced dP/dtMAX indicating reduced contractile state.21 
 
Comparison with TEE 
As an alternative to invasive volume measurements several groups have used TEE to 
obtain on-line area determination.30-33 This method is less invasive but when used to 
construct pressure-area loops it still requires a LV catheter for pressure measurements, 
and a loading intervention. Schmidlin et al. tested whether pressure-area relations may 
be used as a surrogate for pressure-volume relations to detect changes in contractile 
state and they concluded that pressure-area analysis provides the same changes as 
pressure-volume analysis.33 However the calculations derived from area estimates have 
several limitations. During the cardiac cycle the through-plane motion of the LV 
complicates volume calculations by short axis area estimates. This effect is even more 
prominent during acute loading interventions. On the contrary, the intraventricular 
placement of the conductance catheter provides on-line volume measurements of almost 
the whole ventricle unaffected by translations or rotations of the heart within the thorax. 
In general, on-line area determination by TEE requires optimal image quality and the 
stability and reproducibility of measurements is more successful at higher preload 
conditions by minimizing effects of tracing errors.31 Area estimates derived during caval 
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vein occlusion could become very small thereby decreasing precision of the digital 
echocardiographic quantification method for calculation of pressure-area relations. In 
addition the precision is reduced in the presence of regional wall motion 
abnormalities.30 Conventional assessment of diastolic function by TEE (i.e. without 
simultaneous LV pressure measurement) has two disadvantages compared with the 
conductance catheter method. First, assessment of both active and passive components 
requires two separate TEE views, being the midpapillary esophageal long-axis and 
transgastric short-axis view, respectively.32 Second, the active diastolic relaxation 
measured by mitral Doppler flow analysis is heart-rate and load-dependent. 
 
In conclusion, despite the above limitations, the limitations of TEE are outweighed by 
its proven clinical value to visualize the endoventricular wall and to quantify segmental 
wall motion. On the other hand, the important value of the conductance catheter is that 
it yields accurate, load-independent quantitative data on basic systolic and diastolic 
function. The possibility to measure these fundamental quantities in addition to the data 
provided by TEE may prove to be important in selected patient-groups and is ideal to 
evaluate e.g. new surgical techniques or anesthetic agents or procedures. The 
physiological effects on systolic and diastolic function reported in this study will be 
useful reference data for future studies in patients with depressed LV function 
undergoing cardiac surgery. 
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LETTER TO THE EDITOR 
 
Left ventricular function after cardiopulmonary bypass is related to the length-
dependent regulation of myocardial function 
 
Stefan G. De Hert, MD, PhD 
Philippe J. Van der Linden, MD, PhD 
Anesth Analg 2004; 99: 311-312 
 
 
We read with interest the paper of Tulner and colleagues, in which they reported, in 
eight coronary surgery patients, the use of the conductance catheter method for the peri-
operative assessment of left ventricular (LV) function.1 After cardiopulmonary bypass 
(CPB), the authors observed a preserved systolic function, an acceleration of LV 
pressure fall, and an increase in end-diastolic pressure (EDP). They suggested that these 
data may constitute useful reference values for further studies in patients undergoing 
cardiac surgery. We think that some caution is indicated with respect to this statement.  
Recovery of LV function after CPB is a complex phenomenon and various patterns 
have been described over the years, most of them reporting a transient decrease in 
cardiac function. Different factors may be responsible for this variability. Apart from 
differences in patient population and cardioprotective strategies, specific weaning 
procedures and the choice of the anesthetic regimen may also influence post-CPB 
myocardial recovery. For instance, early restoration of preload conditions can prevent 
the transient depression of both systolic and diastolic dysfunction after weaning from 
CPB (ref. 30 in the article by Tulner et al.).2 Similarly, the use of a volatile anesthetic 
regimen was associated with a better early recovery of myocardial function than a total 
intravenous regimen.3,4  
More important however is the individual variability in cardiac functional reserve. It has 
been shown in coronary surgery patients that an increase in cardiac load resulted in a 
variable hemodynamic response that could not be explained by differences in 
preoperative variables. Some patients showed an improvement, whereas other patients 
showed either no change or even an impairment of LV function. These patients 
developed a decrease in maximal rate of pressure development (dP/dtmax), a delayed 
myocardial relaxation (increase in tau) with enhanced load dependence of LV pressure 
fall, and a major increase in EDP. These patients showed systolic and diastolic 
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dysfunction post-CPB, and necessitated inotropic support to be weaned from CPB.5 
This latter response has been attributed to a deficient length-dependent regulation of 
myocardial function.6 On the other hand, patients who developed improvement of 
myocardial function with an increase in cardiac load (manifested by an increase in 
dP/dtmax, an acceleration of LV pressure fall with a decrease in tau, less load 
dependence of LV pressure fall and a minor change in EDP), typically showed no (or 
only minor) decrease in myocardial function post-CPB.5 
In view of these data, it seems that the results reported by Tulner et al. concern a 
subgroup of patients with good cardiac functional reserve and an adequate length-
dependent regulation of myocardial function, resulting in a preserved myocardial 
function post-CPB. Therefore, this particular response, although present in some 
patients, cannot be withheld as the sole reference for the patient population undergoing 
coronary surgery with CPB. 
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IN RESPONSE 
 
We thank De Hert and Van der Linden for their insightful comments on our paper and 
we would like to respond on some of the issues brought forward.1 The aim of our study 
was two-fold: First to describe our approach to quantify peri-operative LV function, and 
second to obtain a reference data set for future studies in patients undergoing cardiac 
surgery. The comments of De Hert and Van der Linden focus on the latter aspect of our 
study. 
We fully agree that the published literature indicates a substantial variability in recovery 
of LV function after cardiopulmonary bypass and we acknowledge the extensive list of 
possible factors influencing this variable outcome. In fact, this is exactly the reason why 
we felt it was necessary to generate a data set that would be applicable to the anesthetic 
and cardioprotective approach followed in our institute. Specifically, we use low-dose 
target-controlled infusion of propofol, remifentanil and sufentanil, and intermittent 
antegrade warm-blood cardioplegic arrest during normothermic cardiopulmonary 
bypass. The metabolic advantages of this approach have already been published, but 
few data are available on the acute hemodynamic effects. Our study was performed in 
patients with relatively preserved LV function undergoing elective CABG, to ensure 
that the possible changes in LV function could be contributed mainly to the effects of 
anesthesia and cardioplegic arrest, rather than to the surgical intervention. This selection 
may partly explain the preserved post-operative systolic function in our patient group. 
However, De Hert et al. studied a similar patient group and reported a more variable 
outcome that could not be explained by pre-operative LV function.2 Therefore 
differences in anesthesia and cardioplegic approaches between our study and the studies 
by De Hert et al. may need to be considered. One such difference is the use of 
normothermic arrest with blood cardioplegia in our study, whereas the studies of de 
Hert et al. included the use of hypothermia and crystalloid cardioplegia. This may be 
important because recent studies indicate less myocardial cell damage after 
normothermic blood cardioplegia.3 Furthermore, the use of propofol in both studies may 
not be comparable because hypothermia has an important influence on propofol 
pharmacokinetics.4 However, we certainly agree that extrapolation of our findings to 
patients with poor baseline LV function and prolonged cardiac arrest should be done 
with caution. But despite this, we would still conclude that the new data provided by our 
study constitute valuable background information when interpreting the acute 
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hemodynamic effects of complex surgical interventions such as LV reconstruction in 
heart failure patients in whom the same anesthesia and cardioplegia approach is used. 
 
Sven A.F. Tulner and Paul Steendijk. 
Leiden University Medical Center, Leiden, The Netherlands 
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ABSTRACT 
 
Mechanical dyssynchrony is an important co-determinant of cardiac dysfunction in 
heart failure. Treatment, either medical, surgical, or by pacing, may improve cardiac 
function to a large extent by improving mechanical synchrony. Consequently the 
quantification of ventricular mechanical dyssynchrony may have important diagnostic 
and prognostic value and may help to determine optimal therapy. Therefore we 
introduced new indices to quantify temporal and spatial aspects of mechanical 
dyssynchrony derived from on-line segmental conductance catheter signals obtained 
during diagnostic cardiac catheterization. 
To test the feasibility and usefulness of our approach we determined cardiac function 
and left ventricular mechanical dyssynchrony by the conductance catheter in heart 
failure patients with intraventricular conduction delay (n=12) and in patients with 
coronary artery disease (n=6) and relatively preserved left ventricular function. 
The heart failure patients showed depressed systolic and diastolic function. However, 
the most marked hemodynamic differences between the groups were found for 
mechanical dyssynchrony indicating a high sensitivity and specificity of the new 
indices. Comparison of conductance catheter derived indices with septal-to-lateral 
dyssynchrony derived by tissue-Doppler velocity imaging showed highly significant 
correlations. 
The proposed indices provide additional, new and quantitative information on temporal 
and spatial aspects of mechanical dyssynchrony. They may refine diagnosis of cardiac 
dysfunction and evaluation of interventions, and ultimately help to select optimal 
therapy. 
 
 
INTRODUCTION 
 
In addition to intrinsic myocardial abnormalities and abnormal loading conditions, 
cardiac dysfunction in heart failure patients is determined by mechanical 
nonuniformities (dyssynchrony), which lead to inefficient pump performance and 
energy expenditure. There is increasing evidence that pharmacological, surgical and 
pacemaker therapies of heart failure partly exert their beneficial effects by reducing left 
ventricular (LV) dyssynchrony. Consequently, quantification of LV dyssynchrony will 
provide diagnostic and prognostic data, which should help to select and guide therapy. 
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Currently, various indices based on magnetic resonance imaging or echocardiographic 
measurements are being used. In the present study we introduce indices, which quantify 
temporal and spatial aspects of dyssynchrony based on measurements obtained during 
cardiac catheterization using conductance catheter methodology. To test the feasibility 
and usefulness of our approach we compared data from congestive heart failure (CHF) 
patients with left bundle branch block (LBBB) with those from patients with coronary 
artery disease (CAD) who had relatively preserved LV function. In addition we 
compared the conductance catheter derived dyssynchrony indices with septal to lateral 
delay in peak systolic velocity as obtained by tissue-Doppler imaging. 
 
 
METHODS 
 
Patients 
All patients gave informed consent and procedures were conducted in accordance with 
institutional guidelines. The investigation conforms with the principles outlined in the 
Declaration of Helsinki.1 Twelve CHF patients (NYHA class III/IV) with LBBB were 
studied during diagnostic catheterization. Six CAD patients were studied in the 
operating room prior to coronary artery bypass grafting. 
 
Protocol 
CHF patients underwent diagnostic catheterization including thermodilution cardiac 
output, left ventriculography and coronary angiography. In addition, a conductance 
catheter was placed in the LV via the femoral artery, and a temporary pacing lead was 
positioned in the right atrium. 
Prior to catheterization the CHF patients were studied by echocardiography. We 
performed tissue-Doppler imaging as described in detail elsewhere2 to determine 
myocardial velocities in basal septal and lateral segments. The time delay between peak 
systolic velocity in the septum and the lateral wall was determined as an index of 
mechanical dyssynchrony. 
CAD patients received total intravenous anesthesia with target-controlled infusion of 
propofol and remifentanyl (1.5-2μg/ml, resp. 5-10ng/ml blood concentration). A 
continuous cardiac output catheter was placed in the pulmonary artery via the jugular 
vein. Following midline sternotomy and before starting cardiopulmonary bypass a 
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conductance catheter was placed in the LV via a purse-string suture on the ascending 
aorta. External pacing leads were placed on the right atrium. 
Measurements: The conductance catheter enables on-line measurement of 5 segmental 
volume (VSEG,i) slices perpendicular to the LV long axis. We used 7F combined 
pressure-conductance catheters with 1-cm interelectrode spacing (CD Leycom, 
Zoetermeer, The Netherlands). The catheter was connected to a Cardiac Function Lab 
(CD Leycom) for on-line display and acquisition (sample frequency 250Hz) of 
segmental and total LV volumes, LV pressure and ECG. Total LV volume (VLV) is 
obtained as the instantaneous sum of the segmental volumes. VLV was calibrated using 
thermodilution and hypertonic saline dilution as previously described.3 Periods of 
approximately 10s at a paced heart rate of 80bpm were selected for off-line analysis 
using custom-made software. 
 
Global cardiac function and nonuniform mechanical performance 
Global LV function was measured by cardiac index (CI), end-diastolic and end-systolic 
volume index (EDVI, ESVI), ejection fraction (EF), end-systolic and end-diastolic 
pressure (ESP, EDP), maximal and minimal rate of pressure change (dP/dtMAX, 
dP/dtMIN), and the time constant of relaxation (Tau). LV systolic elastance was 
estimated by ESP/ESVI, and in addition (dP/dtMAX)/EDVI was calculated as relatively 
load-independent index of systolic function. 
Nonuniform LV performance was determined from the segmental LV conductance 
signals and characterized by the following indices: 
Mechanical dyssynchrony (DYS): At each time-point a segmental signal was defined as 
dyssynchronous if its change (i.e. dVSEG/dt) was opposite to simultaneous change in the 
total LV volume (dVLV/dt). Segmental dyssynchrony is quantified by calculating the 
percentage of time within the cardiac cycle that a segment is dyssynchronous. Overall 
LV dyssynchrony (DYS) was calculated as the mean of the segmental dyssynchronies.4 
DYS may be calculated within each specified time-interval: We determined DYS during 
systole (DYSS) and diastole (DYSD), with systole defined as the period between the 
moments of dP/dtMAX and dP/dtMIN. 
Internal flow (IF): Nonuniform contraction and filling is associated with ineffective 
shifting of blood volume within the LV. This ‘internal flow’ is quantified by calculating 
the sum of the absolute volume changes of all segments and subtracting the absolute 
total volume change: IF(t) = (Σ|dVSEG,i(t)/dt| - |dVLV(t)/dt|)/2. Note that dVLV(t)/dt 
represents the effective flow into or out of the LV. Thus, IF measures segment-to-
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segment blood volume shifts which do not result in effective filling or ejection. Division 
by 2 takes into account that any 'non-effective' segmental volume change is balanced by 
an equal but opposite volume change in the remaining segments. Internal Flow Fraction 
(IFF) is calculated by integrating IF(t) over the full cardiac cycle and dividing by the 
integrated absolute effective flow. 
Mechanical dispersion (DISP): In the CHF patients we expected a substantial 
dispersion in the onset of contraction between the segments. This dispersion was 
assessed by segmental lag-times, tLAG,i, which were determined by calculating the cross-
correlations between VLV(t) and VSEG,i(t+tLAG,i) for all systolic time-points (i.e. between 
dP/dtMAX and dP/dtMIN). For each segment we determined the tLAG,i which produced the 
highest linear correlation. Thus if tLAG,i<0, segment i precedes the global ejection, and 
vice versa. Mechanical dispersion (DISP) was defined as 2⋅SD of the segmental lag-
times. 
 
Statistical analysis 
All data are presented as mean±SD. Comparisons between the CAD and CHF groups 
were performed by unpaired t-tests. We performed receiver-operating characteristic 
(ROC) curve analysis to test the diagnostic performance of the various indices to 
discriminate the patient groups.5 Sensitivities and specificities at the optimal cut-off 
point were determined. Comparison between conductance-derived and tissue-Doppler 
derived dyssynchrony indices was made by linear regression analysis.  
 
 
RESULTS 
 
Typical pressure-volume loops from a CAD and a CHF patient are shown in Figure 1. 
The bottom panel shows the global LV pressure-volume loops clearly illustrating 
enlarged volumes and increased end-diastolic pressure in the CHF patient. Furthermore, 
whereas the CAD patient displays normal isovolumic trajectories during the contraction 
and relaxation phases, the loops from the CHF patient show a continued decrease in 
volume during these phases presumably reflecting mitral insufficiency. The segmental 
pressure-volume loops displayed in the top panels illustrate the inefficient ventricular 
pump behavior of the CHF patient especially in the apical segments. 
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Figure 1. Segmental and global LV pressure-volume loops in typical CAD and CHF patients 
 
The same signals are also displayed as a function of time in Figure 2. The top panels 
show the segmental and total LV volumes, and LV pressure. The bottom panels show 
calculated internal flows. Contraction and filling patterns are substantially more 
dyssynchronous in the CHF patient compared to the CAD patient. In the CAD patient 
internal flow is largely restricted to the isovolumic contraction and relaxation periods, 
which is consistent with normal physiology since, with mitral and aortic valves closed, 
LV shape changes result in internal segment-to-segment flow. In contrast, in the CHF 
patient substantial ineffective internal flow is present throughout the cardiac cycle. 
Hemodynamic data are summarized in Table 1. EF and dP/dtMAX indicate more 
pronounced systolic dysfunction while ESP/ESVI and (dP/dtMAX)/EDVI show 
depressed contractile state, whereas Tau and EDP indicate impaired diastolic function in 
CHF. Differences in EDVI, ESVI and CI were present but did not reach statistical 
significance. Pronounced differences between CAD and CHF were found in DYS, IFF 
and DISP. 
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CAD DYS (%) CHF DYS (%)
apex 33.0 36.6
21.6 34.8
mid 16.3 35.4
10.8 32.9
base 16.1 29.4
mean mean
VLV 19.6 33.8
PLV
IFF (%) IFF (%)
Internal 17.5 105.3
Flow
time (s) time (s)  
 
Figure 2. Typical examples of segmental and total LV volume signals and calculated internal flow in 
CAD and CHF patients. DYS: mechanical dyssynchrony; IFF: internal flow fraction 
 
For both groups dyssynchrony and internal flows were highest in diastole, and the 
apical segments were the most affected (Figure 3). In both groups mechanical 
dispersion in the long-axis direction was present, but it was twice as large in CHF. 
Figure 3 (right panel) shows that contraction started in the basal segment and, on the 
average, subsequent segments (1cm-slices) followed after 5.9ms for CAD and after 
12.4ms in CHF patients. 
The diagnostic value of the various indices to discriminate the two patient groups was 
tested using ROC analysis. Table 1 shows the results with the optimal cut-off values, 
and corresponding sensitivities and specificities. As expected QRS duration accurately 
delineates the groups with a cut-off value of 107ms. The dyssynchrony indices DYS 
and IFF show excellent sensitivity/specificity values, which are higher than the best 
hemodynamic indices EF and dP/dtMAX. The other hemodynamic indices show lower 
sensitivity/specificity reflecting a substantial overlap of the values between the two 
groups. 
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Table 1. Cardiac function, left ventricular mechanical dyssynchrony and receiver-operating 
characteristic (ROC) curve analysis in CAD (n=6) and CHF (n=12) patients 
 
Cardiac function and 
mechanical dyssynchrony 
 ROC curve analysis 
 CAD CHF p  
cut-
off 
sensitivity specificity 
Gender (M/F) 5/1 9/3 .709     
Age (years) 63±7 67±9 .399     
QRS duration (ms) 86±16 186±24 <.001  107 100% 100% 
CI (L/min/m2) 2.6±0.8 2.0±0.5 .099  1.88 58.3% 100% 
EDVI (mL/m2) 73±33 107±37 .077  89 58.3% 83.3% 
ESVI (mL/m2) 45±25 74±32 .068  58 66.7% 66.7% 
EF (%) 48±16 26±9 .001  37.6 91.7% 83.3% 
dP/dtMAX (mmHg/s) 1106±160 764±228 .005  928 83.3% 100% 
-dP/dtMIN (mmHg/s) 1012±229 827±263 .164  797 58.3% 100% 
Tau (ms) 58±9 77±16 .017  66.5 75% 100% 
ESP (mmHg) 86±18 106±32 .167  91 75% 83.3% 
EDP (mmHg) 9±5 18±8 .024  11.4 75% 83.3% 
ESP/ESVI (mmHg/mL/m2) 2.7±1.9 1.8±1.0 .183  1.89 66.7% 66.7% 
dP/dtMAX/EDVI(mmHg/s/mL/m2) 17±7 8±4 .002  11.3 75% 83.3% 
DYS (%) 19±8 32±3 <.001  19.6 100% 83.3% 
DYSS (%) 11±11 30±6 <.001  13.9 100% 83.3% 
DYSD (%) 24±6 34±2 <.001  25.7 100% 83.3% 
IFF (%) 20±14 78±24 <.001  47.0 91.7% 100% 
IFFS (%) 13±19 63±30 .002  11.3 100% 83.3% 
IFFD (%) 25±12 90±29 <.001  33.1 100% 100% 
DISP (%) 33±13 75±37 .026  39.9 83.3% 80% 
Values given as mean±SD, p-values determined by unpaired t-tests. CI: cardiac index; EDVI, ESVI: end-
diastolic and end-systolic volume index; EF: ejection fraction; dP/dtMAX and MIN: maximal and minimal 
rate of LV pressure change; Tau: time constant of relaxation; ESP, EDP: end-systolic and end-diastolic 
pressure; DYS: mechanical dyssynchrony; DYSS, DYSD: systolic and diastolic DYS; IFF: internal flow 
fraction; IFFS, IFFD: systolic and diastolic IFF, DISP: mechanical dispersion 
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Figure 3. Average segmental dyssynchrony and dispersion lag-times in CAD and CHF patients. The inset 
shows the conductance catheter positioned in the LV and the division in 5 segments from apex to base 
 
Tissue-Doppler measurements were performed in the CHF patients and revealed a 
significant difference in the timing of peak systolic velocities of the septum and the 
lateral wall. The average septal-to-lateral delay was 89±43 ms, indicating a 
dyssynchronous intraventricular contraction pattern. We compared the septal-to-lateral 
delay times with the conductance derived dyssynchrony indices using linear regression 
analysis. The results (Figure 4) show highly significant correlations with DYS (r2=0.59, 
p=0.003) and IFF (r2=0.63, p=0.002). The relation with DISP did not reach statistical 
significance (r2=0.26, p=0.089). 
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Figure 4. Linear regression of conductance catheter derived indices of mechanical dyssynchrony (DYS: 
mechanical dyssynchrony; IFF: internal flow fraction; DISP: mechanical dispersion) versus septal-to-
lateral (S-L) delay in the timing of peak systolic myocardial velocity as obtained by tissue-Doppler 
echocardiography 
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DISCUSSION 
 
Dyssynchrony plays a regulating role already in normal physiology, but is especially 
important in pathological conditions such as hypertrophy, ischemia, infarction, or heart 
failure.6,7,8,9,10 Currently, cardiac resynchronization by biventricular pacing is emerging 
as an important therapy for heart failure.11,12 Recently, MRI and echocardiography have 
been used to visualize mechanical dyssynchrony, further emphasizing the important role 
of mechanical dyssynchrony in cardiac dysfunction.10,13,14-18  However, these methods 
are laborious and require substantial operator interaction and expertise. 
We introduce novel indices to quantify dyssynchrony based on volume signals acquired 
with the conductance catheter during cardiac catheterization. The conductance catheter 
was validated previously and the segmental signals reflect instantaneous volume slices 
perpendicular to the LV long-axis as obtained by cine-CT.3,19 Currently, the 
conductance catheter is used mainly to assess global systolic and diastolic function.20-23 
Quantification of nonuniform mechanical function and dyssynchrony may lead to a 
more complete diagnosis of ventricular dysfunction.24,25 Moreover, it may guide 
therapy, since patients with extensive dyssynchrony are likely to benefit from 
resynchronization therapy.26 
We compared CHF versus CAD patients. The groups show pronounced differences for 
DYS, IFF and DISP, which indicates a high sensitivity and specificity of these 
dyssynchrony indices. QRS duration, dP/dtMAX and Tau show a similar discrimination 
between the groups and may also partly reflect dyssynchrony. However, whereas the 
conductance catheter derived indices directly measure regional mechanical events 
throughout the cardiac cycle, QRS duration reflects the underlying electrical activation 
and studies indicate that mechanical and electrical synchrony may diverge.27 Tau and 
dP/dtMAX have also been shown to be markers of dyssynchrony but they more indirectly 
reflect the integrated effects of spatially dispersed mechanical (de)activation during the 
isovolumic relaxation and contraction periods. Dyssynchrony is likely to be most 
pronounced in the isovolumic phases, which explains the sensitivity of parameters that 
reflect these periods. However, the consequences of dyssynchrony on the effectiveness 
of ejection and filling are important for cardiac pump performance, so that indices 
selectively reflecting those cardiac phases may be of high value. 
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In the CHF patients we compared the conductance derived dyssynchrony indices with 
the delay in timing of peak systolic velocity between the septal and lateral wall as 
obtained by tissue-Doppler echocardiography. Septal-to-lateral delay has recently been 
introduced as an index of mechanical dyssynchrony. We found a significant correlation 
for both DYS and IFF, but DISP did not reach a statistically significant correlation. The 
various indices measure different characteristics. Whereas the tissue-Doppler method 
compares the timing of peak velocity between two regions that are likely to show the 
largest phase shift, the conductance-derived indices are based on a comparison of the 
volume changes of short axis slices and global LV volume changes. Apparently patients 
with a larger septal-to-lateral delay also show more segmental dyssynchrony as 
reflected by DISP and IFF. Whether this correspondence is specific for LBBB-CHF 
patients or is more generally valid requires further study. The lack of correlation with 
DISP is unclear. It may be because the index is less sensitive than DISP or IFF as 
shown in the comparison between CAD and CHF patients, or the index may inherently 
be more prone to errors. Interestingly, within the group of CHF patients neither septal-
to-lateral delay nor the conductance derived indices showed a significant correlation 
with QRS duration (Figure 5). This finding is consistent with other reports indicating 
that electrical dyssynchrony does not necessarily predict mechanical dyssynchrony, 
which prompts a need for methods to accurately detect mechanical dyssynchrony.10,28 
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Figure 5. Linear regression of indices of mechanical dyssynchrony (S-L delay: septal-to-lateral delay of 
peak systolic velocity obtained by tissue-Doppler echocardiography; DYS: mechanical dyssynchrony; 
IFF: internal flow fraction; DISP: mechanical dispersion) vs QRS duration as index of electrical 
dyssynchrony 
 
Our approach may offer several technical advantages. After catheter placement, the 
signals are obtained continuously without operator interaction. In the present study the 
analysis was performed off-line, but real-time display of dyssynchrony indices is 
technically feasible and should enable immediate quantification of the effects of 
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interventions and, e.g., effects of changes in pacemaker settings. The method is 
invasive, but positioning of the catheter in the LV largely eliminates problems with 
through-plane motion inherent in most imaging methods. Heart failure is often 
associated with substantial beat-to-beat hemodynamic variations due to changes in cycle 
length, cardio-pulmonary interaction and conduction disturbances. Thus, techniques -
like MRI- that require hemodynamic steady state and beat-averaging to increase signal-
to-noise may filter out important components of dyssynchrony. Furthermore, the 
temporal resolution of the conductance signals (4ms) is relatively high. 
 
Determination of absolute LV volume from the conductance catheter requires careful 
calibration.3 In the present study calibration factor parallel conductance was obtained by 
the hypertonic saline method and slope factor alpha by thermodilution. Slope factor 
alpha was significantly lower in the CHF patients than in the CAD patients (0.38±0.22 
vs 0.67±0.08, p<0.01) and parallel conductance was significantly higher (214±60 vs 
131±48mL, p<0.01). These findings are consistent with previous studies and reflect 
more electrical field inhomogeneity in the enlarged hearts in the CHF group. However, 
the conductance catheter has been used extensively in enlarged hearts and validation 
studies show that accurate volumes estimates can be obtained provided that appropriate 
calibration is performed.29 As an advantage the dyssynchrony indices can be calculated 
from the raw segmental conductance signals and do not require calibration. Correction 
for parallel conductance (offset factor) is not required because the calculations are based 
on volume changes, and correction for slope factor alpha is not required because 
segmental volume changes are judged relative to the global LV volume changes. The 
latter however implicitly assumes that the segmental slope factors are all the same (and 
thus equal to the slope factor for global volume). This assumption may be a concern 
because theoretical studies indicate that volume in the segments closest to the current 
electrodes may be relatively underestimated due to electric field inhomogeneity 
especially in enlarged hearts.30-32 To test the effects of such underestimations, if present, 
on our dyssynchrony indices we recalculated DYS, IFF and DISP after correcting 
segments 1 and 5 for an assumed underestimation of 20% and segments 2 and 4 for an 
assumed underestimation of 10%. Theoretical studies indicate that underestimation in 
this order of magnitude may be present.30,32 The results were compared with the original 
data using Bland-Altman analysis (Figure 6).33 
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Figure 6. Bland-Altman analysis comparing conductance catheter derived indices of mechanical 
dyssynchrony before and after correction of assumed underestimation of segmental volumes due to 
electric field inhomogeneity. Open circles represent CHF patients, closed circles CAD patients 
 
The analysis shows no significant bias and fairly narrow limits of agreement for each of 
the indices indicating that the influence of a potential underestimation of the outer 
segments on the dyssynchrony indices is relatively small. Although the mean 
dyssynchronies were higher in the CHF patients the differences as detected by the 
Bland-Altman analysis were not systematically different between the two groups. 
The methods for quantifying dyssynchrony presented in this study show similarities 
with an approach previously published by Strum et al.34 They used segmental volume 
signals obtained from conductance catheters to quantify regional wall motion 
abnormalities and referenced amplitudes and phase angles of the segmental signals to 
the global LV volume signal. The phase angle analysis is comparable to our DISP 
index. However, Strum et al measured (in degrees) the relative distances between time-
points of regional minimal volume and global end-systole, whereas we used the entire 
systolic wave forms and used cross-correlation to determine the lag-time between 
segmental and global volume signals. In addition, they compared regional maximal 
stroke volume with effective stroke volume. The latter was measured using maximums 
and minimums of the total LV volume as gated markers of the time when regional 
contraction would contribute to total LV ejection. This effective stroke volume analysis 
is comparable to our internal flow calculation (IFF index), which determines at each 
time point throughout the cardiac cycle whether segmental volume changes are effective 
(i.e. contributing to global volume changes) or lead to ineffective (segment-to-segment) 
internal flow. Strum et al applied these concepts in animal studies where reversible 
regional myocardial dysfunction was induced by intracoronary infusion of esmolol and 
global inotropy was modulated by dobutamine infusions.35,36  
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Limitations 
Optimally the conductance catheter is placed in a straight position from the aortic valve 
to the LV apex. In the operating room we used transesophageal echocardiography and in 
the catheterization laboratory we used angiography to guide positioning.37 However 
occasionally arrhythmias necessitate pulling back the catheter slightly from the apical 
position. In addition the distance from the pigtail to the first measurement electrode is 
approximately 2 cm. Thus volume changes in the most apical part of the LV are not 
measured. If this region is highly dyssynchronous, as might be the case in patients with 
apical infarcts, underestimation of dyssynchrony by our methodology may be expected. 
The patient groups in our study were investigated under different conditions. For 
practical purposes we studied the CAD patients in the operating room during anesthesia 
and after sternotomy, whereas the CHF patients were awake and studied in the 
catheterization laboratory. These differences may have affected the comparisons 
between the two groups. Propofol-remifentanyl anesthesia is known to have myocardial 
depressant and vasodilating properties, whereas sternotomy and pericardiotomy are 
associated with alterations in loading conditions.38,39,40 Given the anesthesia-related 
cardiodepression in the CAD patients, one may expect that the differences in the 
hemodynamic indices would have been more pronounced in case both groups had been 
studied awake. Whether these changes affect the level of dyssynchrony is not well 
known, but studies in dogs with regional stunning show unchanged LV wall asynchrony 
after systemic inotropic stimulation.41 Thus we do not expect that the differences in 
mechanical dyssynchrony between the groups were importantly influenced by the 
different experimental conditions. 
Furthermore, we did not study normal subjects. Thus, future studies are required to 
establish a 'normal' range for the dyssynchrony indices. 
Finally, the segmental conductance catheter signals do not provide an anatomical view 
but represent the total volume of slices perpendicular to the LV long-axis. Thus, e.g. in 
CAD patients, abnormal regional wall motion might be obscured by compensatory wall 
motions within the same circumferential segment. The proposed dyssynchrony indices 
therefore reflect intersegmental differences in contraction and filling and may 
underestimate phase changes obtained by comparing regional lateral and septal wall 
motions, e.g. using tissue Doppler imaging. 
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In conclusion, the proposed indices quantify various aspects of mechanical 
dyssynchrony using conductance catheter methodology which, at the same time, can be 
used for assessment of global systolic and diastolic (dys)function. Diagnostic and 
prognostic value of the dyssynchrony indices requires further investigation. 
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ABSTRACT 
 
Background. Recent studies indicate that normothermic cardiopulmonary bypass 
(CPB) with intermittent antegrade warm blood cardioplegia (IAWBC) may have 
metabolic and clinical advantages, but limited data exist on its effects on myocardial 
function. Therefore, we investigated the acute effects of this approach on systolic and 
diastolic left ventricular function and on chronotropic responses. 
Methods. In 10 patients undergoing isolated CABG we obtained on-line left ventricular 
pressure-volume loops using the conductance catheter before and after normothermic 
CPB with IAWBC. Steady state and load-independent indices of left ventricular 
function derived from pressure-volume relations were obtained during right atrial 
pacing (80-100-120 beats/min) to determine baseline systolic and diastolic function and 
chronotropic responses. 
Results. The mean time of CPB was 105±36 min (median 103, range 60-167 min) with 
a mean aortic cross-clamp time of 75±27 min (median 69, range 43-129 min). Baseline 
(80 beats/min) end-systolic elastance (EES) did not change after CPB (1.22±0.53 to 
1.12±0.28 mmHg/ml, P>0.2), while the diastolic chamber stiffness constant (kED) 
significantly increased (0.014±0.005 to 0.040±0.007 ml-1, p=0.018) and relaxation time 
constant (τ) significantly decreased (61±3 to 49±2 ms, p=0.004). Before CPB, 
incremental atrial pacing had no significant effects on EES and τ but significant negative 
effects on kED (0.014±0.005 to 0.045±0.012 ml-1, p=0.013). After CPB, atrial pacing had 
significant positive effects on EES, τ and kED (EES: 1.12±0.28 to 2.60±1.54 mmHg/ml, 
p=0.021; τ: 49±2 to 45±2 ms, p=0.009; kED: 0.040±0.007 to 0.026±0.005 mmHg, 
p=0.010), indicating improved systolic and diastolic chronotropic responses. 
Conclusion. On-pump normothermic CABG with IAWBC preserved systolic function, 
increased diastolic stiffness, and improved systolic and diastolic chronotropic responses. 
Normalization of the chronotropic responses post-CPB is likely due to effects of 
successful revascularization and subsequent relief of ischemia. 
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INTRODUCTION 
 
Coronary artery bypass grafting (CABG) using cardiopulmonary bypass (CPB) is a 
routine and safe procedure with a mortality rate of approximately 2% in elective cases. 
As traditional cold heart and cold cardioplegic arrest have been shown to reduce post-
operative myocardial function, improvements in cardioplegic approaches are still 
valuable.1 Moreover, the number of patients with heart failure who are eligible for 
surgical intervention is rapidly increasing and preservation of left ventricular function 
by cardioprotection in these patients should be optimal. Warm blood cardioplegia 
represents an accepted alternative method for myocardial protection. Recent studies 
indicate that warm blood cardioplegia results in less myocardial damage than cold 
crystalloid cardioplegia, whereas comparisons against cold blood cardioplegia indicated 
metabolic advantages, a reduced rate of low output syndrome, and improved post-
operative LV function.2,3,4,5 To facilitate construction of distal coronary anastomoses 
intermittent antegrade warm blood cardioplegia (IAWBC) is currently used by many 
surgeons and has shown to be a safe approach  with potentially important metabolic 
advantages.6,7,8,9 However, the acute effects of IAWBC on post-operative myocardial 
function have not been studied extensively. With on-pump CABG, postoperative 
myocardial function may be affected by at least three factors: the extracorporal 
circulation, the revascularization and the cardioplegic cardiac arrest. In addition, the 
interpretation of postoperative hemodynamic measurements is complicated by possible 
alterations in loading conditions and heart rate in comparison to preoperative values. 
The aim of the present study was to quantify the physiological effects of on-pump 
CABG using IAWBC on systolic and diastolic left ventricular function. To this end, we 
measured pressure-volume loops by conductance catheter and quantified systolic and 
diastolic left ventricular function by load-independent parameters derived from 
pressure-volume relations. To assess chronotropic responses the measurements pre- and 
post-CPB were performed during right atrial pacing at 80, 100 and 120 beats/min. 
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METHODS 
 
Patients 
Patients undergoing elective isolated CABG were studied pre- and post-CPB. All 
patients had multi-vessel coronary artery disease and a relatively normal left ventricular 
ejection fraction (> 40%). The ejection fraction was derived from preoperative 
echocardiography. Patients included in the study had regular sinus rhythm and none of 
them had significant valvular disease. The study protocol was reviewed and approved 
by the medical ethics committee of our institute board and all included patients gave 
informed consent. 
 
Anaesthesia 
Patients received premedication (2 mg Lorazepam, sublingual) two hours before 
surgery. All patients received total intravenous anesthesia with target-controlled 
infusion of propofol, remifentanyl and sufentanyl. Pancuronium bromide 0.1 mg/kg was 
given to facilitate intubation. No further muscle relaxation was used. To monitor cardiac 
function and facilitate positioning of the conductance catheter a transesophageal 
multiplane echo (TEE) probe was inserted after induction of anesthesia. Subsequently, a 
thermal filament catheter was placed in the pulmonary artery via the right internal 
jugular vein for semi-continuous cardiac output “stat” measurements (Edwards 
Lifesciences, Uden, The Netherlands). The patients were ventilated with an oxygen/air 
mixture (FiO2 = 40%) at a ventilatory rate of 12-15/min and ventilatory volume was 
adjusted to maintain arterial CO2 tension between 3.5 and 4 kPa. 
 
Cardiopulmonary bypass and cardioplegic arrest 
The cardiopulmonary bypass system consisted of a centrifugal pump (Stockert SIII, 
Stockert instrumente GmbH, Munchen, Germany), a closed venous reservoir, a Trillium 
coated Affinity hollow fiber oxygenator (Medtronic Cardiac Surgery, Kerkrade, The 
Netherlands), a cardiotomy reservoir, and an arterial filter (Dideco, Mirandola Italy). 
The systems were primed with 1300 ml Ringer solution, 200 ml 20% Human albumin 
Cealb®solution (Sanquin, Amsterdam, The Netherlands), 100 ml 20% Mannitol and 
5000 IU of heparin. CPB was performed with a nonpulsatile flow of 2.4 L/min/m2 and 
the core temperature was maintained at 35 0C. Heparin (300 IU/kg) was administered 
before cannulation. Additional heparin was administered if the activating clotting time 
(ACT, Hemochron, Edison, USA) was less than 400 seconds. After cessation of CPB 
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protamine sulfate was administered  (1 mg/ 100 IU heparin). All patients received 
intermittent antegrade warm blood cardioplegia as described by Calafiore et al.6 
Normothermic blood (temperature 35-37°C) was collected from the oxygenator and was 
infused into the aortic root using a roller pump with a mean mean flow of 280 ml/min. 
The tubing was connected to a syringe pump containing potassium in a concentration of 
2 mmol/ml. The first dose (2 min duration, or longer if necessary to obtain a flat ECG) 
was given immediately after aorta cross-clamping and subsequent doses (2 min 
duration) after construction of each distal anastomosis or after 15 minutes. During the 
first dose an initial 2 ml bolus of potassium solution was given and subsequently the 
syringe pump was set to 150 ml/hr. During the second dose the syringe pump speed was 
set to 120 ml/hr, and to 60 ml/hr during all subsequent doses. Consequently, 14 mmol 
potassium was given during the first infusion, 8 mmol during the second, and 4 mmol in 
all subsequent infusions. 
 
Study protocol 
Before and directly after CPB, conductance catheter measurements were performed as 
described previously: Briefly, temporary epicardial pacemaker wires were placed on the 
right atrium to enable measurement at fixed heart rates.10 A tourniquet was placed 
around the inferior vena cava to enable temporary preload reductions. An 8F sheath was 
placed in the ascending aorta for introduction of the conductance catheter. The 
conductance catheter was introduced under TEE guidance and placed along the long 
axis of the left ventricle. Position was optimized by inspection of the segmental volume 
signals. Conductance catheter calibration was performed using calibration factors alpha 
(α) derived from thermodilution and parallel conductance correction volume (Vc) 
determined by hypertonic saline injections.11,12 Continuous left ventricular pressure and 
volume signals derived from the conductance catheter were displayed and acquired at a 
250 Hz sampling rate using a Leycom CFL (CD Leycom, Zoetermeer, The 
Netherlands). Data were acquired during steady state and during temporary caval vein 
occlusion, all with the ventilator turned off at end-expiration. Acquisition was repeated 
at atrial pacing rates (80, 100 and 120 beats/min). From these signals hemodynamic 
indices were derived as described below. 
 
Pressure-volume analysis 
Post-process data analysis was performed by custom-made software. Indices of global, 
systolic and diastolic left ventricular function (heart rate, cardiac output, stroke volume, 
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stroke work, ejection fraction, dP/dtMAX, dP/dtMIN, end-diastolic volume, end-systolic 
volume, end-diastolic pressure, end-systolic pressure, relaxation time constant τ) were 
calculated from steady state pressure-volume loops at 80, 100 and 120 beats/min. 
Systolic and diastolic pressure-volume relations were derived from pressure-volume 
loops acquired during caval vein occlusion at heart rates of 80, 100 and 120 beats/min. 
The slope of the end-systolic pressure-volume relationship (end-systolic elastance, EES) 
was used as relatively load-independent index of systolic left ventricular contractility.13 
Exponential regression of the end-diastolic pressure-volume relationship was used to 
determine the stiffness constant kED as a measure of diastolic chamber stiffness.14 
 
Ischemic markers 
We evaluated post-operative troponin T levels at regular intervals up to 48 hours (1, 3, 
6, 12, 24 and 48 hours). Twelve-lead electrocardiographic recordings before and after 
CPB were routinely performed and assessed by the cardiologist for signs of myocardial 
infarction. Peri- and postoperative myocardial ischemia or infarction was defined as 
serum troponin T levels above 1 μg/l, ECG changes suspective for myocardial 
infarction, and new echocardiographic regional left ventricular wall motion 
abnormalities. 
 
Statistical analysis 
The pre- and post-CPB data were compared with paired t-tests and we used a multiple 
linear regression implementation of repeated measures analysis of variance to analyze 
the effects of chronotropic stimulation pre-CPB and post-CPB, respectively.15 Data are 
presented as mean ± SEM. A p-value less than 0.05 was considered statistically 
significant. 
 
 
RESULTS 
 
Ten patients (9 men; age 62±10 years) were enrolled in this study. All patients had 
multi-vessel disease (mean number of affected vessels 2.7±0.5) and four had previous 
myocardial infarction. The mean pre-operative echocardiographic left ventricular 
ejection fraction was 58±9%. Mean CPB-time was 105±36 min (median 103, range 60-
167 min) with a mean aortic cross-clamp time of 75±27 min (median 69, range 43-129 
min). Note that the actual ischemic time is less because approximately 15% of cross-
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clamp time is used for cardioplegic delivery. The mean number of anastomoses was 
4±1; the left internal thoracic artery was anastomosed to the left anterior descending 
artery in all cases and used as a jump-graft to the diagonal artery in 6 cases. The right 
internal thoracic artery was anastomosed to the obtuse marginal artery in three cases, 
while it was used as a free graft off the left internal thoracic artery and anastomosed to 
both obtuse marginal and right descending posterior arteries in 5 cases. In two patients 
venous bypass grafts were used for revascularization of both these vessels. 
Weaning from CPB was uneventful: four patients received low dosages of dobutamine 
post-CPB (≤ 5 μg/kg/min). There were no peri-operative myocardial infarctions. 
Troponin-T concentrations remained below the diagnostic criteria in all patients 48 
hours postoperatively (Figure 1). The hospital stay was uncomplicated in all patients 
except in one patient who developed mediastinitis and stayed in the hospital for 35 days. 
The mean length of hospital stay was 11 days (range 6-35 days, median 8 days). The 
mean length of stay in the intensive care unit was 1.9 days (range 1-3, median 2 days). 
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Figure 1. Postoperative troponin T plasma levels. The concentration of troponin T (TnT) remained below 
the diagnostic criteria for myocardial infarction in all patients in the post-operative period up to 48 hrs. 
Symbols show median values, error bars indicate ranges 
 
Pressure-volume data  
Hemodynamic data from pre- and post-CPB at paced heart rates of 80 (baseline), 100 
and 120 beats/min are summarized in Table 1. Figure 2 shows pressure and volume 
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signals and corresponding pressure-volume loops during preload reduction at paced 
heart rate of 80 beats/min before and after CPB in a typical patient. The effects of 
pacing pre- and post-CPB on the main systolic and diastolic function indices are 
presented in Figure 3. 
 
Table 1. Hemodynamic data obtained at incremental paced heart rate, pre- and post CPB 
  Pre-CPB   Post-CPB  
 pre-80 pre-100 pre-120 post-80 post-100 post-120 
HR (beats/min) 81.5±1.6 101.1±0.6 * 120.0±1.4 * 86.2±3.9 & 102.5±1.3 # 121.2±0.3 # 
CO (l/min) 6.0±0.6 5.9±0.7 6.0±0.7 5.6±0.3 5.9±0.3 6.2±0.3 # 
SV (ml) 73±7 58±6 * 50±5 * 66±3 58±3 # 51±2 # 
EF (%) 45±7 41±6 * 38±6 * 50±8 & 47±8 47±9 
ESV (ml) 123±38 118±37 * 112±36 * 93±27 93±27 87±27 
EDV (ml) 191±41 171±41 * 159±40 * 152±26 149±28 137±28 # 
ESP (mmHg) 80±5 77±6 72±5 * 78±6 76±3 70±5 # 
EDP (mmHg) 10.1±1.2 7.2±0.7 * 9.0±1.1 16.3±2.8 & 14.9±2.7 11.5±1.9 # 
SW (mmHg.ml) 5,584±729 4,630±645 * 3,567±455 * 4,471±383 4,007±367 # 3,312±260 #
dP/dtMAX(mmHg/s) 981±90 1,004±102 1,014±123 991±84 985±64 997±64 
dP/dtMIN (mmHg/s) -937±94 -956±110 -896±88 -923±67 -936±59 -903±70 
τ (ms) 61±3 58±3 57±3 49±2 & 49±3 45±2 # 
EES (mmHg/ml) 1.22±0.53 1.21±0.43 1.43±0.61 1.12±0.28 1.76±0.92 2.60±1.54 # 
kED (ml-1) 0.014±0.005 0.015±0.008 0.045±0.012* 0.040±0.007& 0.023±0.005# 0.026±0.005#
pre-80, pre-100, pre-120: paced heart rate 80 beats/min (respectively 100, 120 beats/min) pre-CPB; 
post-80, post-100, post-120: paced heart rate 80 beats/min (respectively 100, 120 beats/min) post-CPB. 
HR = heart rate, CO = cardiac output, SV = stroke volume, EF = ejection fraction, ESV = end-systolic 
volume, EDV = end-diastolic volume, ESP = end-systolic pressure, EDP = end-diastolic pressure, SW = 
stroke work, dP/dtMAX maximal rate of pressure change during contraction; dP/dtMIN maximal rate of 
pressure change during relaxation; τ = relaxation time constant, EES = end-systolic elastance, kED = 
diastolic chamber stiffness constant. Significances: * : p<0.05 vs pre-80; # p<0.05 vs post-80; & p<0.05 
post-80 vs pre-80 
 
Baseline data. Hemodynamic data at baseline (i.e. at 80 beats/min) pre- and post-CPB 
are included in Table 1 and Figure 3. Cardiac output and stroke volume remained 
unchanged after CPB, while left ventricular ejection fraction improved significantly. 
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End-diastolic volume (EDV) and end-systolic volume (ESV) had a clear tendency to 
decrease post-CPB (EDV: -39 ml; ESV: -30 ml), but these changes did not reach 
statistical significance. Both end-diastolic pressure and diastolic chamber stiffness 
increased significantly after CPB, while the relaxation time constant τ decreased 
significantly. End-systolic elastance (EES) remained unchanged after CPB. 
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Figure 2. Typical LV pressure and volume signals and pressure-volume loops during preload reduction 
by transient vena cava occlusion, pre- and post-CPB, at paced heart rate of 80 beats/min 
 
Effects of pacing. Hemodynamic data pre- and post-CPB at 80, 100, and 120 beats/min 
are given in Table 1 and Figure 3. Note that post-CPB the mean baseline heart rate was 
86±4 beats/min because in some patients sinus rhythm exceeded the target pacing rate 
of 80 beats/min. Cardiac output increased with incremental pacing post-CPB, while pre-
CPB pacing did not affect cardiac output. Stroke volume decreased both before and 
after CPB with pacing, but this decrease was less pronounced after CPB (-24 ml pre-
CPB vs -14 ml post-CPB). The smaller reduction in stroke volume with pacing post-
CPB was the result of a less pronounced reduction in end-diastolic volume (pre-CPB: -
33 ml; post-CPB: -15 ml), since end-systolic volume decreased by 11 ml pre-CPB and 
by 6 ml post-CPB. Apparently, the capability of the ventricle to fill despite a high heart 
rate is relatively improved post-CPB. This is supported by the results for the diastolic 
indices. Active relaxation, τ, improved during pacing post-CPB, while it remained 
unchanged during pacing pre-CPB. Furthermore, the end-diastolic chamber stiffness 
constant increased significantly during pacing pre-CPB, whereas it decreased during 
pacing post-CPB. It should be mentioned that baseline diastolic stiffness (i.e. at 80 
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beats/min) was higher post-CPB as compared to pre-CPB, but with pacing at 120 
beat/min the post-CPB values dropped below the pre-CPB values. 
 
#
CO
(L/min)
&
EF *
(%)
Tau & #
(ms)
#
EES
(mmHg/ml)
* &
k ED # #
(ml-1)
80 100 120 80 100 120
pre-CPB post-CPB
5.0
6.0
7.0
20
40
60
30
50
70
0.0
2.5
5.0
0.00
0.03
0.06
 
Figure 3. Main systolic and diastolic hemodynamic indices pre-and post-CPB at paced heart rates of 80, 
100 and 120 beats/min. Significances: * : p<0.05 vs pre-80; # : p<0.05 vs post-80; & : p<0.05 post-80 vs 
pre-80 
 
During pacing end-diastolic pressure remained constant pre-CPB, which is the result of 
a reduced end-diastolic volume (which should lower end-diastolic pressure) combined 
with an increased diastolic stiffness (which increases end-diastolic pressure). However, 
post-CPB end-diastolic pressure gradually dropped with incremental pacing, since both 
end-diastolic volume and stiffness decreased. With regard to systolic function, pre-CPB 
EF decreased significantly at 120 beats/min, whereas it was unchanged post-CPB. 
dP/dtMAX was unchanged both before and after CPB. Furthermore, no systematic effects 
were seen on EES during pacing pre-CPB, but post-CPB EES increased significantly at 
120 beats/min indicating an improvement in systolic function (Figure 3). 
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DISCUSSION 
 
CABG is increasingly performed in heart failure patients with concomitant surgical 
valvular repair and/or left ventricular restoration. Optimal preservation of myocardial 
function is important to facilitate these surgical procedures. Traditional cold heart and 
cold cardioplegic arrest may have negative effects on post-operative myocardial 
function and currently normothermic procedures are increasingly used as an 
alternative.1 Previous studies indicate that normothermic arrest with warm blood 
cardioplegia provides metabolic benefits and less cell damage, possibly mediated by a 
better protection from from ischemia-reperfusion injury.2,3,9 However, few data are 
available on the acute effects on ventricular function. The aim of our study was 
therefore to quantify the effects of normothermic on-pump CABG and IAWBC on 
systolic and diastolic left ventricular function. In brief, our results show that this 
approach has no negative effects on baseline systolic function, whereas it tended to 
improve the response of systolic function during incremental pacing. With regard to 
diastolic function we found an improved early relaxation, but the end-diastolic stiffness 
was increased at baseline. However, incremental pacing revealed improved relaxation 
and filling characteristics post-CPB, whereas pre-CPB the diastolic indices remained 
constant or worsened during pacing. 
 
Baseline hemodynamic changes 
The baseline hemodynamic results (i.e. comparing pre- vs. post-CPB at 80 beats/min) 
show a slight but significant increase of ejection fraction after CPB, which is due to a 
marked decrease in end-diastolic volume (-39 ml) with a relatively unchanged stroke 
volume. Stroke volume remained largely unchanged due to a similar decrease of end-
systolic volume (-30 ml) after CPB. Note that, except for EF, none of these volumetric 
changes reached statistical significance. The effect on EDV is the result of impairment 
of late passive diastolic function (kED and EDP increased significantly after CPB), 
despite the fact that active relaxation (τ) significantly improved after CPB. The 
improved ejection fraction and the finding of a reduced end-systolic volume with 
maintained end-systolic pressure both point towards an improved systolic function. 
However, the load-independent contractility index EES did not change significantly. 
Therefore, we would conclude that normothermic CPB with IAWBC at least preserves 
systolic function in this patient group. This is in contrast with studies using cold blood 
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cardioplegia during hypothermia in which a reduced systolic left ventricular function 
after CPB was reported.1 
With respect to diastolic function we found a somewhat prolonged τ at baseline pre-
CPB, which has already been shown to be representative for patients with coronary 
artery disease.16,17 In our study τ decreased significantly after CPB with warm blood 
cardioplegia indicating an improved early, active relaxation. This normalization of τ 
after revascularization is consistent with previous studies regardless of the use of cold or 
warm blood cardioplegia and is most likely related to enhancement of the, highly 
oxygen-dependent, calcium re-uptake process by the sarcoplasmic reticulum after 
revascularization, and not due to effects of CPB.18 After CPB increased circulating 
catecholamines resulting from CPB and ischemia may influence active relaxation. 
However, the unchanged systolic pressure and heart rate after CPB indicate that this 
effect is unlikely to be very prominent in our study. In contrast to the improvement in τ, 
the diastolic chamber stiffness constant, which represents passive late diastolic function 
was significantly increased post-CPB. This increased stiffness (thus reduced diastolic 
compliance) is likely due to temporary myocardial edema and increased water content 
after CPB.19,20 This finding is important when interpreting changes in diastolic function 
after surgical interventions such as ventricular restoration and other procedures.21 
Apparently, part of the changes in diastolic function, at least in the acute phase, are 
related to the cardioplegic arrest and CPB, and should not be attributed to the surgical 
procedure per se. 
 
Chronotropic responses 
We found a significant improvement of cardiac output during incremental atrial pacing 
post-CPB, whereas cardiac output remained constant pre-CPB. This effect reflected a 
more pronounced decrease in stroke volume with pacing pre-CPB, compared to post-
CPB. In normal physiology maintained stroke volume (or a limited reduction) during 
increased heart rate is obtained by a combination of increased systolic function 
(Bowditch effect), which reduces or maintains end-systolic volume, and an improved 
relaxation, which limits the reduction in end-diastolic volume resulting from the 
reduced diastolic filling time. Our results indicate that neither of these mechanisms is 
operative in patients with coronary artery disease (CAD) pre-CPB and consequently 
cardiac output did not increase during incremental pacing. Moreover, diastolic stiffness 
substantially increased during pacing which further limited filling. The finding that 
systolic function does not improve or even decreases with increased heart rate in CAD 
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patients is consistent with previous studies.22 A recent echocardiographic study in 
patients undergoing CABG indicates an increased diastolic stiffness during pacing very 
similar to our findings.23 Numerous studies have documented increased diastolic 
pressure, increased stiffness and upward shifts of the diastolic pressure-volume relation 
with pacing angina, however our study shows that more subtle increases in diastolic 
stiffness are obtained with a relatively small increase in heart rate in CAD patients with 
relatively preserved EF.24 
After CPB, diastolic chamber stiffness, end-diastolic pressure and τ all significantly 
decreased during pacing which may explain the improvement of cardiac output at higher 
heart rates. In addition, EES gradually increased with incremental pacing post-CPB, 
whereas it remained constant pre-CPB, indicating that improvement in systolic function 
contributed to the increase in cardiac output. 
The effects of pacing pre- vs. post-CPB in our study largely mimic the effects of 
exercise before and after revascularization surgery as described in a study by Caroll et 
al.25 After surgery, but not before, both pacing and exercise induced improvements in 
systolic and diastolic function, which enable the required increase in cardiac output. 
However, during exercise end-diastolic pressure and volume increased whereas during 
pacing in our study these indices decreased. These differences are presumably due to 
recruitment of blood volume during exercise leading to increased preload, which does 
not occur during pacing. 
The impaired chronotropic responses pre-CPB as found in our study are presumably due 
to coronary artery disease and the normalization of these responses post-CPB due to 
effects of successful revascularization and subsequent relief of ischemia. 
 
Limitations 
We did not include a control group with a cold cardioplegic approach. However, this 
approach is well documented in the literature and we compared our results against those 
reports. Furthermore, our study was performed in patients with relatively normal LV 
function, whereas the advantages of IAWBC are presumably most important for 
patients with poor LV function. However, in heart failure patients the effects of IAWBC 
would be difficult to assess separately because the surgical interventions (CABG and 
additional procedures like mitral annuloplasty and/or surgical restoration) may 
importantly affect post-operative LV function. 
In conclusion, this study shows that intermittent antegrade warm blood cardioplegia 
during normothermic cardiopulmonary bypass provides excellent myocardial protection 
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of systolic properties, whereas improved diastolic and systolic left ventricular 
chronotropic responses were found acutely after surgery. This cardioprotective stategy 
may be particularly advantageous in patients with heart failure who undergo complex 
surgical procedures with long procedure times. 
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ABSTRACT 
 
Objective. Recent studies show beneficial long-term effects of restrictive mitral 
annuloplasty (RMA) in patients with end-stage heart failure (HF). However, concerns 
are raised about possible adverse effects on early post-operative systolic and diastolic 
function, which may limit application of this approach in HF patients. Therefore, we 
evaluated acute effects of RMA on left ventricular (LV) function by load-independent 
pressure-volume relations. 
Methods. In 23 patients (HF n=10; control n=13) we determined LV systolic and 
diastolic function before and after surgery by pressure-volume analysis using the 
conductance catheter. All HF patients underwent stringent RMA (two sizes under), and 
4 received additional CABG. Transesophageal echocardiography was used for 
evaluation of valve repair. Patients with preserved LV function who underwent isolated 
CABG served as controls. 
Results. RMA (ring size 25±1) restored leaflet coaptation (8.0±0.2mm) with normal 
pressure gradients (2.9±1.8mmHg). RMA did not change cardiac output (5.0±1.8 to 
5.3±0.9L/min, NS), LV ejection fraction (29±5 to 32±8%, NS) or end-systolic elastance 
(0.86±0.50 to 0.99±1.05mmHg/mL, NS). After RMA, end-diastolic volume tended to 
decrease (237±89 to 226±52mL, NS), while end-diastolic pressure remained unchanged 
(14±6 to 15±5mmHg, NS). Diastolic chamber stiffness tended to increase (0.027±0.035 
to 0.041±0.047mL-1, NS), however not significantly. Peak LV wall stress was 
unchanged (356±91 to 346±85 mmHg, NS). Baseline values in the control group were 
different, but changes in most parameters after surgery showed similar non-significant 
trends. 
Conclusion. Mitral valve repair by RMA effectively restores mitral valve competence 
without inducing significant acute changes in LV systolic or diastolic function in 
patients with end-stage heart failure. 
 
 
INTRODUCTION 
 
Chronic mitral regurgitation is a serious complication in patients with end-stage heart 
failure. Patients with mitral regurgitation have a significantly decreased survival at 2 
years follow-up versus patients without mitral regurgitation.1 
The mechanism of mitral regurgitation in end-stage heart failure is multifactorial. 
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Briefly, it is related to changes in left ventricular (LV) geometry with a subsequent 
displacement of the subvalvular apparatus, annular dilatation2 and restrictive leaflet 
motion (class IIIb according to Carpentier's classification3), which results in coaptation 
failure.4,5 From a physiological point of view, mitral regurgitation in these patients will 
lead to LV overload and reduction of forward stroke volume. This occurs initially in 
response to exercise and subsequently at rest, which in turn activates systemic and local 
neurohormonal systems and cytokines that worsen cardiac loading conditions and 
promote LV remodeling and dysfunction.6 This may create a vicious circle wherein 
regurgitation begets more regurgitation. 
Previous studies have shown that interrupting this vicious cycle by mitral valve repair is 
safe, and improves clinical outcome.7 Several groups advocate the use of a stringent 
restrictive ring, two sizes under, to achieve better leaflet coaptation and possibly prevent 
recurrence of mitral regurgitation and promote reverse remodeling.8 Mid-term results 
(18 months follow-up) with this approach indicate reverse remodeling in 58% of 
patients.9 However, the acute effects of restrictive mitral annuloplasty (RMA) on LV 
systolic and diastolic function in patients with end-stage heart failure are unknown. 
There are concerns that correction of mitral regurgitation may decrease LV systolic 
function in the acute phase due to afterload increase caused by closure of a low 
resistance runoff into the left atrium. In addition, it has been suggested that undersizing 
the mitral annulus may affect LV contractility due to increased mechanical tension on 
the base of heart.10 With regard to diastolic function RMA might impair filling. In 
contrast, Bolling hypothesized that undersizing the mitral annulus will lead to acute 
beneficial geometric changes of the base of the left ventricle, which may reduce LV 
volume and wall stress.11 The purpose of this study was therefore to quantify the acute 
effects of RMA on global and intrinsic LV systolic and diastolic function in these 
patients. 
 
 
METHODS 
 
A total of 23 patients were studied in the operating room before and after 
cardiopulmonary bypass (CPB) by pressure-volume analysis using the conductance 
catheter method. We included 10 patients with end-stage heart failure (HF) with co-
existent severe mitral regurgitation who underwent mitral valve repair by stringent 
restrictive annuloplasty and 13 control patients with preserved LV function who 
Chapter 5 
 82
underwent elective CABG. The control group was used to distinguish effects of mitral 
annuloplasty from effects of CPB and cardioplegic cardiac arrest, per se. In both groups 
surgery was performed during normothermic CPB with intermittent antegrade warm 
blood cardioplegia. The study protocol was approved by the institutional review board 
and all patients provided informed written consent. 
 
Patient selection and echocardiographic criteria 
The patients in the RMA group fulfilled the following criteria: 
1) NYHA class III or IV 
2) LVEF < 30% 
3) Mitral regurgitation grade ≥ 2 assessed by transesophageal echocardiography 
(TEE) preoperatively (without general anesthesia to avoid underestimation of the 
severity of the mitral regurgitation). The severity of mitral regurgitation was graded 
semi-quantitatively from color-flow Doppler and characterized as: mild, 1+ (jet area/left 
atrial area <10%); moderate, 2+ (jet area/left atrial area 10% to 20%); moderately 
severe, 3+ (jet area/left atrial area 20% to 45%); and severe, 4+ (jet area/left atrial area 
>45%).12 In patients with mitral regurgitation grade 2 an intra-operative dynamic 
loading test was performed as described by Dion et al.5 If this test was positive, that is if 
it resulted in a definite worsening of the severity of mitral regurgitation, restrictive 
mitral annuloplasty was performed. 
4) The mechanism of mitral regurgitation was based on malcoaptation due to 
systolic restrictive motion of the mitral leaflets. 
5) Maximal medical therapy for heart failure including diuretics, afterload 
reduction and beta-blocking agents. 
Patients with primary mitral valve dysfunction (mitral valve prolapse, rheumatic valve 
disease, mitral valve stenosis) were excluded from the study. Also patients with a 
previously implanted biological or mechanical prosthesis in aortic position were not 
included in this study. 
The control group was recruited from patients with preserved LV function (LVEF > 
40%) who underwent elective CABG for multivessel coronary artery disease and who 
needed no additional valvular surgery. The patient characteristics of both groups are 
summarized in Table 1. 
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Table 1. Patient characteristics 
 RMA Control 
No. of patients 10 13 
Male/ Female 5/5 11/2 
Age (years) 56±18 63±8 
NYHA 3.6±0.5 - 
LVEF (%) 25±5 58±9 
Mitral Regurgitation (grade) 3.3±0.5 - 
 
 
Anesthesia 
All patients received total intravenous anesthesia with target-controlled infusion of 
propofol, remifentanil and sufentanil. Hypnotic state was monitored with a Bispectral 
Index (BIS) monitor (Aspect medical systems, Newton, MA). A single dose of 
pancuronium bromide (0.1mg/kg) was given to facilitate intubation. During surgery the 
propofol concentration was adjusted between 1.5μg/ml and 2.0μg/ml to maintain a BIS 
value below 60. Remifentanil was titrated between 5 and 10ng/ml in response to the 
patient's hemodynamic reaction on surgical stimuli. Sufentanil was started at a targeted 
concentration of 0.1ng/ml after start of surgery to allow smooth transition of the patient 
analgesic state from the operating room to the ICU. The patients were ventilated with an 
oxygen/air mixture (FiO2=40%) at a ventilatory rate of 12-15/min and ventilatory 
volume was adjusted to maintain normal PaCO2. A thermal filament catheter was placed 
in the pulmonary artery via the right internal jugular vein for semi-continuous 
thermodilution cardiac output measurements (Edwards Lifesciences, Uden, The 
Netherlands). To facilitate positioning of the conductance catheter and to evaluate the 
effects of mitral valve repair a multiplane TEE probe was inserted. We anticipated that 
the heart failure patient would need inotropic support after surgery. Since this would 
bias our LV function measurements, we started inotropic support directly after 
induction of anesthesia with a low loading dose of 0.25mg/kg enoximone in ten minutes 
and thereafter we gave continuous infusion at a rate of 0.50μg/kg/min, which was 
maintained during the whole operation. 
 
Surgical techniques 
After median sternotomy and, if indicated, harvesting of bypass material, the 
pericardium was opened and normothermic cardiopulmonary bypass was instituted with 
intermittent antegrade warm blood cardioplegic arrest.13 After completion of the 
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anastomosis, a stringent restrictive mitral annuloplasty was performed via a transseptal 
approach using a Carpentier Edwards Physio-ring (Edwards Lifesciences, USA).14 The 
ring size was determined by measuring the size of the anterior mitral leaflet and a ring 
two sizes smaller than the measured size was implanted. After weaning from CPB, TEE 
evaluation was immediately performed in all patients to assess residual mitral 
regurgitation, transmitral diastolic pressure gradient (determined from continuous-wave 
Doppler) and the length of coaptation of the leaflets. 
 
Study protocol  
Before and directly after CPB, conductance catheter measurements were performed as 
described previously.15 Briefly, temporary epicardial pacemaker wires were placed on 
the right atrium to enable pre-CPB and post-CPB measurements at fixed equal heart 
rates. A tourniquet was placed around the inferior vena cava to enable temporary 
preload reductions. An 8F sheath was placed in the ascending aorta for introduction of 
the conductance catheter. The conductance catheter was introduced under TEE guidance 
and placed along the long axis of the LV. Position was optimized by inspection of the 
segmental volume signals. Conductance catheter calibration was performed before and 
after CPB using calibration factors alpha (α) derived from thermodilution and parallel 
conductance correction volume (VC) determined by the hypertonic saline method.16 At 
each stage we performed at least two injections of 7 mL 10% saline into the pulmonary 
artery via the distal port of the thermodilution catheter. Continuous LV pressure and 
volume signals derived from the conductance catheter were displayed and acquired at a 
250 Hz sampling rate using a Leycom CFL-512 (CD Leycom, Zoetermeer, The 
Netherlands). Data were acquired during steady state and during temporary caval vein 
occlusion, all with the ventilator turned off at end-expiration. Acquisition was 
performed at a fixed atrial pacing rate of 80 beats/min. From these signals 
hemodynamic indices were derived as described below. 
 
Pressure-volume analysis 
Global LV function: Parameters of global systolic and diastolic function (heart rate 
(HR), cardiac output (CO), stroke volume (SV), stroke work (SW), pressure-volume 
area (PVA), LV ejection fraction (LVEF), dP/dtMAX, dP/dtMIN, end-diastolic volume 
(EDV), end-systolic volume (ESV), end-diastolic pressure (EDP), end-systolic pressure 
(ESP), relaxation constant (Tau) were calculated from steady state beats using custom-
made software. Mechanical dyssynchrony (DYSS) and internal flow fraction (IFF) was 
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calculated as previously described.17 Effective arterial elastance (Ea), a measure of 
afterload, was calculated as ESP/SV. Time-varying wall stress, WS(t), was calculated 
from the LV pressure and volume signals (P(t), V(t)) as described by Arts et al.: WS(t)= 
P(t)·[1+3·V(t)/VWALL]. LV wall volume (VWALL) was estimated based on the diastolic 
posterior wall thickness derived from M-mode echocardiography.18 The gradient across 
the LV outflow tract was calculated as the difference between peak LV pressure and 
peak aortic pressure. 
 
Systolic and diastolic LV pressure-volume relations: Systolic function was 
characterized by the slope of the end-systolic pressure-volume relationship (End-
systolic elastance, EES), the slope of the relation between the dP/dtMAX and EDV (S-dP), 
and the slope of the preload recruitable stroke work relation (S-PRSW). The position of 
the ESPVR was quantified by calculating the ESV-intercept at a fixed end-systolic 
pressure (ESVIND). The positions of the dP/dtMAX - EDV relation and the PRSW relation 
were determined by calculating the intercepts at a fixed end-diastolic volume, dP/dtMAX, 
IND and SWIND, respectively. As previously described, the fixed end-systolic pressure 
and end-diastolic volume levels were set retrospectively as the mean ESP and EDV in 
each group.17 Diastolic chamber stiffness (Ked) was quantified by exponential regression 
of the end-diastolic pressure-volume relationship.19,20 
 
Statistical analysis 
Pre- and post-CPB data were compared with paired t-tests. Statistical significance was 
assumed at p<0.05. All data are presented as the mean±SD. 
 
 
RESULTS 
 
All HF patients were successfully weaned from CPB after successful mitral valve 
repair. In six patients the origin of HF was ischemic, in four non-ischemic. In four 
ischemic patients additional CABG was performed; the other 2 patients had irreversible 
ischemia and did not receive CABG. In three patients with severe tricuspid 
regurgitation, a concomitant restrictive tricuspid ring annuloplasty (ring size 26) was 
performed. Six (60%) patients needed inotropic support more than 24 hours 
postoperatively. However, none of the patients required intra-aortic balloon pump 
support. The median stay in the intensive care unit in this group was 4 days (range 2 to 
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7 days) with a median total hospital stay of 14 days (range 7 to 18 days). All patients 
could be discharged in good clinical condition from the hospital. The surgical details of 
both groups are summarized in Table 2. 
 
Table 2. Surgical data 
 RMA (n=10) Control (n=13) 
CPB- time (median, minutes) 137 (range 105-287) 104 (range 60-167) 
Aox-time (median, minutes) 96 (range 65-196) 75 (range 43-129) 
Pre-MR 
- AM-size (mm) 
- AML-size (mm) 
- AM/AML ratio 
3.3±0.5 
4.1±0.4 
2.9±0.3 
1.4±0.2 
- 
- 
- 
- 
Ring-size 25±1 - 
CABG No. pts 
Anastomosis 
4 
3.8±1.0 
13 
3.7±0.9 
Length of coaptation 0.8±0.2 - 
Transmitral gradient (mmHg) 2.9±1.8 - 
ICU-duration (median, days) 4 (range 2-7) 2 (range 1-4) 
Hospital stay (median, days) 14 (range 7-18) 9 (range 6-35) 
RMA: restrictive mitral annuloplasty, CPB: cardiopulmonary bypass, Aox: aortic cross clamping time, 
MR: mitral regurgitation, AM: mitral annulus, AML: anterior mitral leaflet 
 
Echocardiography 
Mitral regurgitation quantified before the operation was due to annular dilation and 
systolic restrictive motion of the mitral leaflets, and ≥ grade 3 in all patients. After 
weaning from CPB intra-operative TEE showed a mean length of coaptation of 8±2mm 
without residual mitral regurgitation (Table 2, Figure 1). The mean transmitral diastolic 
pressure gradient was 2.9±1.8mmHg (range 1.2 to 7.5mmHg). None of the patients 
showed systolic anterior movement of the anterior leaflet. 
 
Hemodynamic indices in RMA and control patients (Table 3) 
Cardiac output and LV ejection fraction remained unchanged after RMA. End-systolic 
and end-diastolic volume tended to decrease, but these changes did not reach statistical 
significance. The active relaxation (Tau) was significantly improved, from 73±18 to 
63±15ms (p=0.047). End-diastolic pressure did not increase significantly, and dP/dtMAX, 
dP/dtMIN and stroke work were also unchanged. Effective arterial elastance (Ea, a 
measure of afterload) was unchanged after RMA. After ring insertion the pressure 
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gradient across the LV outflow tract was unchanged (from 2.1±3.3 to 2.8±3.3mmHg; 
p=0.662). Mechanical dyssynchrony showed a clear tendency to decrease after RMA, 
but the changes did not reach statistical significance (p=0.084). 
 
   
 
Figure 1. Transesophageal echocardiographic long-axis view before and after restrictive mitral 
annuloplasty in a 41 year-old patient with ischemic dilated cardiomyopathy (LVEF: 20%) and severe 
mitral regurgitation (grade 4). Mitral annular dilatation was demonstrated as the relative ratio between 
the diastolic mitral annular diameter (5.2mm) and the diastolic length of the anterior mitral leaflet 
(3.6mm) exceeded 1.3 (1.44). Restrictive mitral annuloplasty (Edwards Physio-ring size 26) was 
performed and postoperative mitral leaflet coaptation was 12mm with a normal inflow pressure gradient 
(3.5mmHg) and no residual mitral regurgitation. Additional restrictive tricuspidal ring annuloplasty was 
performed for severe tricuspidal regurgitation (grade 3) 
 
The mechanical efficiency, calculated as SW/PVA, was unchanged after RMA. 
Similarly, peak LV wall stress (PWS: 356±91 to 346±85mmHg, p=0.668) and end-
diastolic wall stress (WSED: 64±30 to 68±17mmHg, p=0.639) were unchanged. 
Although baseline values of most parameters in the control patients were substantially 
different from those in the RMA patients (consistent with the depressed LV function in 
the RMA patients), the changes after surgery were very similar. Like in the RMA 
patients, most parameters were unchanged except Tau, which was significantly 
improved in both groups, but the change in Tau was approximately the same in both 
groups (-10.1±5.0ms in the RMA patients, and -11.1±5.4ms in the control group, 
p=0.829). As a difference, LV ejection fraction was significantly improved in the 
control patients (46±15% to 52±18%, p=0.025), whereas the increase in the RMA 
patients did not reach statistical significance (29±5% to 32±8%, p=0.315). 
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Table 3. Hemodynamic data pre- and post surgery in RMA and control (CABG) patients 
 RMA (n=10) Control (n=13) 
 Pre Post p Pre Post p 
HR (beats/min) 85±7 88±13 0.491 82±3 86±8 0.113 
CO (L/min) 5.0±1.8 5.3±0.9 0.516 4.9±1.2 5.9±1.4 0.193 
SV (mL) 68±25 69±10 0.905 59±15 69±19 0.350 
LVEF (%) 29±5 32±8 0.315 46±15 52±18 0.025 
EDV (mL) 237±89 226±52 0.564 142±52 146±45 0.720 
ESV (mL) 171±67 163±51 0.459 86±49 82±47 0.190 
ESP (mmHg) 78±8 79±14 0.706 74±13 79±14 0.517 
EDP (mmHg) 14±6 15±5 0.356 8±2 14±5 0.001 
dP/dtMAX (mmHg/s) 713±154 775±197 0.444 992±282 970±137 0.701 
dP/dtMIN (mmHg/s) -754±105 -802±161 0.351 -880±208 -954±185 0.474 
SW (mmHg.mL) 4,299±1,335 4,162±1,258 0.703 4,400±1,605 5,004±1,827 0.714 
PVA (mmHg.mL) 9,422±3,460 9,072±2,924 0.808 5,873±2,079 6,376±2,517 0.761 
SW/PVA 0.50±0.17 0.49±0.15 0.826 0.75±0.06 0.80±0.10 0.306 
Tau (ms) 73±18 63±15 0.047 62±6 51±5 <0.001 
EA (mmHg/mL) 1.39±0.60 1.29±0.36 0.546 1.27±0.20 1.22±0.38 0.984 
DYSS (%) 23.6±4.3 18.5±6.7 0.084 17.8±4.1 17.1±2.7 0.217 
IFF (%) 31.7±15.4 24.6±20.2 0.459 19.4±8.6 17.2±6.3 0.127 
EES (mmHg/mL) 0.86±0.50 0.99±1.05 0.688 1.31±0.93 1.26±0.72 0.836 
ESVIND (mL) 169±81 161±68 0.572 82±50 69±37 0.048 
S-dP (mmHg/s/mL) 6.6±5.4 7.2±8.9 0.858 8.5±5.4 7.4±4.2 0.583 
dP/dtMAX,,IND(mmHg/s) 734±633 771±264 0.832 1,160±625 1,129±467 0.313 
S-PRSW (mmHg) 64±54 60±41 0.855 65±30 55±20 0.594 
SWIND (mmHg.mL) 4,693±3,140 5,093±3,702 0.725 5,678±3,532 5,473±2,544 0.985 
PWS (mmHg) 356±91 346±85 0.668 - - - 
WSED (mmHg) 64±30 68±17 0.639 - - - 
KED (mL-1) 0.027±0.035 0.041±0.047 0.542 0.021±0.014 0.038±0.019 0.015 
HR: heart rate, CO: cardiac output, SV: stroke volume, LVEF: left ventricular ejection fraction, EDV: 
end-diastolic volume, ESV: end-systolic volume, ESP: end-systolic pressure, EDP: end-diastolic 
pressure, SW: stroke work, PVA: pressure-volume area, Tau: relaxation time constant, EA: effective 
arterial elastance, DYSS: mechanical dyssynchrony, IFF: internal flow fraction, EES: end-systolic 
elastance, ESVIND: intercept of ESPVR at mean ESP, S-dP: slope of dP/dtMAX–EDV relation, dP/dtMAX, IND 
, intercept of dP/dtMAX–EDV relation at mean EDV, S-PRSW: slope of the PRSW relation, SWIND, 
intercept of PRSW relation at mean EDV, PWS: peak wall stress, WSED: end-diastolic wall stress, KED: 
diastolic chamber stiffness constant 
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Pressure-volume relations (Figure 2) 
Because steady state hemodynamic indices, as reported in the previous section, are load-
dependent we also assessed systolic and diastolic function by pressure-volume relations. 
The slopes of these relations are sensitive and load-independent measures of LV 
function. Pressure-volume relations were determined from data acquired during 
temporary preload reduction obtained by vena cava occlusion. The mean reduction in 
EDV was 33±13mL in the control group and 39±16mL in the RMA group. In both the 
RMA and control groups the slopes of the systolic relations (EES, S-dP, S-PRSW) did 
not show significant changes after surgery. Baseline values confirmed depressed LV 
function in the RMA group. With regard to diastolic function, the diastolic chamber 
stiffness constant (KED) increased in both groups (control: 0.021±0.014 to 
0.038±0.014mL-1, p=0.015; RMA: 0.027±0.035 to 0.041±0.047mL-1, p=0.542), but the 
increase did not reach statistical significance in the RMA group. 
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Figure 2. Pressure-volume relations before and after RMA in a patient with end-stage heart failure. In 
this patient the end-diastolic pressure-volume relation (EDPVR) demonstrates an increased diastolic 
stiffness. This was also found in the group as a whole, but the effect was not statistically significant. The 
slope (EES) of the end-systolic pressure-volume relation (ESPVR) in this patient decreased slightly. On the 
average, there was a small increase in EES in the RMA patients, but this change did not reach was not 
statistical significance 
 
 
DISCUSSION 
 
Mitral valve regurgitation is an important pathology in end-stage heart failure 
characterized by annular dilatation and restrictive leaflet motion.21 Morbidity and 
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mortality is high if mitral regurgitation is treated conservatively.22 Grigioni et al. clearly 
demonstrated that the severity of mitral regurgitation is directly related to mortality 
risk.1 
Therefore, it seems reasonable to correct mitral regurgitation in patients with end-stage 
heart failure to improve prognosis. Currently, mitral annuloplasty is not routinely 
performed in these patients because substantial mortality and high recurrence rates are 
reported, and no evidence from randomized studies is available.7,23 However, several 
recent studies have shown relatively low operative mortality and suggest improved 
long-term survival after stringent restrictive mitral annuloplasty.9,11,24 Unfortunately, 
insights in the acute effects of RMA on systolic and diastolic LV performance are still 
limited and concerns are raised about possible adverse acute effects on systolic and 
diastolic LV function, which would limit application of this approach in patients with 
end-stage heart failure. The aim of our study was therefore to quantify these effects by 
use of load-independent pressure-volume indices. 
We found unchanged systolic function after RMA. This is interesting, because earlier 
studies had predicted adverse effects, which would be the result of an afterload 
mismatch created by closure of a low-resistance run off into the left atrium. However, 
this "pop-off" effect may not exist and the high mortality in earlier studies appears 
mainly related to loss of LV function by disruption of the sub-valvular apparatus, 
because in that time, valve replacement (rather than repair) was mostly performed.25 
Effect on systolic function may also result from acute remodeling of the base of the 
heart due to the undersized ring. Bolling et al. argue that this would improve systolic 
function, however a study by David et al. implies a negative effect on systolic function 
because an undersized ring presumably impairs stretching and shortening of the 
proximal part of the basoconstrictor muscles (similar to a rigid ring).26,27 In our study, 
we did not find any evidence for an altered, either reduced or improved, systolic 
function. In addition, systolic anterior motion of the anterior leaflet leading to LV 
outflow tract obstruction was not found in our series. 
With regard to diastolic function we found an increase in diastolic chamber stiffness. 
This effect was present in both groups, but it was only statistically significant in the 
control patients. This increase in diastolic chamber stiffness is probably mainly an effect 
of cardioplegic arrest, leading to interstitial myocardial edema.28 LV wall stress was 
unchanged after RMA consistent with largely unchanged end-diastolic volume and 
pressure. 
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The number of studies, in which effects of RMA on LV performance are evaluated, is 
limited. Several studies show improved LV ejection fraction and reduced end-diastolic 
volume.8,11,24,29 Bishay et al. reported improved LV function and reversed remodeling at 
two years follow up in patients with severe LV dysfunction.30 However, this group was 
heterogeneous and the patients underwent either mitral annuloplasty with various 
techniques or mitral valve replacement. Bax et al. studied patients who strictly 
underwent restrictive mitral annuloplasty, and showed that reverse remodeling of the 
LV is a gradual and time-dependent process.9 These results are consistent with our 
findings, which show no acute effects on LV performance after RMA. Interestingly, our 
results show a clear tendency for a reduced mechanical dyssynchrony after RMA. This 
index has recently been shown a very sensitive marker of LV dysfunction and 
potentially this improvement may contribute to beneficial long-term effects.17 
 
Limitations 
The sample size in our study was relatively small and potentially positive effects on 
systolic function may be demonstrated in a larger group of patients. However, we 
performed pre- and post-CPB measurements in each patient, which optimizes the 
statistical power to detect possible effects of the surgical intervention. In addition, the 
RMA group was heterogeneous since in four patients additional CABG was performed. 
This subgroup was too small for meaningful statistical analysis, but the effects on 
pressure-volume relations in these patients did not appear to be different compared to 
the effects in the whole group. Furthermore, beneficial effects on LV systolic function 
in these patients would not be expected early after surgery as effects of 
revascularization on hibernating myocardium often occur later after surgery.31 
Measurements of global LV function were performed immediately after surgery with 
open chest and during inotropic support. The confounding effects of inotropic support 
were limited by also performing the measurements before surgery under inotropic 
support, but possible altered β-receptor sensitivity cannot be excluded. Assessment of 
regional function and of long-term effects under physiological conditions requires 
further studies. 
 
In conclusion, mitral valve repair by RMA effectively restores mitral valve leaflet 
coaptation in patients with end-stage heart failure and severe mitral regurgitation, 
without significant acute changes in baseline hemodynamics and LV systolic and 
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diastolic function. Our findings support the use of this approach even in patients with 
severely depressed LV function in view of the expected beneficial long-term results. 
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ABSTRACT 
 
Objectives. Surgical ventricular restoration (SVR) aims at improving cardiac function 
by normalization of left ventricular (LV) shape and size. Recent studies indicate that 
SVR is highly effective with an excellent five-year outcome in patients with ischemic 
dilated cardiomyopathy. We used pressure-volume analysis to investigate acute changes 
in systolic and diastolic LV function, mechanical dyssynchrony and efficiency, and wall 
stress. 
Methods. In three patient groups (total, n=33), pressure-volume loops were measured 
by conductance catheter before and after surgery. The main study group consisted of 10 
patients with ischemic dilated cardiomyopathy (NYHA III/IV, LV ejection fraction 
<30%) who underwent SVR and CABG. In this group, 7 patients underwent additional 
restrictive mitral annuloplasty (RMA). To assess potential confounding effects of RMA 
and cardiopulmonary bypass, we included a group of 10 patients (NYHA III/IV, LV 
ejection fraction <30%) who underwent isolated RMA and a group of 13 patients with 
preserved LV function who underwent isolated CABG. 
Results. After SVR, end-diastolic and end-systolic volumes were reduced: 211±54 to 
169±34 mL (p=0.03), and 147±41 to 110±59 mL (p=0.04), respectively. LV ejection 
fraction (27±7 to 37±13%, p=0.04) and end-systolic elastance (1.12±0.71 to 1.57±0.63 
mmHg/mL, p=0.03) improved. Peak wall stress (358±108 to 244±79 mmHg, p<0.01) 
and mechanical dyssynchrony (26±4 to 19±6%, p<0.01) were reduced, whereas 
mechanical efficiency improved (0.34±13 to 0.49±0.14, p=0.03). End-diastolic pressure 
increased (13±6 to 20±5 mmHg, p<0.01), whereas the diastolic chamber stiffness 
constant tended to be increased (0.021±0.009 to 0.037±0.021 mL-1, NS). 
Conclusions. SVR achieves normalization of LV volumes and improves systolic 
function and mechanical efficiency by reducing LV wall stress and mechanical 
dyssynchrony. 
 
 
INTRODUCTION 
 
Surgical ventricular restoration (SVR) by means of endoventricular circular patch plasty 
(Dor procedure) is beneficial in patients with left ventricular (LV) post-infarction 
aneurysm. Previous studies have shown that this procedure is safe, improves functional 
class, long-term survival, and LV ejection fraction.1,2 The exclusion of akinetic or 
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dyskinetic segments achieves acute volume reduction, changes in LV shape, and 
decreases of LV dyssynchrony.3,4 These acute changes will influence LV global and 
intrinsic systolic and diastolic function. The use of pressure-volume analysis to assess 
these effects is advantageous because pressure-volume relations accurately reflect 
intrinsic LV function, and are relatively independent of loading conditions.5,6 Moreover, 
pressure-volume signals can be used to quantify mechanical dyssynchrony and LV wall 
stress.7 
Theoretical studies predict that volume reduction surgery results in leftward and upward 
shifts of the end-systolic and end-diastolic pressure-volume relations in the pressure-
volume diagram, indicating a positive effect on systolic function but an adverse effect 
on diastolic function.8,9 However, these effects are likely to be modulated by the 
material properties and the size of the resected or excluded region. Artrip et al. 
quantified the differential effects of volume reduction on end-systolic and end-diastolic 
function in a mathematical model.10 Their findings indicate that an overall negative 
effect on LV pump function results if weak but contracting myocardium is resected (like 
in the Batista procedure), beneficial effects if the excised region is dyskinetic, and 
equivocal effects with akinetic scar resection. However, whether these models are 
realistic is unknown since in-vivo data on the effects of SVR and related procedures on 
LV pressure-volume relations in humans are very limited. One important aspect, which 
is not taken into account by these particular models, is (alterations in) mechanical 
dyssynchrony. Recent studies demonstrated that LV mechanical synchrony substantially 
improves after SVR resulting in more efficient myocardial pump function.3,4 
Furthermore, a recent Special Report from the RESTORE group emphasized the 
importance of considering interaction and (re)arrangement of myocardial layers and 
fiber orientation, and stressed the need for additional studies to quantify the effects of 
SVR and to get a better insight in the underlying mechanisms.11 
As SVR reversely remodels ventricular size and shape, this approach may alter systolic 
and diastolic function.11,12 Additionally, SVR may decrease LV wall stress and 
myocardial oxygen consumption by reducing end-diastolic volume, resulting in 
improved functioning of the remote myocardium.13 The aim of this study was to 
determine the acute effects of SVR on systolic and diastolic pressure-volume 
relationships, LV wall stress, and mechanical dyssynchrony and efficiency in patients 
with ischemic dilated cardiomyopathy. 
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METHODS 
 
Patients 
The main study group consisted of 10 patients with ischemic dilated cardiomyopathy 
who underwent SVR. SVR is often combined with restrictive mitral annuloplasty 
(RMA) and therefore we also included a group of patients with left ventricular 
dysfunction in which isolated RMA was performed. To assess confounding effects of 
cardiopulmonary bypass and cardioplegic cardiac arrest we also included a control 
group of patients with normal LV function who underwent elective coronary artery 
bypass grafting (CABG). Thus, the following groups were studied: 
1) SVR-group (n=10): Chronic heart failure, New York Heart Association (NYHA) 
class III/IV, LV ejection fraction < 30%, LV aneurysm with or without mitral 
regurgitation 
2) RMA-group (n=10): Chronic heart failure, NYHA class III/IV, LV ejection 
fraction < 30%, mitral regurgitation grade ≥ 2 
3) CABG-group (n=13): normal LV function (LV ejection fraction > 40%), 
elective CABG 
Note that some patients in the SVR-group underwent additional RMA, whereas in both 
the SVR- and the RMA-group, CABG was performed if indicated. Details are provided 
in the Results section. The study was approved by the institutional review committee 
and all patients gave informed consent. The patient characteristics of the three groups 
are summarized in Table 1. 
 
Anaesthesia and cardioplegic arrest 
All patients received total intravenous anesthesia with target-controlled infusion of 
propofol, remifentanyl and sufentanyl. A single dose of pancuronium bromide 
(0.1mg/kg) was given to facilitate intubation. Subsequently, a thermal filament catheter 
was placed in the pulmonary artery via the right internal jugular vein for semi-
continuous cardiac output measurements (Edwards Lifesciences, Uden, The 
Netherlands). To facilitate positioning of the conductance catheter and to evaluate the 
effects of mitral valve repair, a multiplane transesophageal echo probe was inserted. All 
patients underwent normothermic cardiopulmonary bypass and received intermittent 
antegrade warm blood cardioplegia as described by Calafiore et al.14  
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Table 1. Patient characteristics 
 SVR-group RMA-group CABG-group 
# Patients (n) 10 10 13 
Male/Female  (n) 8/2 5/5 11/2 
Age (years) 63±7 56±18 63±8 
QRS duration (ms) 122±38 105±27 91±13 
LVEF (%) 26±9 25±5 58±9 
Coronary disease 
  2 Vessels 
  3 Vessels 
 
4 
6 
 
4 
2 
 
5 
8 
MR-grade 
  I 
  II 
  III 
  IV 
 
3 
3 
4 
0 
 
0 
0 
7 
3 
 
- 
- 
- 
- 
SVR indicates Surgical ventricular restoration; RMA, Restrictive mitral annuloplasty; LVEF, left 
ventricular ejection fraction; MR-grade, grade of mitral regurgitation assessed by pre-operative 
transesophageal echocardiography 
 
We anticipated that the heart failure patient would need inotropic support after surgery. 
Since this would bias our LV function measurements, we started inotropic support 
directly after induction with a low loading dose of 0.25 mg/kg enoximone in 10 minutes 
and thereafter we gave continuous infusion at a rate of 0.50 μg/kg/min, which was 
maintained during the whole operation. 
 
Surgical techniques  
Dor plasty. SVR was performed by means of endoventricular circular patch plasty as 
previously described by Dor.15,16 Briefly, the LV was opened through the infarcted area. 
An endocardial encircling suture (Fontan stitch) was placed at the transitional zone 
between scarred and normal tissue. A balloon containing 55 mL/m2 saline was 
introduced into the LV and the Fontan stitch was tightened to approximate the 
ventricular wall to the balloon. An oval dacron patch was tailored and used to close the 
residual orifice. The excluded scar tissue was closed over the patch to ensure 
hemostasis. Care was taken to eliminate all the septal scar and to delineate a new LV 
apex with the goal to restore the normal elliptical shape. 
 
Mitral valve repair. A stringent restrictive (2 sizes smaller than measured) mitral 
annuloplasty (RMA) was performed via an atrial transseptal approach using a 
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Carpentier Edwards Physio ring (Edwards Lifesciences, USA). After weaning from 
cardiopulmonary bypass, transesophageal echocardiographic evaluation was performed 
in all patients to confirm disappearance of mitral regurgitation and assess the length of 
leaflet coaptation (aiming at ≥ 8 mm). 
 
Study protocol  
Before and directly after cardiopulmonary bypass, conductance catheter measurements 
were performed as described previously.17 Briefly, temporary epicardial pacemaker 
wires were placed on the right atrium to enable measurements at fixed heart rates. A 
tourniquet was placed around the inferior caval vein to enable temporary preload 
reductions. An 8F sheath was placed in the ascending aorta for introduction of the 
conductance catheter. The conductance catheter was introduced under transesophageal 
echocardiographic guidance and placed along the long axis of the LV. Position was 
optimized by inspection of the segmental volume signals. Conductance catheter 
calibration was performed using calibration factors alpha (α) derived from 
thermodilution and parallel conductance correction volume (Vc) determined by 
hypertonic saline injections.5,18 Continuous LV pressure and volume signals derived 
from the conductance catheter were displayed and acquired at a 250 Hz sampling rate 
using a Leycom CFL-512 (CD Leycom, Zoetermeer, The Netherlands). Data were 
acquired during steady state and during temporary caval vein occlusion, all with the 
ventilator turned off at end-expiration. Acquisition was performed at a fixed atrial 
pacing rate of 80 beats/min. From these signals hemodynamic indexes were derived as 
described below. 
 
Data analysis 
Global LV function. We determined indexes of global, systolic and diastolic LV 
function. Cardiac output was obtained by thermodilution, heart rate, mean arterial 
pressure, stroke volume, LV ejection fraction, minimal and maximal rate of LV pressure 
change (dP/dtMAX, dP/dtMIN), end-diastolic volume, end-systolic volume, end-diastolic 
pressure, end-systolic pressure were obtained from steady state beats using custom-
made software. In addition, we assessed the early, active part of relaxation by the 
relaxation time constant (τ), which was determined by fitting LV pressure decay 
(starting at the moment of minimal dP/dt) with an exponential curve, as described 
previously19: P(t) = A + B·exp(-t/τ). Time-varying wall stress, WS(t), was calculated 
from instantaneous LV pressure and volume signals (P(t), V(t) respectively) as 
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described by Arts et al.20: WS(t) = P(t)·[1 + 3·V(t) / VWALL]. LV wall volume (VWALL) 
was estimated based on the diastolic posterior wall thickness derived from M-mode 
echocardiography. 
 
Mechanical work and efficiency. Stroke work (SW) was determined as the area of the 
pressure-volume loop, which represents the external work performed by the ventricle. 
Pressure-volume area (PVA), a measure of total mechanical work, was calculated as the 
sum of stroke work and potential energy. The latter represents mechanical energy loss 
converted to heat during the cardiac cycle and is quantified by the triangular area 
enclosed by the pressure-volume loop, the end-systolic pressure-volume relation and the 
end-diastolic pressure-volume relation. 21,22 Mechanical efficiency (ME) was calculated 
as the ratio of stroke work and pressure-volume area: ME = SW / PVA.23 
 
Mechanical dyssynchrony. Nonuniform LV performance (dyssynchrony) was 
determined from the segmental LV conductance signals and quantified by calculating 
the percentage of time within the cardiac cycle that a specific segment is 
dyssynchronous (i.e. opposite in phase with the global LV volume signal). Overall LV 
mechanical dyssynchrony was determined as the mean of the segmental dyssynchronies. 
In addition, we calculated the internal flow fraction, which quantifies the ineffective, 
segment-to-segment shifting of blood volume within the LV due to nonuniform 
contraction and filling. This approach was described and validated vs. tissue-Doppler 
imaging in a previous study.7 
 
Systolic and diastolic pressure-volume relations. Ventricular function was assessed by 
systolic and diastolic pressure-volume relations derived from pressure-volume loops 
acquired during gradual preload reduction by vena cava occlusion. The end-systolic 
pressure-volume relation (ESPVR) was obtained as a linear fit to the end-systolic 
pressure-volume points and characterized by its slope, end-systolic elastance (EES), and 
the volume intercept at an end-systolic pressure of 80 mmHg (ESV80). The end-diastolic 
pressure-volume points were fitted with an exponential curve: EDP = A + B·exp 
(KED·EDV). As illustrated in Figure 1, this relation was quantified by the diastolic 
stiffness constant (KED), the pressure intercept at an end-diastolic volume of 0 mL 
(EDP0), and the calculated volume intercept at an end-diastolic pressure of 14 mmHg 
(EDV14).24,25 
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Figure 1. The end-systolic pressure-volume relation (ESPVR) and the end-diastolic pressure-volume 
relation (EDPVR) in the pressure-volume diagram. The linear ESPVR is characterized by its slope, end-
systolic elastance (EES), and its volume intercept at an end-systolic pressure of 80 mmHg (ESV80). The 
exponential EDPVR is characterized by the pressure-intercept at an end-diastolic volume of 0 mmHg 
(EDP0), the volume intercept at an end-diastolic pressure of 14 mmHg (EDV14), and the diastolic stiffness 
constant KED. (See text for further details) 
 
 
Statistical analysis 
Pre- and post-surgery clinical and hemodynamic indexes were compared with paired t-
tests. Changes in systolic and diastolic pressure-volume relations were tested by 
multivariate analysis of covariance, using the Wilks’ lambda statistic to test whether 
there were differences between conditions for the combination of parameters describing 
the relations.26 Statistical significance was assumed at p < 0.05. All data are presented 
as the mean ± SD. 
 
 
RESULTS 
 
Surgical data are summarized in Table 2. In the SVR-group, all patients were treated 
with endoventricular circular patch plasty: 7 patients had a dyskinetic scar on pre-
operative echocardiography, the remaining 3 patients had an akinetic scar. All patients 
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in the SVR-group had coronary disease and received additional CABG (2.8±1.4 distal 
anastomoses per patient). In the SVR-group 7 patients had mitral regurgitation of grade 
2 or more and received additional restrictive mitral annuloplasty. In the RMA-group, 4 
patients received additional CABG (4.0±0.8 distal anastomoses per patient), while the 
other 6 patients in this group underwent isolated restrictive mitral annuloplasty as 2 had 
irreversible ischemia and 4 had non-ischemic dilated cardiomyopathy. All patients were 
successfully weaned from cardiopulmonary bypass. In the SVR-group, 2 patients 
received intra-aortic balloon pump support and 7 patients needed inotropic support for 
more than 24 hours. 
 
Table 2: Surgical data 
 SVR-group 
(n=10) 
RMA-group 
(n=10) 
CABG-group 
(n=13) 
Surgery 
SVR + CABG 
SVR + CABG + RMA 
Isolated RMA 
RMA + CABG 
CABG 
 
3 
7 
- 
- 
- 
 
- 
- 
6 
4 
- 
 
- 
- 
- 
- 
13 
CPB- time (median, minutes) 244 (range 105-287) 137 (range 105-287) 104 (range 60-167) 
Aox-time (median, minutes) 172 (range 65-196) 96 (range 65-196) 75 (range 43-129) 
# pts with IABP support 2 0 0 
# pts with >24 hrs inotropes*  7 5 0 
ICU-duration (median, days) 4 (range 3-16) 4 (range 2-7) 2  (range 1-4) 
Hospital stay (median, days) 14 (range 9-30) 14 (range 7-18) 9 (range 6-35) 
SVR indicates Surgical ventricular restoration; RMA, Restrictive mitral annuloplasty; CPB, 
Cardiopulmonary bypass; Aox-time, aortic cross clamping time; IABP, Intra-aortic balloon pump 
support; ICU, Intensive care unit; * dobutamine > 2 μg/kg/min 
 
In the RMA-group, 5 patients needed inotropic support for more than 24 hours. None of 
the patients had signs of peri-operative myocardial infarction. In patients with mitral 
regurgitation, restrictive mitral annuloplasty suppressed regurgitation in all cases and 
restored leaflet coaptation (8±2 mm) with normal peak pressure gradients (3.0±2.0 
mmHg). All patients were discharged from hospital in good clinical condition. 
 
Figure 2 shows typical pressure-volume relations before and after SVR. After SVR, 
end-diastolic and end-systolic volumes were significantly reduced with unchanged 
stroke volume indicating improved LV ejection fraction. Before surgery, LV volume 
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decreased during the pre-systolic ('isovolumetric') contraction phase, reflecting severe 
mitral regurgitation. This effect disappeared in the post-SVR loops as mitral 
regurgitation was treated by successful RMA. After SVR, a leftward shift of the end-
systolic and end-diastolic pressure-volume relation was present with an increased slope 
of both relations. These effects indicate improved systolic function and increased 
diastolic chamber stiffness after surgery. 
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Figure 2. Typical example of pressure-volume relations in a patient with ischemic dilated 
cardiomyopathy before (PRE) and after (POST) surgical ventricular restoration. The steady state 
pressure-volume loops show a significant reduction in end-diastolic and end-systolic volumes with 
unchanged stroke volume indicating improved LV ejection fraction. Before surgery, LV volume decreased 
during the pre-systolic contraction phase, reflecting severe mitral regurgitation. This effect disappeared 
in the post-surgery loops as mitral regurgitation was treated by restrictive mitral annuloplasty. The load-
independent end-systolic pressure volume relationship (ESPVR) showed a leftward shift with increased 
slope indicating improved systolic function. The end-diastolic pressure-volume relationship (EDPVR) 
also showed a leftward shift with increased slope indicating increased diastolic chamber stiffness post-
surgery 
 
 
Hemodynamic data 
Mean hemodynamic data before and after SVR is summarized in Table 3 and the 
dyssynchrony parameters for all three groups are shown in Figure 3. LV stroke volume 
and cardiac output were unchanged after SVR. LV ejection fraction was significantly 
increased and there was an approximately 25% reduction in end-diastolic and end-
systolic volumes. End-diastolic and end-systolic volumes were decreased towards 
"normal" values comparable to the values in the CABG-control-group. In the CABG-
control-group, end-systolic volume and end-diastolic volume were unchanged after 
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surgery (86±49 to 82±47 mL (P=0.190) and 142±52 to 146±45 mL (P=0.720), 
respectively). After SVR, stroke work was not significantly altered, but potential energy 
was substantially reduced (-52%), resulting in a decreased total mechanical work and, 
consequently, a significantly increased mechanical efficiency. Peak LV wall stress was 
significantly reduced after SVR (from 358±108 to 244±79 mmHg, p<0.01), but 
remained unchanged in the RMA-group (356±91 to 346±85 mmHg, p=0.668). 
 
Table 3: Hemodynamic data before (pre) and after (post) SVR 
 SVR-group (n=10) 
 Pre Post P-value 
HR (beats/min) 81±3 84±7 0.22 
CO (L/min) 4.6±1.1 5.4±1.4 0.15 
MAP 78±9 63±4 <0.01 
ESP 95±18 80±15 0.03 
EDV (mL) 211±54 169±34 0.03 
ESV (mL) 147±41 110±59 0.04 
LVEF (%) 27±7 37±13 0.04 
SW (mmHg.L) 4.8±1.5 4.2±1.2 0.32 
PE (mmHg.L) 10.6±6.1 5.1±3.5 <0.01 
PVA (mmHg.L) 15.4±5.9 9.3±3.5 <0.01 
ME 0.34±0.13 0.49±0.14 0.03 
dP/dtMAX (mmHg/s) 846±232 819±198 0.64 
dP/dtMIN (mmHg/s) -804±191 -750±110 0.25 
PWS (mmHg) 358±108 244±79 < 0.01 
EDP (mmHg) 13±6 20±5 < 0.01 
τ (ms) 85±13 70±12 < 0.01 
DYSS (%) 26±4 19±6 < 0.01 
IFF (%) 35±14 21±15 0.01 
SVR indicates surgical ventricular restoration; HR, heart rate; CO, cardiac output; MAP, mean arterial 
pressure; ESP, end-systolic pressure; EDV, end-diastolic volume; ESV, end-systolic volume; LVEF, left 
ventricular ejection fraction; SW, stroke work; PE, potential energy; PVA, pressure-volume area; ME, 
mechanical efficiency; PWS, peak wall stress; EDP, end-diastolic pressure; τ, relaxation time constant; 
DYSS, mechanical dyssynchrony; IFF: internal flow fraction 
 
Active relaxation (τ) was improved, while end-diastolic pressure was significantly 
increased. Mechanical dyssynchrony and the internal flow fraction were reduced in all 
groups, however these changes were most pronounced and only reached statistical 
significance in the SVR-group (Figure 3). 
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Figure 3. Acute effects of surgery on mechanical dyssynchrony indexes in the SVR-, RMA and CABG-
groups.  DYSS indicates mechanical dyssynchrony; IFF, internal flow fraction. * indicates p<0.05. 
Marginal significances (p<0.10) are tabulated 
 
The effects on the load-independent pressure-volume indexes are summarized in Table 
4. The end-systolic pressure-volume relation did not show significant changes in the 
CABG- and RMA-groups. In contrast, in the SVR-group, ESV80 decreased significantly 
and EES increased significantly, representing a leftward shift and increased slope of the 
end-systolic pressure-volume relation, both indicating improved systolic function. With 
regard to diastolic function, the end-diastolic pressure-volume relation was significantly 
altered only in the SVR-group (P=0.011): particularly, EDV14 decreased significantly 
indicating a leftward shift of the curve, whereas KED tended to increase, suggesting 
decreased diastolic compliance. The changes in the diastolic pressure-volume relations 
for the RMA- and CABG-groups were in the same direction but were not statistically 
significant, although in the CABG-group marginal significance was reached (P=0.097). 
 
Average pressure-volume loops 
To summarize the effects, Figure 4 shows schematic average pressure-volume loops for 
all of the three groups. The pressure-volume loops are based on the average end-systolic 
and end-diastolic pressures and volumes in each group. The most pronounced effects 
were seen after SVR. After SVR, there was a significant acute reverse remodeling, 
demonstrated by the substantial reduction in end-diastolic and end-systolic volumes.  
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Table 4: End-systolic and end-diastolic pressure-volume relations before and after surgery 
   SVR-group RMA-group CABG-group 
ESPVR Wilks’ lambda  0.439 0.942 0.591 
  P-value 0.037 0.810 0.122 
 r-value Pre 0.98±0.01 0.95±0.03 0.95±0.03 
  Post 0.97±0.04 0.96±0.03 0.92±0.13 
 ESV80 (mL) Pre 143±58 171±82 86±51 
  Post 89±40 164±69 72±38 
  P-value 0.015 NS NS 
 EES (mmHg/mL) Pre 1.12±0.63 0.86±0.50 1.31±0.93 
  Post 1.57±0.55 0.99±1.05 1.26±0.72 
  P-value 0.032 NS NS 
EDPVR Wilks’ lambda  0.177 0.785 0.428 
  P-value 0.011 0.842 0.097 
 r-value Pre 0.98±0.02 0.97±0.04 0.95±0.05 
  Post 0.96±0.10 0.98±0.02 0.98±0.01 
 EDP0 (mmHg) Pre 3.6±2.8 3.0±2.3 1.8±2.4 
  Post 5.2±3.0 4.2±3.3 2.2±3.7 
  P-value 0.261 NS NS 
 EDV14 (mL) Pre 235±65 262±130 174±51 
  Post 152±35 240±65 144±43 
  P-value 0.001 NS NS 
 KED (1/mL) Pre 0.021±0.009 0.027±0.035 0.021±0.014 
  Post 0.037±0.021 0.041±0.047 0.038±0.019 
  P-value 0.147 NS NS 
 
SVR indicates surgical ventricular restoration; RMA, restrictive mitral annuloplasty; CABG, coronary 
artery bypass grafting; ESPVR, end-systolic pressure-volume relation; EDPVR, end-diastolic pressure-
volume relation; r-value, correlation coefficient; ESV80, volume intercept of the ESPVR at end-systolic 
pressure 80 mmHg; EES, end-systolic elastance (slope of the ESPVR); EDP0, pressure intercept of the 
EDPVR at end-diastolic volume 0 mL; EDV14, volume intercept of EDPVR at end-diastolic pressure 14 
mmHg; KED, diastolic stiffness constant; NS, not significant (indicated by Wilks’ lambda) 
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Figure 4. Average steady state pressure-volume loops before (PRE) and after (POST) SVR (surgical 
ventricular restoration), isolated RMA (restrictive mitral annuloplasty), and CABG (coronary artery 
bypass grafting). The average loops (based on mean end-systolic and end-diastolic volumes and 
pressure) illustrate the effects on systolic and diastolic LV volumes and pressures.  Please note that the 
apparent stroke work (area of the pressure-volume loop) derived from these schematic loops could be 
misleading: First, pre-surgery the actual loops often show a volume decrease in the 'iso-volumic' 
contraction phase (reflecting pre-systolic mitral insufficiency), which is not shown in the schematic 
(‘square’) loops and causes the pre-surgery schematic loops to overestimate actual SW. Second, if 
afterload impedance is relatively low the end-systolic pressure may be substantially lower than the peak 
systolic pressure, which may cause the schematic post-surgery loops to underestimate the real stroke 
work. Thus, the change in stroke work in the SVR-group, derived from the schematic loops, appears to be 
larger than it, in fact, was (Table 2: non-significant 12% decrease) 
 
 
DISCUSSION 
 
Surgical ventricular restoration by means of endoventricular circular patch plasty (Dor 
procedure) is increasingly performed in patients with severe LV dysfunction after 
anterior myocardial infarction, for either akinesia or dyskinesia.16 We quantified the 
immediate hemodynamic effects of SVR on load-independent systolic and diastolic LV 
pressure-volume relations in combination with effects on LV wall stress and mechanical 
dyssynchrony and efficiency in patients with ischemic dilated cardiomyopathy. Our 
results show that SVR significantly improved LV systolic function (LV ejection 
fraction, end-systolic pressure-volume relation), and reduced LV wall stress and 
mechanical dyssynchrony. In addition, LV mechanical efficiency was significantly 
improved. LV diastolic function, however, appeared to be compromised: the diastolic 
pressure-volume relation was significantly shifted towards smaller volumes and tended 
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to be steeper, evidenced by an increased diastolic stiffness constant, although the latter 
effect did not reach statistical significance. 
The relatively small changes in systolic function in the patients who underwent isolated 
restrictive mitral annuloplasty and in the patients who underwent elective CABG 
indicate that the systolic improvements in the SVR group were mainly related to LV 
restoration. The increase in LV ejection fraction after SVR was attributed to the surgical 
reduction in end-diastolic volume, as LV stroke volume was unchanged. However, LV 
ejection fraction may not be an accurate parameter of systolic improvement after SVR 
because loading conditions may have changed substantially after surgery. Thus, load-
independent pressure-volume relations are needed to quantify alterations in systolic 
function. The slope of the end-systolic pressure-volume relation, end-systolic elastance 
EES, is a load-independent parameter of systolic function and EES increased significantly 
after SVR. Moreover, the end-systolic pressure-volume relation was significantly 
shifted towards smaller volumes, also indicating improved systolic function.26,27 This 
improvement may be the result of increased systolic stiffness induced by exclusion of a 
large compliant area, as predicted by computational models,10 or due to improved 
function of the remote myocardium by reduced LV wall stress, and reduced LV 
mechanical dyssynchrony after exclusion of the aneurysm.3,4 
Regarding diastolic function, relaxation time constant τ was significantly reduced, 
indicating faster relaxation. This time-constant quantifies the speed of LV pressure 
decay during isovolumic relation, i.e. between aortic valve closure and mitral valve 
opening, which represent the very early, and active, part of relaxation, which is 
considered to be importantly co-determined by systolic function.28 This change may 
result from coronary revascularization - which may enhance the oxygen dependent re-
uptake process of calcium by the sarcoplasmic reticulum - or from an afterload 
reduction as active relaxation is afterload dependent.29 Passive diastolic function was 
assessed by the diastolic pressure-volume relationship. Our results show that SVR 
induced a substantial leftward shift of the end-diastolic pressure-volume relation as 
quantified by the significant decrease in EDV14. In addition, the diastolic stiffness 
constant KED tended to increase, indicating by an enhanced steepness of the curve. 
Interestingly, diastolic chamber stiffness had a tendency to increase in all groups with a 
similar magnitude, although the effects did not reach statistical significance. This 
suggests that the increased diastolic stiffness may be contributed largely to the effect of 
the cardiopulmonary bypass and cardioplegic arrest leading to interstitial edema.30 In 
our center, normothermic cardiopulmonary bypass and intermittent antegrade warm 
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blood cardioplegia is routinely used31 because this approach may provide metabolic 
benefits32,33 and less cell damage,34 possibly mediated by a better protection from  
ischemia-reperfusion injury. Our study was not designed to investigate whether 
alternative cardioplegic approaches have less effect on post-operative diastolic function, 
but previous experimental studies do not appear to show important differences 
regarding myocardial edema formation and post-operative diastolic compliance between 
warm and cold blood approaches.35 
The results in our study are in line with predictions of Artrip et al. which were based on 
a composite model of the left ventricle.10 The results of their study emphasize the 
importance of the material properties of the region being removed. It was predicted that 
resection of weak but contracting muscle such as may occur with the partial left 
ventriculectomy (Batista procedure) will lead to a greater leftward shift for the end-
diastolic pressure-volume relation than for the end-systolic pressure-volume relation 
resulting in an overall negative effects on cardiac performance. Schreuder et al. studied 
the acute effects of partial left ventriculectomy in humans with dilated cardiomyopathy 
on LV pressure-volume relations and found significant improvements of systolic 
function and mechanical synchrony after surgery.36 The effects on intrinsic diastolic 
function like that of the end-diastolic pressure-volume relation were not described in 
detail, but the significant increase of end-diastolic pressure two till five days after 
surgery suggests diastolic impairment after surgery. Most centers have abandoned the 
Batista procedure because of high surgical mortality and late return of heart failure, but 
studies by Suma's group indicate that by utilizing intraoperative echocardiography to 
select the optimal excision, partial left ventriculectomy may effectively treat severe 
heart failure in selected patients with nonischemic dilated cardiomyopathy.37 
However, our study focuses on patients with ischemic dilated cardiomyopathy, for 
which case Artrip's model would predict improvement of overall cardiac pump function. 
Recent studies assessed the acute effects of SVR on pressure-volume relations and 
found improved systolic function and reduced mechanical dyssynchrony.4 However, the 
effects on diastolic load-independent indices, which may be important after volume 
reduction and insertion of an akinetic stiff patch, were not studied. To our best 
knowledge, the present study is the first to show the effects of SVR in patients with 
ischemic dilated cardiomyopathy on both systolic and diastolic pressure-volume 
relations in comparison to other surgical procedures. As expected, the results showed a 
leftward shift of both the end-systolic and the end-diastolic pressure-volume relation. 
Indexed by ESV80 and EDV14, respectively, the end-systolic pressure-volume relation 
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shifted by -55±18 mL, whereas the end-diastolic pressure-volume relation shifted by -
84±17 mL. Consequently, when compared at the same end-diastolic pressure (of 14 
mmHg), the hypothetical maximal total work, quantified by the area enclosed by the 
end-systolic pressure-volume relation, the end-diastolic pressure-volume relation, and 
the end-diastolic volume at 14 mmHg was decreased (from 13.4 to 10.1 mmHg·L). This 
finding could be interpreted as a decrease in overall pump function.10 However, in 
practice, the LV worked at a higher end-diastolic pressure after SVR, resulting in a 
maintained stroke work and cardiac output. Moreover, under physiological conditions 
the total work is only partly converted to effective external work (i.e. the area of the 
pressure-volume loop, stroke work), the remainder is dissipated as heat (the potential 
energy component of the pressure-volume area). Interestingly, our results show that, 
whereas stroke work remained fairly constant, the potential energy component was 
importantly reduced, indicating an improved mechanical efficiency of the ventricular 
contraction. This acute improvement presumably is caused by reduced mechanical 
dyssynchrony and reduced wall stress due to the restoration of LV shape. Consistent 
with our findings, Di Donato et al. recently demonstrated reduction of mechanical 
dyssynchrony after the Dor procedure.3 Usually, LV geometry in patients with chronic 
dilated cardiomyopathy is associated with a more transverse orientation of apico-septal 
muscle fibers and this orientation results in less efficient contraction and a decrease in 
LV pump function.12 SVR achieves restoration of the LV geometry towards a more 
elliptical shape,11,38 and the increase in systolic function after SVR, found in our study, 
may be partly the result of improvement of geometric rearrangement with restoration of 
LV apico-septal fiber orientation. 
Our approach involved the use of an intraventricular balloon filled with 55 ml/m2 saline 
to standardize the surgery, to avoid creating a too small cavity, and to achieve an 
elliptical shape of the left ventricle. Previous studies using a shaper device 
recommended a similar residual volume.39 However, at this point it is unknown which 
factors determine the optimal residual volume in individual patients. Also, the material 
properties of the patch may influence the results. A recent mathematical model study 
recommended repair without a patch whenever possible.40 Potentially, the modified 
linear closure described by Mickleborough et al. could be advantageous.41 However, 
this approach limits options for septal exclusion as compared to the Dor procedure. 
Therefore, as pointed out in a recent editorial by Buckberg,42 the linear closure would 
only be applicable to a selected patient population. Future studies are required to 
investigate these issues. 
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Limitations 
Our study is limited by the fact that the interventions were not randomized and thus 
baseline differences between the study groups may have introduced bias. Comparisons 
between groups may also be affected by differences in procedure times (Table 2), which 
were longer in the SVR-group. The ‘recovery time’ (CPB-time minus the cross-clamp 
time) was also longer in the SVR-group than in the RMA-group (72 vs. 41 min). 
Although this difference is partly explained by a more extensive echocardiographic 
evaluation (which is generally performed still on-pump), it may also indicate that post-
operative function is affected by length of the procedure. A direct comparison between 
patients in the SVR group who did or did not receive additional RMA (7 vs. 3 patients) 
is not statistically meaningful because the numbers are too small, and any conclusion 
would be very speculative and could be misleading. 
We anticipated that most of the heart failure patients would need inotropic support after 
surgery. Therefore, to avoid bias, in the SVR- and the RMA-groups inotropic support 
was started before surgery and, thus, pre- and post-measurement were both done during 
inotropic support. In the CABG group none of the patients received inotropic support. 
This may have resulted in slightly less pronounced differences between the CABG 
group on the one hand and the SVR/RMA groups on the other hand.  
A methodological limitation may be present for the calculation of conductance catheter 
slope factor α, which corrects underestimation of volume changes, which is due to 
electric field inhomogeneity and mismatch of the catheter segments with the LV long 
axis. In our study, this factor was calculated by matching the uncalibrated conductance 
stroke volume with stroke volume obtained by thermodilution. Because this comparison 
with right-sided stroke volume determined by thermodilution would be hampered in 
case of mitral insufficiency, we determined uncalibrated conductance catheter stroke 
volume as the volume at the moment of dP/dtMAX minus the volume at the moment of 
dP/dtMIN. With this approach pre- and post-systolic mitral insufficiency is not included 
in the uncalibrated conductance stroke volume. However, some overestimation of actual 
forward stroke volume may remain, which theoretically would result in a slight 
underestimation of absolute volumes in patients with mitral insufficiency. 
 
In conclusion, SVR by endoventricular circular patch plasty leads to acute 
normalization of LV volumes with improved systolic function. At the expense of a 
higher diastolic pressure resulting from altered diastolic properties, cardiac pump 
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function indexed by stroke work and cardiac output was not importantly altered. 
However, mechanical efficiency was significantly improved, presumably resulting from 
reduced wall stress and reduced mechanical dyssynchrony. Interestingly, the diastolic 
chamber stiffness constant was not more altered after SVR than after the surgical 
procedures in the other groups, suggesting that this effect was importantly related to 
procedure-induced myocardial edema and may be partially transient. Additional mitral 
valve repair is feasible and restores leaflet coaptation, while this procedure in itself does 
not importantly affect systolic and diastolic LV function in the acute phase. Future 
studies should be directed toward the long-term effects of SVR on systolic and diastolic 
pressure-volume relationships. 
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INTRODUCTION 
 
The conductance catheter developed by Baan et al. enables continuous on-line 
measurements of left ventricular (LV) volume and pressure.1,2 This method has been 
used extensively to assess global systolic and diastolic ventricular function and more 
recently the ability of this instrument to pick-up multiple segmental volume signals has 
been used to quantify mechanical ventricular dyssynchrony.3-13,14,15 These 
characteristics offer interesting possibilities to apply this technique in patients 
considered for or treated with cardiac resynchronization therapy (CRT). The aim of the 
present review is therefore to give an overview of the (potential) applications of 
pressure-volume measurements by conductance catheter in relation to CRT, and discuss 
the possibilities and limitations of this approach. 
 
 
METHODS 
 
The conductance catheter method 
The method has been described extensively in previous publications.2,16,17 Briefly, the 
conductance methodology is based on the measurement of the electrical conductance of 
the blood contained in the LV cavity. To this end the catheter contains multiple 
electrodes to generate an intra-cavitary electric field and pick-up the resulting voltage 
gradients. In its present form the catheter has 12 electrodes and should be positioned 
along the long axis of the LV as depicted in figure 1. The two most distal and two most 
proximal electrodes are employed to generate an electrical field. This dual pair of 
current electrodes enables the use of a dual excitation mode, which has been shown to 
improve the accuracy of the method especially in dilated hearts.16 The remaining 8 
electrodes are used pair wise to measure up to 7 segmental conductance signals (Gi) 
which represent the instantaneous volumes of corresponding slices (note that the figure 
shows only 5 segments). 
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Figure 1. The combined pressure-conductance catheter positioned in the left ventricle. The electrodes are 
used to setup an intracavitary electric field and measure segmental conductances. Note the pressure 
sensor positioned in segment 3 
 
To convert the measured conductance (i.e. applied current divided by the measured 
voltage gradient) to an absolute volume signal the specific conductivity of blood (σ) and 
the electrode spacing (L) have to be taken into account. In addition, the measured 
conductance contains an offset factor, which is due to the conductance of the structures 
surrounding the cavity. This so-called parallel conductance (Gp) may be determined by 
the hypertonic saline dilution method and subsequently subtracted.2,17 Finally, the 
conductance-derived stroke volume generally underestimates actual stroke volume due 
to electrical field inhomogeneity and because the segments do not fully cover the LV 
long axis. This underestimation is corrected by introducing a slope factor (α), which 
may determined by comparing conductance-derived stroke volume with an independent 
estimate of stroke volume (e.g. determined by thermodilution). Consequently, absolute 
LV volume (VLV) is derived from measured conductance G(t) as: 
 
VLV(t) = (1/α) ⋅ (L2/σ) ⋅ [G(t) – GP] 
 
Note that G(t) is the instantaneous sum of the segmental conductances: 
 
G(t) = Σ Gi(t) 
 
The equation also holds at a segmental level: 
 
Vseg,i(t) = (1/α) ⋅ (L2/σ) ⋅ [Gi(t) – GiP] 
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As shown in figure 1 the conductance catheter also contains a solid-state, high-fidelity 
pressure sensor to measure instantaneous LV pressure. 
 
Catheters, equipment and software 
Currently, most pressure-volume studies performed in humans use combined pressure-
conductance catheters. Typically, these catheters are 7F, over-the-wire, pigtail catheters 
and are produced by several companies (e.g. CDLeycom, Zoetermeer, The Netherlands; 
Millar Instruments, Houston, Texas). To generate the electric field, measure the 
resulting voltages, acquire and handle the various signals the catheter must be connected 
to dedicated equipment. For this purpose all studies presented and discussed in this 
review used the Cardiac Function Lab CFL-512 or the Sigma 5 DF (CDLeycom, 
Zoetermeer, The Netherlands). Data analysis is generally performed with software 
installed on the CFL-512 or by using other commercially available physiological data-
analysis software, or software that is custom-made by the various research groups. 
 
Pressure-volume signals, loops and relations 
When positioned in the LV, the combined pressure-conductance catheter yields 
continuous segmental volume signals and LV pressure. Total LV volume is calculated 
as the instantaneous sum of the segmental signals. An example of these signals obtained 
in a patient with coronary artery disease and relatively normal LV function and 
contraction pattern is shown in figure 2. The temporal resolution in this example is 4 
ms. The volume signals show a normal ejection during systole and a biphasic filling 
pattern during diastole reflecting early rapid filling, diastasis and the atrial contribution 
to filling. 
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Figure 2. Typical left ventricular segmental (SEG 1 to SEG 5) and total LV volume (LVV) signals and left 
ventricular pressure (LVP). Corresponding pressure-volume loops are shown in Figure 3 
 
To characterize pump-function of the LV, pressure and volume signals may be 
combined to construct pressure-volume loops as depicted in figure 3. Each loop 
represents one cardiac cycle. The distinct cardiac phases, filling, isovolumic contraction, 
ejection and isovolumic relaxation, are indicated in the figure. The phases are separated 
by opening and closure of mitral and aortic valves, which moments coincide with the 
'corners' of the pressure-volume loop. Important parameters characterizing LV function 
can be directly determined from the pressure-volume loops, or from the pressure and 
volume-time curves and their derivatives. Such parameters include indices of pump 
function (stroke volume, cardiac output, and stroke work), systolic function (end-
systolic pressure, end-systolic volume, ejection fraction, peak ejection rate (dV/dtMAX), 
and dP/dtMAX) and diastolic function (end-diastolic volume, end-diastolic pressure, peak 
filling rate (dV/dtMIN), dP/dtMIN, and relaxation time constant τ). 
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Figure 3. Pressure-volume loops. Cardiac phases and time-points of opening and closure of mitral and 
aortic valves are indicated 
 
An important limitation of all of the above mentioned indices is that they are, more-or-
less, load dependent. A possible approach to amend this is to construct pressure-volume 
relations from which indices can be derived which are less load-dependent and therefore 
better measures of intrinsic systolic or diastolic ventricular function. Construction of 
pressure-volume relations requires pressure-volume loops obtained at different loading 
conditions. Importantly, such alteration in loading should be induced by interventions 
that minimally affect intrinsic myocardial function. An elegant way to achieve this is to 
use a balloon occlusion of the inferior vena cava. This procedure enables a rapid, purely 
mechanical, reduction in preload, which prevents reflex mechanisms and is easily 
reversed by deflation of the balloon. This method has been described in detail in several 
publications.5,6 A typical example of pressure-volume loops acquired during caval 
occlusion is shown in figure 4.  
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Figure 4. Pressure-volume loops during preload reduction by vena cava occlusion. Systolic and diastolic 
function indices are derived from the curves fitted to the end-systolic and end-diastolic pressure-volume 
points, respectively 
 
The relation between the pressure-volume points at end-systole, the end-systolic 
pressure-volume relation (ESPVR) has been shown a sensitive and relatively load-
independent description of LV systolic function.18 Both the slope of the ESPVR, which 
determines end-systolic elastance (EES) and the position of the ESPVR (in recent 
generally papers characterized by the volume-intercept at a fixed pressure, e.g. end-
systolic volume at 100 mmHg, ESV100) are used as indices of systolic function.19-21 The 
relation between the end-diastolic pressure-volume points, the end-diastolic pressure-
volume relation (EDPVR), may be fitted with a linear curve. The slope of this curve 
(dEDP/dEDV) represents diastolic stiffness. More commonly, the term diastolic 
compliance is used, which is the inverse of this slope (dEDV/dEDP). If the EDPVR is 
constructed over a wider range it is generally clear that this relation is non-linear and 
better approximated by an exponential fit, such as EDP = A⋅exp(k⋅EDV) and diastolic 
function characterized by the diastolic stiffness constant (k).7 In addition, several other 
relations, which may be derived from pressure-volume loops during a loading 
interventions have been used to quantify LV function, such as the relation between 
dP/dtMAX and end-diastolic volume and the preload recruitable stroke work relation (i.e. 
SW vs EDV).18,20,22-24 
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Mechanical dyssynchrony 
Several studies have confirmed the hypothesis that baseline dyssynchrony (i.e. pre-
implantation) is an important determinant of the success of CRT in individual 
patients.25-27 Currently the primary variable to identify patients that are most likely to 
benefit is QRS duration. However, electrical and mechanical dyssynchrony may diverge  
and recent studies indicate that direct analysis of mechanical dyssynchrony may have 
higher predictive value.25,28 Mechanical dyssynchrony may be quantified by means of 
MRI, echocardiographic or tissue Doppler techniques.26,29,30,31,32 Recently, we 
introduced indices of mechanical dyssynchrony derived from the segmental volume 
signals obtained with the conductance catheter.33,34 The methods and indices are 
described and validated in detail elsewhere.35 Briefly, a segmental volume signal is 
compared with the simultaneous global volume signal and a segment is marked as 
dyssynchronous at time-point t if the instantaneous change in the segmental volume 
signal is opposite to the change in the global volume signal at that same time-point. An 
index of regional dyssynchrony is obtained by calculation the percentage of time during 
the cardiac cycle that a specific segment is dyssynchronous. A global index of 
mechanical dyssynchrony is subsequently derived by calculating the mean value over 
all segments. Furthermore, nonuniform contraction and filling is associated with 
ineffective movements of blood volume within the LV. This 'internal flow' may be 
quantified by calculating segment-to-segment flow (i.e. segmental volume changes that 
do not result in effective changes in total LV volume). An internal flow fraction (IFF) is 
obtained by dividing the average internal flow by effective global LV flow. A 
comparative study in heart failure patients with LBBB showed good correlation 
between these conductance derived dyssynchrony indices and tissue-Doppler derived 
septal-to-lateral delay in peak systolic velocity.31,36 
 
 
PRESSURE-VOLUME MEASUREMENTS DURING CRT 
 
We may distinguish several fields of application where pressure-volume measurements 
by conductance catheter may play a role in the context of CRT. In principle, the 
methodology can be applied to study the basic physiological mechanisms involved, as a 
tool to select patients that might benefit from CRT, to optimize the therapy, and to 
evaluate the treatment effects of CRT. In the following we will briefly review several 
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applications of pressure-volume measurements, and discuss the possibilities and 
limitations in these four fields. 
 
Mechanisms 
We and several other groups have used pressure-volume analysis to investigate the 
physiological mechanisms of CRT. The two primary targets of CRT are normalization 
of the pattern of LV activation and optimization of the atrial-ventricular delay.37 In 
patients with intraventricular conduction delay mechanical synchrony can be improved 
by pre-excitation of the otherwise late-activated region. As shown in figure 5 
(unpublished data) this may result in dramatic acute systolic improvements evident from 
increased stroke volume and increased stroke work. In this case the improvements are 
obtained largely from a reduced end-systolic volume, whereas end-diastolic volume is 
unaltered. Similar results were presented by Nelson et al. who very elegantly 
demonstrated that the improvement in systolic function is achieved with a minimal 
change or even a reduction in myocardial oxygen consumption. 38 
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Figure 5. Acute effects of biventricular pacing on LV pressure-volume loops. Note the increased stroke 
volume (width of pressure-volume loops) and stroke work (area of pressure volume loop) during CRT 
 
A nice demonstration of the influence of asynchronous activation on LV function was 
presented by Simantirakis et al.39 They determined systolic and diastolic LV function by 
pressure-volume loops in patients with long-term right ventricular apical pacing. 
Restoration of normal activation was achieved by switching from DDD to AAI pacing 
mode. The results indicate an acute improvement in systolic function evident from an 
increased end-systolic elastance, preload recruitable stroke work and dP/dtMAX-EDV 
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slope. Diastolic function was unaltered. Similar to the study by Nelson et al. it was 
found that myocardial oxygen consumption was unchanged and therefore the 
improvement in contractility must be attributed to a more economic functioning of the 
heart.38 Although mechanical dysfunction arising from right ventricular apex pacing is 
not necessarily equivalent to that found in patients with intrinsic conduction delay (such 
as LBBB), this study clearly illustrates the acute improvements that can be obtained 
after restoration of normal activation.40 
Pressure-volume loop analysis has been applied to study the influence of pacing site and 
AV-delay in an experimental animal model of left bundle branch block (LBBB) by 
Verbeek et al.41 They show that experimental LBBB acutely induces inter- and 
intraventricular electrical asynchrony which is reflected in reductions in dP/dtMAX, 
stroke volume and stroke work. LV pacing recovered LV function and maximal 
improvement was obtained with intra-ventricular resynchronization of activation, which 
depended on LV pacing site and required optimalization of the AV-delay. 
An interesting alternative hypothesis regarding the working mechanism of CRT has 
been put forward by the group of Frenneaux.42 They hypothesized that the mechanism 
of response may be an improvement in LV filling as well as ventricular systolic 
resynchronization. This hypothesis is based on the finding that patients with heart 
failure and high end-diastolic pressure (>15mmHg) often exhibit so-called diastolic 
ventricular interaction indicating that filling of the LV is constrained (external 
constraint) by the stretched pericardium and the pressure and volume overloaded the 
right ventricle.43 In this condition LV pacing may advance LV filling relative to right 
ventricular filling and thereby delay the onset of diastolic ventricular interaction and 
improve LV filling. Recently, they have employed conductance catheter derived 
pressure-volume measurements during unloading by vena cava occlusion to assess 
external constraint (example is shown in figure 6) with and without LV pacing.44 The 
results indicate a reduction in external constraint during LV pacing. The resulting 
increase in the effective filling pressure is followed by an increase in LV end-diastolic 
volume and a subsequent increase in stroke volume and stroke work via the Starling 
mechanism. 
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Figure 6. An example of the end-diastolic pressure-volume relation during inferior vena caval occlusion 
of a patient with significant external constraint. The baseline end-diastolic pressure-volume point is 
marked with an asterix. During vena cava occlusion LV end-diastolic pressure decreases but initially LV 
end-diastolic volume increases as represented by the initial right- and downward shift the pressure-
volume points. Then LV end-diastolic volume also starts to decrease as indicated by the left- and 
downward movement of the pressure-volume points. A quadratic regression has been fitted to the 
subsequent points. External constraint was defined as the pressure difference between the baseline point 
and the regression line (distance between the two thin horizontal lines) indicated by the dotted vertical 
arrow 
 
Patient selection 
Currently, selection criteria for CRT are typically NYHA III-IV, poor LV function 
(LVEF < 30-35%) and a wide QRS (> 120-150 ms) with LBBB configuration. However 
a substantial percentage of patients that fulfill the traditional inclusion criteria do not 
benefit from CRT.45 Several approaches to amend this problem have been used or 
suggested. E.g. the MIRACLE trial used two additional selection criteria: LV end-
diastolic dimension of 55 mm or more and a six-minute walking distance of 450 m or 
less.46 Recent studies indicate that acute hemodynamic improvement may be predicted 
by baseline mechanical dyssynchrony, therefore the number of nonresponders may be 
reduced by adding a pre-implantation assessment of mechanical dyssynchrony and 
exclude patients who do not show important dyssynchrony.25-27 An alternative approach 
is followed by the group in Bad Oeynhausen by performing an invasive pre-
implantation test procedure in all CRT candidates to identify responders, and optimize 
lead position and pacing mode: Temporary pacing electrodes are placed in the right 
atrium and the right ventricle, and the LV is paced through a temporary lead in a lateral 
cardiac vein.47 Various pacing modes are tested and acute hemodynamic benefit is 
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quantified by measuring femoral artery pulse pressure as a surrogate for stroke volume. 
Subsequent permanent implantation of a CRT device is only considered in patients 
showing an increase in pulse pressure greater than 10%. In on-going studies 
measurements of pressure-volume signals have been added to this protocol. Figure 7 
shows a typical example. 
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Figure 7. Pre-implantation hemodynamic testing. LV volume, LV pressure, LV dP/dt and femoral artery 
pressure at baseline and during CRT with LV pacing and biventricular pacing with AV delays set at 140, 
120, 100 and 80 ms. Note that the optimal stroke volume (amplitude of LV volume signal) with a 
reduction in end-diastolic volume is obtained during LV pacing with an AV delay of 120 ms. Similar 
effects, but with a less pronounced reduction in end-diastolic volume are obtained in this example with 
biventricular pacing 
 
Optimization 
Current CRT involves atrial synchronized ventricular pacing to optimize AV timing, 
and biventricular pacing to improve intraventricular and interventricular synchrony. 
Acute hemodynamic studies indicate that optimal contractility and stroke volume 
requires a patient-specific AV interval48,49, whereas an optimal RV-LV timing may 
contribute to a further improvement in synchrony and ejection fraction.32 Comparison 
between LV and biventricular pacing has been the subject of several studies50 but this 
issue remains unresolved.37 With regard to lead position the best hemodynamic 
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response of LV pacing is generally obtained through pacing in the mid-lateral or 
posterior LV51-53, which is achieved with leads placed in the posterior or lateral 
branches of the coronary sinus. Despite advances in percutaneous techniques, special 
guiding sheaths and improved lead design47,54, suboptimal lead positioning may still be 
an important cause of non-response to CRT. Intraoperative epicardial lead placement is 
currently mainly used as rescue in patients with failed endocardial leads, but may 
provide an alternative approach with possibilities for optimal lead placement.55,56 
Finally some studies suggest that multiple LV sites may be required for optimal 
hemodynamic results.57 Despite a large number of studies many questions regarding 
optimization of CRT remain disputed. Conceivably studies with the conductance 
catheter may resolve some of these issues by providing on-line pressure-volume loops 
which may guide optimization of CRT. 
 
Evaluation 
Studies have demonstrated acute hemodynamic improvement after CRT, followed by 
improvement in symptoms, quality of life and exercise capacity.46,48,58 More recent 
studies have provided objective evidence for improved systolic performance and 
reversed remodeling during long-term CRT which may provide the basis for the clinical 
improvements.27,59 The evaluation of long-term hemodynamic effects is complex 
because it involves alterations in both systolic and diastolic function, and in loading 
conditions. Although initially the improved systolic function most likely largely reflects 
improved contraction synchrony, long-term alternation in intrinsic myocardial function 
may be present e.g. due to alterations in wall stress or sympathetic activity.60 
Interpretation of traditional diastolic indices is complicated because alterations in filling 
time and mitral insufficiency are present and may interact with changes in intrinsic 
myocardial function. Analysis in terms of pressure-volume loops and pressure-volume 
relations is attractive because it provides relatively load-independent indices of systolic 
and diastolic function. In on-going studies we investigate patients before pacemaker 
implantation and after 6 months of CRT. The example shown in Figure 8 illustrates 
reversed remodeling with improved systolic and diastolic function and reduction in 
mitral regurgitation. Analysis of the segmental conductance signals yielded improved 
systolic and diastolic mechanical synchrony and reduced internal flow.61 
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Figure 8. Effects of chronic CRT. Pressure-volume loops at baseline (PRE) and after 6 months of chronic 
CRT (POST). Note the left ward shift of the pressure-volume loop indicating substantial reversed 
remodeling. Diastolic pressure decreased and the diastolic part of the pressure-volume loop indicates 
improved diastolic compliance 
 
 
CONCLUSION 
 
We conclude that, in the context of CRT, pressure-volume measurements by 
conductance catheter have been mainly applied to study the basic mechanisms of 
dyssynchronous and resynchronized cardiac contraction. In this field important new 
insights were obtained from pressure-volume measurements. There are certainly 
possibilities and distinct advantages in the field of patient selection but this application 
will remain limited by the invasive character of the conductance method. Currently, 
ongoing studies apply pressure-volume measurements to optimize CRT in individual 
patients and evaluate the long-term hemodynamic effects of CRT. The possibility to 
assess cardiac function and mechanical dyssynchrony during implantation and study the 
immediate effects of changes in lead position, AV and VV-delay, in an on-line and 
quantitative fashion makes this a promising tool to optimize CRT. Load-independent 
quantitative parameters of systolic and diastolic function derived from pressure-volume 
relations should provide more insight in the working mechanisms of chronic CRT. 
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ABSTRACT 
 
Background. Acute hemodynamic effects of cardiac resynchronization therapy (CRT) 
have been reported previously, but detailed invasive studies showing hemodynamic 
consequences of long-term CRT are not available. 
Methods and Results. We studied 22 patients scheduled for implantation of a CRT 
device based on conventional criteria (NYHA class III or IV, left ventricular (LV) 
ejection fraction <35%, left bundle-branch block, QRS duration >120ms). During 
diagnostic catheterization prior to CRT we acquired pressure-volume loops using 
conductance catheters during right atrial pacing at 80, 100, 120 and 140 beats/min. 
These studies were repeated during biventricular pacing at the same heart rates after 6 
months of CRT. Our data show significant clinical benefit of CRT (NYHA class: 
3.1±0.5 to 2.1±0.8; Quality-of-Life score: 44±12 to 31±16; 6-min hall-walk: 260±149 to 
396±129m; all p<0.001), improved LV ejection fraction (29±10 to 40±13%, p<0.01), 
decreased diastolic pressure (18±8 to 13±6mmHg, p<0.05), and reverse remodeling 
(end-diastolic volume: 257±67 to 205±54mL, p<0.01). Previously reported acute 
improvements in LV function remained present at 6 months: dP/dtMAX (+18%, p<0.01), 
dP/dtMIN (+13%, p<0.01), stroke work (+34%, p<0.01). Effects of increased heart rate 
were improved towards more physiological responses for LV ejection fraction, cardiac 
output and dP/dtMAX. Moreover, our study shows improved ventricular-arterial coupling 
(+69%, p<0.01) and improved mechanical efficiency (+44%, p<0.01). 
Conclusions. Hemodynamic improvements with CRT, which were previously shown in 
acute invasive studies, are maintained long-term. In addition, ventricular-arterial 
coupling, mechanical efficiency, and chronotropic responses are improved after 6 
months of CRT. These findings may help to explain the improved functional status and 
exercise tolerance in heart failure patients treated with CRT. 
 
 
INTRODUCTION 
 
Cardiac resynchronization therapy (CRT) improves quality of life, symptoms, and 
exercise capacity in patients with heart failure and intraventricular conduction delay.1 A 
recent study confirmed these favorable effects and also demonstrated that CRT 
significantly reduced the risk of death.2 Whereas previous randomized controlled trials 
have clearly demonstrated beneficial clinical effects over a period of up to 6 months, 
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small-scaled studies suggest that these clinical improvements are maintained long-
term.3-5 The primary working mechanism of CRT is the optimization of the mechanical 
activation pattern of the left ventricle (LV), which is achieved by pre-excitation of the 
region which is otherwise activated late due to delayed intrinsic conduction.6 In addition 
to this intraventricular resynchronization, additional benefit may be obtained by 
optimizing the delay between atrial and ventricular systole, and the timing of LV and 
right ventricle (RV) stimulation. Acute improvements in mechanical dyssynchrony 
resulting in enhanced systolic function have been demonstrated by various studies.7-10 
Invasive studies have shown increased LV ejection fraction and stroke volume, 
accompanied by increased systolic pressure, dP/dtMAX, and stroke work, and reduced 
diastolic pressure.9,11 Interestingly, these improvements in cardiac function are obtained 
at diminished energy cost.12 In the long-term, CRT is associated with LV reversed 
remodeling13 and improved myocardial efficiency.14 However, currently no invasive 
studies are available regarding the effects of long-term CRT on systolic and diastolic 
hemodynamic parameters. In this study we assessed the long-term hemodynamic effects 
of CRT, and investigated the underlying mechanisms. To this end, we acquired 
pressure-volume loops prior to CRT during right atrial pacing at 80, 100, 120 and 140 
beats/min, and these studies were repeated during biventricular pacing at the same heart 
rates after 6 months of CRT. 
 
 
METHODS 
 
Patients 
Twenty-two patients (mean age, 66±11 years; 17 men) with NYHA class III or IV heart 
failure despite optimized medical treatment, echocardiographic LV ejection fraction 
<35% and QRS duration >120ms scheduled for implantation of a CRT device were 
included. The protocol was approved by our institutional review committee and all 
patients gave informed consent. The etiology of heart failure was ischemic in 14 and 
non-ischemic in 8 patients. All patients received stable medical therapy for chronic 
heart failure, including diuretics (n=19), spironolactone (n=8), β-blockers (n=10), ACE 
inhibitors (n=20), and amiodarone (n=6). Medication was unchanged and no new 
therapies were installed during the 6-months follow-up period. In addition to the 
invasive studies described in detail below, we performed echocardiography, 6-minute 
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hall-walk tests, and quality of life assessments by the Minnesota Living with Heart 
Failure Questionnaire at baseline and after 6 months of CRT. 
 
Protocol 
Baseline (i.e. pre-CRT) hemodynamic data were obtained during routine diagnostic 
right and left heart catheterization, including thermodilution cardiac output, left 
ventriculography and coronary angiography. To acquire pressure-volume loops at 
incremental heart rates, a 7F combined pressure-conductance catheter (CD Leycom, 
Zoetermeer, The Netherlands) was placed in the LV via the femoral artery, and a 
temporary pacing lead was placed in the right atrium. Pressure-volume signals were 
displayed on-line and digitized at a sample frequency of 250Hz (Leycom CFL, CD 
Leycom). LV volume was calibrated using thermodilution and hypertonic saline 
dilution as previously described.15,16 Right atrial pacing was performed at 80, 100, 120 
and 140 beats/min. Data were acquired consecutively approximately 60s after changing 
to a higher rate, and periods of at least 20s were selected for off-line analysis. All 
measurements were repeated during recatheterization after at least 6 months of chronic 
CRT. During this session biventricular pacing was performed at 80, 100, 120 and 140 
beats/min by reprogramming the CRT device. The atrioventricular (AV) delay was kept 
fixed at the optimal clinical setting based on Doppler mitral flow velocity recordings 
obtained previously at the outpatient clinic. 
 
Data analysis 
Analysis of the steady state pressure-volume loops was performed using custom 
software as previously described.17 Briefly, for each patient and each pacing rate 
hemodynamic indexes were calculated as the mean of all beats during a steady state 
period of approximately 20s. LV function was quantified by cardiac output and stroke 
volume, end-diastolic and end-systolic volume, LV ejection fraction, end-systolic and 
end-diastolic pressure, maximal and minimal rate of LV pressure change (dP/dtMAX, 
dP/dtMIN). The time constant of relaxation (τ) was determined using phase-plot 
analysis.18 Stroke work was calculated as the area of the pressure-volume loop. LV end-
systolic elastance (EES) was estimated by end-systolic pressure divided by end-systolic 
volume, and end-diastolic stiffness (EED) by end-diastolic pressure divided by end-
diastolic volume. Effective arterial elastance (EA) was calculated as end-systolic 
pressure divided by stroke volume.19 Ventricular-arterial coupling was quantified as 
EES/EA,20 and mechanical efficiency was calculated as the ratio of external stroke work 
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and pressure-volume area (a measure of total mechanical work).21 Nonuniform LV 
performance was determined from the segmental LV conductance signals and quantified 
by calculating the percentage of time within the cardiac cycle that a specific segment is 
dyssynchronous (i.e. opposite in phase with the global LV volume signal). Overall LV 
mechanical dyssynchrony was determined as the mean of the segmental dyssynchronies. 
In addition, we calculated the internal flow fraction, which quantifies the ineffective 
shifting of blood volume within the LV due to nonuniform contraction and filling. This 
approach was described and validated in a previous study.17 Time-varying wall stress, 
WS(t), was calculated from the instantaneous LV pressure and volume signals (P(t) and 
V(t), respectively) as described by Arts et al.22: WS(t) = P(t)·(1+3·V(t) / LVM). LV 
mass (LVM) was calculated from M-mode echocardiography according to the 
conventions proposed by the American Society of Echocardiography.23 Atrioventricular 
delay was determined as the time between the right atrial pacing and the start of left 
ventricular contraction.24 
 
Statistical analysis 
We used a linear mixed-effects model to account for repeated measurements on each 
patient. In this model, patients were included as random effects and conditions 
(baseline, CRT), pacing (80, 100, 120, and 140 beats/min), and their interaction as fixed 
effects.25 To assess statistical significances between pacing levels and conditions, 
appropriate contrasts were selected. Data are presented as mean±SD. A p-value <0.05 
was considered statistically significant. 
 
 
RESULTS 
 
Clinical assessment and atrioventricular delay 
All patients were successfully implanted with a CRT device (Contac Renewal, Guidant 
(n=21), or InSync III, Medtronic (n=1)). All patients received CRT for at least 6 months 
(7.2±1.6 months). Table 1 shows the clinical parameters which all improved 
significantly, consistent with previous reports1. AV delay was optimized based on 
Doppler mitral flow velocity recordings at our outpatient clinic shortly after pacemaker 
implantation: The AV delay was set to achieve the longest left ventricular filling time 
without premature truncation of the A-wave by mitral valve closure.26 Baseline AV 
delay (during right atrial pacing at 80 beats/min) was 184±96 ms and tended to decrease 
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at higher pacing rates. Mean optimized AV delay with biventricular pacing was 97±15 
ms and was unchanged at the higher pacing rates (Table 2). 
 
Table 1. Clinical parameters at baseline (pre-CRT) and after 6 months of CRT 
 Baseline 6-mo CRT 
NYHA class 3.05±0.49 2.05±0.79 **** 
Quality of life score 44±12 31±16 **** 
6-min hall-walk, m 260±149 396±129 **** 
* p<0.05, ** p<0.01, *** p<0.005, **** p<0.001 vs. baseline by paired t-tests 
 
Left ventricular function 
Figure 1 shows typical examples of pressure-volume loops at 80 beats/min at baseline 
and after 6 months of CRT from two patients. Full hemodynamic data including the 
effects of increased pacing rate from all patients are summarized in Table 2. 
Comparison of 6 months of CRT vs. baseline at the lowest pacing rate (80 beats/min, 
p80) shows that cardiac output and LV ejection fraction improved significantly, whereas 
end-diastolic volume and end-systolic volume were significantly reduced. The latter 
indicates substantial reversed remodeling consistent with previous reports.13 Improved 
systolic function was evidenced by a significantly increased dP/dtMAX, EES and stroke 
work. In addition, end-diastolic pressure was significantly reduced. Diastolic stiffness 
EED and τ showed a non-significant tendency to reduce. dP/dtMIN was significantly 
improved indicating improved active relaxation. The increase in EES combined with a 
modest decrease in EA resulted in a significantly improved ventricular-arterial coupling 
ratio (EES/EA). The significant increase in external stroke work with unchanged total 
mechanical work resulted in a significantly improved mechanical efficiency. 
 
Legends of table 2. p80..p140 indicates paced at 80..140 beats/min; BL, baseline (i.e. pre-CRT) ; CRT, 6-
months cardiac resynchronization therapy; Condition effect, BL vs. CRT; Pacing effect, effect of 
incremental paced heart rate; Interaction effect, condition-pacing interaction; HR, heart rate; AVD, 
atrioventricular delay; CO, cardiac output; ESV, end-systolic volume; EDV, end-diastolic volume; EF, 
ejection fraction; SW, stroke work; ESP, end-systolic pressure; EDP, end-diastolic pressure; τ, 
relaxation time constant; PWS, peak wall stress; WSED, end-diastolic wall stress; DYS, mechanical 
dyssynchrony; IFF, internal flow fraction; EA, effective arterial elastance; EES, end-systolic elastance; 
EED, end-diastolic stiffness; PVA, pressure-volume area; ME = SW/PVA, mechanical efficiency; and 
EES/EA, ventricular-arterial coupling. Statistical significances and contrasts (changes vs. p80) were 
determined by using a linear mixed-effects model (see text for details). CRT-p80 vs. BL-p80: # p<0.05, ## 
p<0.01. Changes vs. p80 at same condition (BL or CRT): * p<0.05, ** p<0.01 
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Table 2. Left ventricular function indexes at baseline (pre-CRT) and at 6 months of CRT 
   Changes vs. p80 P-values of Effects 
  p80 p100 p120 p140 Condition Pacing Interaction
HR (beats/min) BL 78.6±4.4 21.6±0.7** 43.8±0.8** 62.7±0.8** 0.308 <0.001 0.093 
 CRT 80.1±2.2 20.6±0.7** 41.1±0.7** 61.8±0.8**    
AVD (ms) BL 184±96 -12±16 -20±16 -28±17 <0.001 0.832 0.472 
 CRT 97±15## 0.4±12 2±12 3±13    
CO (L/min) BL 4.36±0.70 0.09±0.17 -0.25±0.19 -1.14±0.20** <0.001 <0.001 0.026 
 CRT 4.98±0.86## 0.45±0.17** 0.08±0.17 -0.32±0.19    
ESV (ml) BL 195±72 4.1±13.6 -5.3±14.7 -15.0±15.9 <0.001 0.615 0.947 
 CRT 137±52## -2.6±12.4 -5.6±12.4 -9.5±14.1    
EDV (mL) BL 257±67 0.6±15.2 -25.7±16.5* -44.9±17.8** <0.001 0.005 0.814 
 CRT 205±54## -4.3±14.0 -14.2±14.0 -21.9±15.8*    
EF (%) BL 29.1±10.4 -3.5±2.4 -8.9±2.6** -12.6±2.8** <0.001 <0.001 0.235 
 CRT 39.5±12.8## -0.2±2.2 -2.3±2.2 -7.4±2.5**    
SW (mmHg·L) BL 4.37±2.07 -0.82±0.39* -1.91±0.42** -2.62±0.49** <0.001 <0.001 0.468 
 CRT 5.87±2.26## -0.43±0.35 -1.06±0.35** -2.24±0.39**    
ESP (mmHg) BL 105±29 -1.2±3.5 -7.0±3.8 -17.6±4.1** <0.001 <0.001 0.701 
 CRT 108±22 -1.8±3.3 -5.7±3.3 -12.1±3.7**    
EDP (mmHg) BL 17.9±8.2 0.9±1.9 1.7±2.0 3.0±2.2 <0.001 0.013 0.614 
 CRT 13.2±6.4# -0.4±1.8 2.1±1.8 5.7±2.1**    
dP/dtMAX (mmHg/s) BL 807±264 51±42 39±45 -42±48 <0.001 0.045 0.296 
 CRT 953±287## 79±39* 98±39* 77±44    
-dP/dtMIN (mmHg/s) BL 829±237 5±34 -36±37 -84±40 <0.001 0.105 0.650 
 CRT 936±281## 17±32 6±32 -25±37    
τ (ms) BL 83.1±12.6 -7.0±2.9* -7.5±3.1* -13.2±3.3** 0.637 <0.001 0.653 
 CRT 81.4±12.7 -3.2±2.7 -8.0±2.7** -10.7±3.0**    
PWS (mmHg) BL 342±89 -2.5±20 -22±21 -54±23* 0.149 0.012 0.940 
 CRT 331±99 -9.5±18 -19±18 -43±21*    
WSED (mmHg) BL 61±26 1.4±8.0 -3.1±8.6 -3.5±9.3 0.142 0.323 0.105 
 CRT 47±31 -2.5±7.3 8.5±7.3 19.7±8.2*    
DYS (%) BL 31.4±3.2 -0.2±1.1 -0.5±1.2 -1.4±1.3 <0.001 0.960 0.346 
 CRT 27.4±4.5## -0.5±1.0 -0.1±1.0 1.2±1.2    
IFF (%) BL 71±23 -0.7±6.4 -1.0±6.8 -3.2±7.3 <0.001 0.979 0.959 
 CRT 42±23## -0.8±6.0 -2.5±6.0 -0.6±6.7    
EA (mmHg/mL) BL 1.94±0.33 0.43±0.11** 1.03±0.12** 2.06±0.12** <0.001 <0.001 <0.001 
 CRT 1.78±0.41 0.25±0.10** 0.74±0.10** 1.29±0.11**    
EES (mmHg/ml) BL 0.67±0.43 -0.03±0.10 -0.04±0.11 -0.11±0.12 <0.001 0.902 0.936 
 CRT 1.00±0.67## -0.02±0.09 -0.03±0.09 -0.02±0.10    
EED (mmHg/mL) BL 0.074±0.038 0.002±0.011 0.014±0.012 0.035±0.014* 0.777 <0.001 0.810 
 CRT 0.067±0.029 0.001±0.010 0.020±0.010 0.050±0.012**    
PVA (mmHg·L) BL 14.5±4.4 -1.50±0.79 -2.90±0.85** -5.20±1.06** 0.056 <0.001 0.505 
 CRT 13.1±3.2 -0.62±0.71 -1.64±0.71* -3.44±0.78**    
ME BL 0.31±0.14 -0.03±0.03 -0.09±0.03** -0.09±0.04* <0.001 <0.001 0.470 
 CRT 0.45±0.15## -0.02±0.02 -0.03±0.02 -0.08±0.03**    
EES/EA BL 0.34±0.21 -0.08±0.04 -0.14±0.04** -0.22±0.05** <0.001 <0.001 0.841 
 CRT 0.57±0.39## -0.09±0.04* -0.19±0.04** -0.23±0.04**    
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Mechanical dyssynchrony and internal flow fraction were significantly reduced. 
Mechanical dyssynchrony was improved at all segmental levels except for the apical 
segment (Figure 2). Despite the significant reduction in LV volumes, LV wall stress 
was not significantly reduced. This was due to a concomitant significant reduction in 
LV mass from 324±92g at baseline to 290±107g (p<0.001) after 6 months of CRT. 
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Figure 1. Effects of chronic CRT in two patients. Typical pressure-volume loops at baseline (grey) and 
after 6 months of chronic CRT (black) are shown (in all cases at a heart rate of 80 beats/min). Note the 
left ward shift of the pressure-volume loops indicating substantial reversed remodeling 
 
Responses to increased heart rate 
Table 2 shows mean values at baseline and 6-months CRT for all hemodynamic indexes 
at 80 beats/min, and the related changes during pacing at 100, 120 and 140 beats/min. 
The mean values of the main indexes are also graphically displayed in Figure 3. At 
baseline, cardiac output did not increase with incremental pacing, but rather cardiac 
output was significantly reduced at 140 beats/min, indicating an exhausted chronotropic 
reserve in these heart failure patients. In contrast, at 6 months follow-up, cardiac output, 
which was significantly higher at 80 beats/min compared to the same heart rate at 
baseline, increased further at 100 beats/min and remained stable at higher rates (Figure 
3A). Similarly, at follow-up, LV ejection fraction was significantly higher at 80 
beats/min, and the reduction in LV ejection fraction at incremental pacing was 
substantially less pronounced than at baseline (Figure 3B). The negative chronotropic 
responses at baseline mainly resulted from a rapid decrease in end-diastolic volume with 
incremental pacing, with a less pronounced drop in end-systolic volume. After 6 months 
of CRT, the reduction in end-diastolic volume was more limited (only significant at 140 
beats/min) whereas end-systolic volume remained unchanged (Figure 3C). 
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Figure 2. Mechanical dyssynchrony (DYS) and internal flow fraction (IFF) at baseline and after 6 months 
of CRT (at 80 beats/min). DYS is also shown per segment. Significances vs. baseline: # p<0.05, ## p<0.01, 
### p<0.005, #### p<0.001 
 
At the same time systolic pressure dropped significantly at 140 beats/min both at 
baseline and at 6 months of CRT, and diastolic pressure tended to increase with pacing 
rate at both time-points. These effects are clearly shown by the average (i.e. based on 
mean end-systolic and end-diastolic pressures and volumes) pressure-volume loops in 
Figure 4. Note the substantial reverse remodeling evidenced by the leftward shift of all 
pressure-volume loops at 6 months of CRT, and the fact that stroke volume (the width 
of the pressure-volume loops) was better maintained during increased heart rate after 6 
months of CRT. 
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Figure 3. Main hemodynamic indexes at baseline and after 6 months of CRT. CO indicates cardiac 
output; EDP, end-diastolic pressure; EF, LV ejection fraction; EES, end-systolic elastance; EA, arterial 
elastance; EDV, end-diastolic volume; ESV, end-systolic volume; ME, mechanical efficiency. The Figures 
show mean±SD at 80, 100, 120 and 140 beats/min (p80, p100, p120 and p140).  Significances vs. p80 at 
the same condition (baseline or CRT): * p<0.05, ** p<0.01. Significances at p80 for CRT vs. baseline: # 
p<0.05, ## p<0.01 
 
Interestingly, after 6 months of CRT, dP/dtMAX showed a significant increase at higher 
pacing levels as compared to the value at 80 beats/min, whereas at baseline no 
significant increases were found during incremental pacing. This indicates a more 
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physiological response after 6 months of CRT. This is illustrated in Figure 5, which 
shows LV pressure and LV dP/dt for the different heart rates at baseline and after 6 
months of CRT in a typical patient. Note the higher dP/dtMAX after 6 months of CRT 
and the gradual increase in dP/dtMAX with increased pacing rate, which was absent at 
baseline. This change towards normalization of chronotropic response was not found for 
dP/dtMIN. Ventricular-arterial coupling, quantified by the ratio of ventricular and arterial 
elastance, was highly abnormal in the heart failure patients, but improved significantly 
after 6 months of CRT. The drop in EES/EA with increased heart rate was still present 
after CRT (Figure 3E). Likewise, mechanical efficiency was improved at follow-up, but 
dropped significantly at 140 beats/min both at baseline and after 6 months of CRT 
(Figure 3F). 
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Figure 4. Mean pressure-volume loops at baseline and after 6 months of CRT. Mean pressure-volume 
loops are based on mean end-systolic and end-diastolic pressures and volumes and are shown at heart 
rates 80, 100, 120 and 140 beats/min. At baseline we used right atrial pacing via a temporary pacing 
lead; at follow-up biventricular pacing was performed by reprogramming the CRT device 
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Figure 5. Typical examples of LV pressure and LV dP/dt during incremental pacing rate at baseline and 
after 6 months of CRT. Note that dP/dtMAX was unchanged with increasing heart rate at baseline, whereas 
dP/dtMAX substantially increased after CRT (See the bottom panels which extent the first 100ms of the 
dP/dt tracings) 
 
 
DISCUSSION 
 
CRT is a highly effective new therapy in patients with left bundle-branch block and 
severe heart failure. Large-scale studies have reported long-term clinical benefit with 
improved LV function and reverse LV remodeling.1,6,13,27 In these studies, follow-up is 
generally performed with echocardiography, and improvements in LV function are 
reported mainly in terms of increased ejection fraction. Detailed invasive hemodynamic 
studies of the acute effects of CRT, including analyses with pressure-volume loops12,28, 
have been published previously, but to our best knowledge no such data are available 
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for chronic CRT. In the present study we obtained invasive hemodynamics by pressure-
volume loops at baseline and after 6 months of CRT. Our data confirm previous 
findings regarding clinical benefit, improved LV ejection fraction and reverse 
remodeling. In addition, it shows that hemodynamic improvements in terms of 
increased dP/dtMAX, dP/dtMIN and stroke work, and reduced end-diastolic pressure, 
previously found in acute studies6,11,28,29, are still present at 6 months follow-up. 
Moreover, our study shows improved ventricular-arterial coupling and improved 
mechanical efficiency. These hemodynamic findings are consistent with the observed 
improvements in clinical and functional status. The altered responses to increased heart 
rate may partly explain the improved exercise capacity of patients treated with CRT. At 
baseline, cardiac output was unchanged when heart rate was increased illustrating the 
exhausted LV function reserve of these patients. At follow-up this is converted to a 
more physiological response although the capacity to increase cardiac output is still 
limited. The latter presumably is partly due to an abnormal relaxation reflected by a 
relatively long isovolumic relaxation time (τ), which did not improve after CRT. In the 
normal heart, τ substantially shortens at higher heart rate, which enables adequate filling 
despite a shortened diastolic period. This response is largely lost in heart failure, and did 
not normalize after 6 months of CRT in our patients. Consistent with our findings, 
previous studies failed to show improvements in isovolumic relaxation neither with 
acute biventricular pacing29,30 nor at long-term.13 A theoretical model by Hay et al.31 
shows a close correlation between increased τ and increased diastolic pressure, which is 
most evident at high heart rates. Our data are consistent with this prediction and show 
that the phenomenon is still present after 6 months of CRT. The improved mechanical 
efficiency found in our study is in line with previous studies on acute effects of CRT by 
Nelson et al.12 and is consistent with studies by, e.g., Sundell et al.14 in patients treated 
long-term. Most likely, the improved mechanical intraventricular synchrony underlies 
the more efficient conversion of total mechanical energy to external stroke work. This is 
most evident from a highly significant reduction in internal flow fraction from 71 to 
42%, which indicates that segmental volume changes are more efficiently used for 
effective ejection rather than for energy-wasting shifting of blood volumes between 
segments within the ventricle. In addition, ventricular-arterial coupling was significantly 
improved which further optimizes production of external work.32,33 However, whereas 
in the normal heart optimal ventricular-arterial coupling is maintained with increased 
heart rate34, EES/EA significantly dropped in our patients and this abnormal response was 
still present after long-term CRT. The baseline values for mechanical efficiency and 
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ventricular-arterial coupling found in our study (0.31 and 0.34, respectively) were in the 
same range but somewhat lower than values reported by Kim et al.35: 0.38 and 0.42, 
respectively. However, the patients in their study had less severe heart failure evidenced 
by an average NYHA classification of 1.8±0.7 and an LV ejection fraction of 37±13%. 
Asanoi et al.36 reported that in the failing heart homeostatic mechanisms maintain 
arterial blood pressure within the normal range, but that this blood pressure level causes 
a deviation from energetically optimal conditions in hearts with a severely reduced 
contractile state. This discrepancy results from worsening of ventricular-arterial 
coupling and decreased mechanical efficiency. Conversely, the improved ventricular-
arterial coupling and mechanical efficiency after 6 months of CRT, as found in our 
study, constitutes a more optimal energetic condition. Interestingly, despite the 
substantial reverse remodeling in our study, wall stress was not significantly reduced 
after 6 months of CRT. This was due to a concomitant reduction in LV mass. We would 
hypothesize that the regression in LV volumes initially leads to a reduction in wall 
stress, which then in turn may cause a reduction in LV hypertrophy. Note however that, 
although not statistically significant, diastolic wall stress was reduced by 23% at 80 
beats/min and by 30% at 100 beats/min. At higher heart rates, wall stress was virtually 
unchanged or even increased compared to baseline (-5% at 120 beat/min, and +24% at 
140 beats/min). This finding is explained by the fact that at baseline end-diastolic 
volume drops substantially at the high heart rates (which also limits the increase in end-
diastolic pressure), whereas end-diastolic volume is better maintained at 6-months 
follow-up. Furthermore, the global model to calculate wall stress does not take into 
account spatial dyssynchrony, and conversion to a more uniform contraction pattern at 
6-months follow-up may lead to reductions in wall stress at a regional level. 
In our study we used simultaneous biventricular pacing in all patients. Sequential 
biventricular pacing has been proposed to optimize CRT, and either right ventricular or 
left ventricular pre-excitation may optimize hemodynamics in individual patients.8,37 
However, Hay et al.28 demonstrated that sequential biventricular stimulation offered 
minimal benefit and that, on the average, most systolic and diastolic function parameters 
reached a maximum with simultaneous pacing. In addition to improvement of intra- and 
interventricular dyssynchrony, the patients may also have benefited from optimization 
of the AV delay. In our study the AV delay was reduced from a baseline value of 
184±96 ms to a mean value of 97±15 ms during CRT. Studies by Auricchio et al.24 
showed that the maximal increases in pulse pressure and dP/dtMAX were obtained at 
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45% of the intrinsic AV interval. Consistently, most studies report optimal AV delays of 
100-120 ms, but small differences in delay have far less influence than pacing site.29 
Because our baseline studies were performed prior to implantation of the CRT device 
we could not assess the acute hemodynamic effects of CRT. However, these effects 
were documented in previous studies. Acute improvements in CO or SV, in most 
studies assessed by changes in aortic pulse pressure, were reported to be in the range of 
7 to 15% 3,11,24,28,29,38,39, which is comparable to the 14% increase found at 6-months in 
our study. Previous studies show an acute reduction of 10 to 18% in end-systolic 
volume, and a relatively smaller reduction in end-diastolic volume of 5 to 9% 8,30,39 , 
which lead to 15 to 33% relative improvement in EF. The reductions in end-systolic and 
end-diastolic volume at 6 months in our study were 30 and 20%, respectively. 
Apparently, the acute improvement in cardiac output is maintained long-term, but both 
end-systolic and end-diastolic volume show a gradual, more or less parallel, further 
reversed remodeling, as previously documented over a 3-months period by Yu et al.27 
With regard to dP/dtMAX, previous studies fairly consistently showed an acute increase 
of 13 to 21% 3,7,11,24,28,29,38, which is close to the 18% increase found in our study at 6-
months follow-up. Yu's study revealed that more than 60% of the gain in dP/dtMAX 
obtained after 3 months CRT is lost immediately after turning off the pacemaker, 
whereas 4 weeks after cessation of CRT dP/dtMAX had completely returned to pre-CRT 
values. Their study also showed that left ventricular volumes increased and other 
echocardiographic benefits were gradually lost over the 4-week period. We did not 
systematically investigate the effects of turning off the pacemaker, but in a few patients 
we registered pressure-volume loops during temporary cessation of pacing in the 
follow-up study. Figure 6 shows two typical examples: The pressure-volume loops 
show an immediate reduction in stroke volume, whereas dP/dtMAX was decreased by 20 
and 7%, respectively. These immediate on-off responses are very similar to those 
registered previously in acute studies.29 
 
Limitations 
The sample size in our study was too small to justify a meaningful responder/non-
responder analysis. Only 4 patients did not show an improved clinical status: 3 patients 
with NYHA class III remained in class III, one class III patient deteriorated to class IV. 
All other patients improved by 1 or 2 NYHA classes. In the 'non-responder' group the 
baseline end-diastolic volume and end-systolic volume (282±73 and 228±70 mL, 
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respectively) appeared to be somewhat higher than in the group as a whole, and ejection 
fraction somewhat lower (21±6%). 
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Figure 6. Immediate effects of cessation of biventricular pacing after 6-months CRT in two patients. 
Typical pressure-volume loops during pacing ON (black) and OFF (grey). Note the immediate reduction 
in stroke volume 
 
In conclusion, our study shows that hemodynamic improvements that were previously 
shown in acute studies are maintained with long-term CRT. In addition, ventricular-
arterial coupling, mechanical efficiency, and chronotropic responses are improved after 
6 months of CRT. These findings may help to explain the improved functional status 
and exercise tolerance in heart failure patients treated with cardiac resynchronization. 
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ABSTRACT 
 
Background. Surgical ventricular restoration (SVR) and restrictive mitral annuloplasty 
(RMA) are increasingly performed for end-stage heart failure. We studied their clinical 
efficacy in patients with end-stage heart failure. 
Methods. We included 33 patients with NYHA class III/IV and left ventricular ejection 
fraction ≤ 35%. In this group, patients with moderate to severe mitral regurgitation 
(grade ≥ 2) underwent RMA and patients with anteroseptal aneurysm underwent SVR. 
A combined procedure (SVR and RMA) was performed in 12 patients, isolated SVR in 
5 patients and isolated RMA in 16 patients. Additional coronary artery bypass grafting 
was done in 27 patients. Clinical parameters, including NYHA classification, Minnesota 
Quality of Life (QoL) questionnaire, and 6-minute walking distance, were assessed at 
baseline and 6 months after surgery. 
Results. In the total group, operative mortality was 3% (n=1), in-hospital mortality was 
9% (n=3), and there was no late mortality. Four patients (12%) needed post-operative 
intra-aortic balloon pump support. The median duration at intensive care was 4 days 
(range: 2-28) with a median hospital stay of 13 days (range: 7-49). All clinical 
parameters were significantly improved at 6 months follow-up (p<0.001); NYHA 
classification was improved from 3.4±0.5 to 1.5±0.5, QoL questionnaire score was 
improved from 44±22 to 16±12, and 6-minute walking distance was increased from 
248±134 to 422±113 m. 
Conclusions. Surgical treatment of end-stage heart failure by SVR and/or RMA was 
associated with 12% mortality at 6 months. Surviving patients showed a highly 
significant clinical improvement. 
 
 
INTRODUCTION 
 
Chronic heart failure is one of the major healthcare problems in the world both in terms 
of patient numbers, hospitalizations, and economic costs. In the United States, 4 to 5 
million people have chronic heart failure, which leads to more than 2 million 
hospitalizations each year.1 Despite optimal medical therapy, many patients remain 
severely symptomatic. In these patients, cardiac transplantation remains the most 
effective surgical therapy with 1-, 5- and 10-year survival rates of 94, 78, and 46%, 
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respectively.2,3 Although effective, heart transplantation is importantly hindered by 
donor shortage, chronic rejection, and complications related to medication. 
Given the limitations of medical therapy and cardiac transplantation, alternative surgical 
therapies such as surgical ventricular restoration (SVR) and restrictive mitral 
annuloplasty (RMA) have been introduced and are currently widely performed in 
patients with end-stage heart failure.4,5 These therapies aim to correct frequently 
observed end-stage complications as left ventricular aneurysm  and mitral 
regurgitation.6,7 If not treated, these complications usually have important adverse 
effects on long-term morbidity and survival.8-10 
A long-term study by the RESTORE-group has demonstrated that SVR is safe and 
highly effective in the treatment of ischemic cardiomyopathy with a reduction of end-
systolic volume and a five-year survival of 69%.11 Several studies reported promising 
results in patients with heart failure treated with RMA with one- and two-year survival 
rates of 86% and 84%, respectively.12,13 
In the present study, clinical efficacy was evaluated six months after surgery in a cohort 
of patients with end-stage heart failure who underwent combined SVR and RMA, 
isolated SVR or isolated RMA. 
 
 
METHODS 
 
Patients 
We included 33 patients with end-stage heart failure, NYHA classification III or IV 
with left ventricular ejection fraction ≤ 35%. These patients underwent heart failure 
surgery for anteroseptal aneurysm and/or moderate to severe mitral regurgitation. 
Twelve patients had both anteroseptal aneurysm and moderate to severe mitral 
regurgitation (grade ≥ 2) and they underwent combined SVR and RMA; 5 patients had 
an anteroseptal aneurysm and underwent isolated SVR (SVR group, n=17). Another 16 
patients had severe mitral regurgitation (grade > 2) and no aneurysm and thus 
underwent isolated restrictive mitral annuloplasty (RMA group, n=16). All patients 
received stable medical therapy for chronic heart failure, including diuretics, 
spironolactone, β-blockers, and ACE-inhibitors. The institutional review board 
approved the study protocol and all patients provided informed consent. Patient 
characteristics are summarized in table 1. 
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Table 1. Patient characteristics 
Variable N=33 
Gender (M/F) 20/13 
Age, yrs 64±12 
Etiology (ischemic vs non-ischemic) 29/4 
NYHA class 3.4±0.5 
Duration of symptoms (median, months) 8 (2-62) 
LVEF, % 27±8 
Medication: 
- Diuretics/spironolactone 
- Nitrates 
- ACE-inhibitors/A-II antagonists 
- β-blockers 
- Anticoagulants/aspirin 
 
25 (76%) 
7  (21%) 
26 (79%) 
21 (64%) 
22 (67%) 
NYHA, New York Heart Association. LVEF, left ventricular ejection fraction, ACE, Angiotensin 
Converting Enzyme; A-II, Angiotensin II 
 
Evaluation of mitral regurgitation 
In patients with moderate to severe mitral regurgitation (grade ≥2) on transthoracic 
echocardiography (TTE), additional transesophageal echocardiography (TEE) was 
performed within 5 days before surgery. The TTE and TEE were performed without 
general anesthesia to avoid underestimation of the severity of mitral regurgitation. The 
severity of mitral regurgitation was graded semi-quantitatively from color-flow Doppler 
in the conventional parasternal long-axis and apical 4-chamber images. Mitral 
regurgitation was classified as: mild=1+ (jet area/atrial area <10%), moderate=2+ (jet 
area/atrial area 10-20%), moderately severe =3+ (jet area/atrial area 20-45%), and 
severe=4+ (jet area/atrial area >45%).14,15 The severity and precise mechanism of mitral 
regurgitation was confirmed from the TEE images. 
When the severity of mitral regurgitation was grade 2, an intraoperative loading test (as 
described previously) was performed.16,17 Briefly, a preload test is performed by rapid 
infusion of volume through the aortic cannula until the pulmonary artery capillary 
wedge pressure increases by 15 mmHg. During this provocative test, the severity of 
mitral regurgitation is continuously monitored, and patients who deteriorated to grade 3 
or 4 mitral regurgitation underwent RMA. Immediately after surgery, TEE was repeated 
to assess residual mitral regurgitation, transmitral diastolic gradient (determined from 
continuous-wave Doppler), and length of coaptation of the mitral leaflets. 
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Surgical procedures 
SVR was performed by the endoventricular circular patch plasty as previously described 
by Dor.18,19 Briefly, the left ventricle was opened through the infarcted area. An 
endocardial encircling suture (Fontan Stitch) was placed at the transitional zone 
between scarred and normal tissue. A balloon containing 55mL/m2 body surface area 
saline was introduced into the left ventricle and the Fontan stitch was tightened to 
approximate the ventricular wall to the balloon. An oval dacron patch was tailored and 
used to close the residual orifice. The excluded scar tissue was closed over the patch to 
ensure hemostasis. Care was taken to eliminate all septal scar and to delineate a new 
apex with the goal to restore the normal elliptical shape. 
Stringent restrictive mitral annuloplasty (2 sizes smaller than measured) was performed 
via an atrial transseptal approach using a Carpentier Edwards Physio ring (Edwards 
Lifesciences, USA) as previously described.20 Additional coronary artery bypass 
grafting was performed, if indicated. 
 
Clinical evaluation 
Patients were evaluated at the outpatient clinic at baseline and at 6 months after surgery. 
Heart failure symptoms were classified using the NYHA score. Quality of Life score 
was assessed using the Minnesota Living with Heart Failure questionnaire.21 This 
questionnaire contains 21 questions concerning the patient's perception of the effects of 
heart failure on daily life activities. Questions are scored from 0 to 5, resulting in a total 
score from 0 to 105, with the highest score reflecting the worst quality of life. Exercise 
tolerance was evaluated using 6-minute hall-walk tests at both visits.22 
 
Statistics 
Baseline and follow-up data were compared with paired t-tests. Statistical significance 
was assumed at p < 0.05. All data are presented as the mean value ± SD. 
 
 
RESULTS 
 
Mean cardiopulmonary bypass (CPB)-time was 192±64 minutes with a mean aortic 
cross-clamp time of 132±49 minutes. Weaning from CPB was uneventful in almost all 
patients. However, in one case a patient developed an irreversible vasoplegic shock after 
weaning from CPB and died during surgery (3% operative mortality) and four patients 
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(12%) needed post-operative intra-aortic balloon pump support. There were no peri-
operative myocardial infarctions. Three additional patients died in the hospital (9%); 
one patient who underwent combined SVR/RMA died 30 days postoperatively due to a 
cerebrovascular accident, one patient (isolated SVR) died 5h postoperatively due to left 
ventricular failure, and one patient (isolated RMA) died 7 days postoperatively due to 
left ventricular failure. Early non-fatal complications consisted of postoperative atrial 
fibrillation (3 patients), cerebrovascular accidents (1 patient), and renal failure (1 
patient). One patient developed postoperative sepsis with an empyema in the pleural 
space, which required surgical evacuation and this patient stayed 54 days at ICU with a 
total hospital stay of 66 days. For the remaining patients, the median duration at 
intensive care was 4 days (range: 2-28) with a median hospital stay of 13 days (range: 
7-49). In the total group, we had no late mortality during the 6 months follow-up period. 
Thus, overall mortality in our patient group was 12% at 6 months and complete clinical 
assessment was performed in the 29 surviving patients. 
 
Mitral regurgitation 
The mean grade of mitral regurgitation at baseline in the patients who underwent RMA 
was 3.0±0.6. The length of the anterior mitral leaflet (AML) was 2.88±0.30 cm with a 
mean mitral annular diameter (MAD) of 4.08±0.55 cm (mean ratio MAD/AML 
1.42±0.18). After surgery, no recurrence of mitral regurgitation was observed in these 
patients (0.3±0.4) with restored length of leaflet coaptation of 0.82±0.19 cm and a mean 
gradient of 2.9±1.3 mmHg. 
 
NYHA score 
In the total group, the mean NYHA score improved from 3.4±0.5 at baseline to 1.5±0.5 
at 6 months follow-up (p< 0.001) (Figure 1). In both the RMA and SVR patients the 
improvements in NYHA score was similar; in the RMA patients NYHA score improved 
from 3.4±0.5 at baseline to 1.5±0.5 at 6 months follow-up (p< 0.001) and in the SVR 
patients NYHA score improved from 3.5±0.5 at baseline to 1.5±0.5 at 6 months follow-
up (p< 0.001). 
 
Quality-of-Life Minnesota score 
Quality of Life score in the total group at baseline was 44±22 and decreased by 64% to 
16±12 at 6 months follow-up (p< 0.001) (Figure 1). The change in the total group was 
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similar to changes in the RMA (-63%) and SVR (-65%) subgroups. In the RMA patients 
Quality of Life score was decreased from 48±23 at baseline to 18±11 at 6 months 
follow-up (p< 0.001) and this score was decreased from 40±21 at baseline to 14±12 at 6 
months follow-up (p=0.002) in the SVR patients. 
 
Six-minute hall-walk test 
The mean walking distance in the total group of patients was 248±134 m at baseline and 
improved by 70% to a mean walking distance of 422±113 m at 6 months follow-up (p< 
0.001) (Figure 1). In the RMA patients the mean distance walked was 238±151 m at 
baseline and improved significantly (p <0.001) to 438±110 m at 6 months follow-up. In 
the SVR patients, the mean walking distance increased from 258±120 m at baseline to 
406±117 m at 6 months follow-up (p< 0.001). 
 
NYHA QoL 6minWD
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*      *
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Figure 1. NYHA classification, quality-of-life (QoL) score, and 6-minute walking distance (6minWD) at 
baseline (BL) and at 6 months follow-up (6MO) for the RMA and the SVR groups. Significant 
improvements were observed in all parameters at 6 months follow-up in both groups. No significant 
differences were found between groups. * p < 0.002 versus baseline 
 
 
DISCUSSION 
 
Heart transplantation is now considered standard treatment for select patients with end-
stage heart disease; but it is only applicable to a small number of patients. In an effort to 
address this problem, alternative surgical therapies are evolving, including SVR and 
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RMA, and other approaches. These operative techniques to alter the shape of the left 
ventricle, in combination with optimal medical management for heart failure, may 
improve survival. In some patients it may even avoid or postpone transplantation. 
The purpose of the present study was to evaluate the clinical efficacy of these treatments 
using NYHA classification, Minnesota Living with Heart failure questionnaire, and 6-
minute hall-walk test in a cohort of patients with end-stage heart failure who underwent 
SVR and/or RMA at our institution. 
We found that the surgical treatment was associated with 12% mortality at 6 months 
and resulted in an improvement in symptoms (NYHA class), accompanied by 
improvement in 6-minute walking distance and Quality of Life score. Our results 
regarding mortality are in line with the results of Dor et al. who reported 12% operative 
mortality in 835 patients with end-stage heart failure.23 Earlier studies by Di Donato et 
al. indicated a 19% in-hospital mortality and 26% mortality at one-year follow-up.24 
However, the mean left ventricular ejection fraction in Di Donato's group was 17±3%, 
while the mean ejection fraction in our series was 27±8% and in Dor's group only about 
10% of the patients had an left ventricular ejection fraction < 20%. More recently, Qin 
et al. reported a lower rate of mortality at six months follow-up of 5% in 60 patients 
who underwent SVR with or without mitral valve repair.25 Similar findings were 
reported by the RESTORE group with a 30-day mortality after SVR of 5.3% (8.7% with 
mitral repair vs. 4.0% without repair).11 However, in this large patient population, also 
patients with NYHA classification I/II were included. In all these previous studies, a 
significant improvement in NYHA classification has been observed at long-term 
follow-up, which was similar to the improvement found in our series. 
The aim of alternative surgical interventions (SVR and RMA) in patients with end-stage 
heart failure is to reduce left ventricular wall stress leading to reduced oxygen demand, 
improved mechanical dyssynchrony and mechanical efficiency. These effects may result 
in improvement of global and intrinsic systolic function. These theoretical assumptions 
were recently confirmed by hemodynamic studies in patients with end-stage heart 
failure.26,27 Operative mortality of both SVR and RMA are acceptable, however long-
term results are limited to survival rates, NYHA classification and hemodynamic 
parameters.11,12,28 Therefore, it is still relatively unknown whether these therapies lead 
to improvement of clinical status of the patient. Although previous studies indicate 
improvement in NYHA classification, to our best knowledge, our study is the first to 
show that these interventions lead to clinical improvement using 6-minute walking 
distance and Quality of Life score at 6-months follow-up. Our study did not include a 
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control group. However, previous epidemiological studies indicate that 1-year mortality 
rate in class III/IV heart failure patients is around 50%. 29 In comparison, the clinical 
efficacy of our surgical approach in terms of Quality of Life and 6-minute walking 
distance appears to be similar to the outcome after biventricular pacing in patients with 
end-stage heart failure.30-32 
 
Limitations 
This study represents a single-center experience in a relatively small cohort of patients 
with a combined surgical approach of SVR and/or RMA. Subgroup analysis did not 
show statistical differences, but the groups were relatively small and treatment 
obviously was not randomized. Moreover, this comparison should be taken with caution 
because, despite similar baseline clinical parameters, the etiology was different between 
groups. 
 
In conclusion, surgical treatment of end-stage heart failure by SVR and RMA seems 
relatively safe and surviving patients have clear clinical benefit at six months follow-up. 
Long-term prospective clinical randomized trials should be performed to assess benefit 
over optimal medical therapy. 
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ABSTRACT 
 
Background. Surgical ventricular restoration (SVR) is increasingly applied in patients 
with ischemic dilated cardiomyopathy. Previous studies show promising results with 
regard to survival and clinical outcome. However, a comprehensive mid-term analysis 
of this approach on left ventricular (LV) and right ventricular (RV) function is not yet 
available. We investigated biventricular function and clinical status at 6-months follow-
up. 
Methods. We investigated the effects of SVR on clinical parameters, LV volume and 
RV reverse remodeling, LV dyssynchrony, tricuspid regurgitation, and pulmonary 
artery pressure in 21 patients with ischemic dilated cardiomyopathy (NYHA class 
III/IV) who underwent SVR and CABG. Additional surgery included mitral 
annuloplasty (n=14) and tricuspid valve annuloplasty (n=8). Clinical parameters 
(NYHA, quality-of-life questionnaire, 6-min hall-walk test) and echocardiographic 
parameters were assessed at baseline and at 6-months. 
Results. At 6-months follow-up, all clinical parameters were significantly improved. 
LV ejection fraction improved from 27±10 to 36±11% (P<0.01), LV end-diastolic 
volume decreased from 248±78 to 152±50mL (P<0.001), and LV end-systolic volume 
from 186±77 to 101±50mL (P<0.001). LV dyssynchrony decreased from 61±41 to 
12±12ms (P<0.001). RV annular diameter decreased from 30±7 to 27±6mm, RV short-
axis from 30±9 to 27±7mm, and RV long-axis from 90±7 to 79±10mm (all P<0.05). 
Finally, significant reductions in severity of tricuspid regurgitation (from 1.3±1.1 to 
0.9±0.6, P=0.001) and pulmonary artery pressure (42±11 to 28±10mmHg, P=0.015) 
were observed. 
Conclusions. SVR resulted in improvement of clinical parameters, significant LV 
volume reduction and reduced LV dyssynchrony at 6-months follow-up. In addition, 
RV reverse remodeling was noted with reductions in tricuspid regurgitation and 
pulmonary artery pressure. 
 
 
INTRODUCTION 
 
Chronic heart failure is one of the major healthcare problems in the world both in terms 
of patient numbers, hospitalizations, and economic costs.1 The prognosis is extremely 
poor with a 5-year survival rate being less than 40%.2 Recently, it has been 
Beneficial mid-term effects of SVR  
 165
demonstrated that surgical ventricular restoration (SVR) improves symptoms and long-
term survival in patients with ischemic cardiomyopathy and severe heart failure.3 
Several studies have reported on the beneficial effects of SVR, including left ventricular 
(LV) volume reduction with an improvement in LV ejection fraction (LVEF), 
associated with a reduction in ventricular arrhythmias and reduced mitral  
regurgitation.4-6 In addition, recent studies have shown that SVR results in an acute 
reduction of LV mechanical dyssynchrony.7,8 
In patients with valvular insufficiencies who undergo SVR, additional mitral and or 
tricuspid valve repair may be needed to optimize patient outcome.9 Therefore, our 
current approach in patients undergoing SVR is to always correct mild to moderate 
mitral and tricuspid regurgitation using annuloplasty. Although preliminary data 
indicate acceptable survival, larger studies are required to establish survival rate. In 
addition, comprehensive data on clinical and hemodynamic status of these patients at 
mid-term follow-up are limited. Therefore, we analyzed clinical status and biventricular 
function in patients with ischemic dilated cardiomyopathy treated at our institution 
before and 6 months after surgery. In particular, we report the effects of our approach 
on LV volume, LV dyssynchrony, right ventricular (RV) reverse remodeling and RV 
functional parameters (severity of tricuspid regurgitation and pulmonary artery 
pressure). 
 
 
METHODS 
 
Patients and Study Protocol 
We studied a group of 21 patients with ischemic dilated cardiomyopathy, who 
underwent SVR and who had complete echocardiographic follow-up including tissue 
Doppler imaging at 6 months. All patients had severe heart failure symptoms and 13 
patients (62%) had accompanying angina pectoris. In particular, 13 (62%) patients were 
in New York Heart Association (NYHA) class III and 8 (38%) were in class IV. All 21 
patients had a previous anteroseptal infarction and the interval between infarction and 
SVR procedure averaged 2.5 years (range 0.25-12 years). All patients had coronary 
artery disease (on average 2.4±0.9 stenosed coronary arteries) and were scheduled for 
additional CABG. Patients with severe mitral and/or tricuspid regurgitation underwent 
additional mitral and/or tricuspid valve repair. Patients who underwent valvular repair 
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were evaluated before and immediately after surgery by transesophageal 
echocardiography (TEE). The baseline characteristics are presented in Table 1. 
 
Table 1. Patient characteristics 
Variable N=21 
Age, yrs  63±11 (35-76) 
Gender (M/F)  14/7 
Delay from previous infarction, mo 30±45 (4-144) 
QRS duration, ms 107±28 (80-202) 
NYHA class 
- class III 
- class IV 
 
13 (62%) 
8 (38%) 
Rhythm 
- sinus rhythm 
- atrial fibrillation 
 
20 (95%) 
1 (5%) 
Coronary artery disease 
- 1-vessel 
- 2-vessel 
- 3-vessel 
 
4 (19%) 
8 (38%) 
9 (43%) 
Medication: 
- Diuretics/spironolactone 
- Nitrates 
- ACE-inhibitors/A-II antagonists 
- β-blockers 
- Anticoagulants/aspirin 
 
18 (86%) 
7 (33%) 
17 (81%) 
16 (76%) 
15 (71%) 
ACE, Angiotensin Converting Enzyme; A-II, Angiotensin II; 
NYHA, New York Heart Association 
 
In all patients, before SVR and 6 months after surgery, two-dimensional transthoracic 
echocardiography (TTE) at rest was performed to calculate LV volumes and LVEF, and 
to assess RV chamber size. Next, tissue Doppler imaging was performed to evaluate LV 
dyssynchrony. At the same time points, clinical status was assessed using NYHA 
classification, the Minnesota quality-of-life questionnaire, and the 6-minute hall-walk 
test. The institutional review board approved the study protocol and all patients 
provided informed consent. 
 
Surgical Procedures 
The surgical procedures were performed with the use of normothermic cardiopulmonary 
bypass with intermittent antegrade warm blood cardioplegia for myocardial protection. 
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After median sternotomy, patients underwent conventional CABG, and internal 
mammary arteries were used whenever possible. Next, SVR was performed by means 
of endoventricular circular patch plasty as previously described by Dor.10,11 Briefly, the 
LV was opened through the infarcted area. An endocardial encircling suture (Fontan 
stitch) was placed at the transitional zone between scarred and normal tissue. A balloon 
containing 55 mL/m2 body surface area saline was introduced into the LV and the 
Fontan stitch was tightened to approximate the ventricular wall to the balloon. An oval 
Dacron patch was tailored and used to close the residual orifice. Care was taken to 
provide an elliptical shape to the residual LV cavity. The excluded scar tissue was 
closed over the patch to ensure hemostasis. In patients with concomitant severe mitral 
regurgitation (grade ≥2), additional mitral valve repair was indicated. In these patients, 
restrictive mitral annuloplasty with implantation of an undersized semi-rigid ring 
(aiming at stringent downsizing of the mitral annulus by 2 sizes) was performed via the 
transseptal approach. After weaning from cardiopulmonary bypass, TEE evaluation was 
performed in these patients to exclude residual mitral regurgitation and assess the length 
of mitral leaflet coaptation (aiming at ≥0,8 cm). In patients with severe tricuspid annular 
dilatation (>3.5 cm) and/or regurgitation (grade ≥2), a concomitant tricuspid 
annuloplasty was performed. 
 
Echocardiography 
Resting echocardiography and tissue Doppler imaging was performed at baseline (pre-
operatively), and at 6-months follow-up. Patients were imaged in the left lateral 
decubitus position using a commercially available system (Vingmed system Seven, 
General Electric-Vingmed, Milwaukee, Wisconsin, USA). Images were obtained using 
a 3.5 MHz transducer, at a depth of 16 cm in the parasternal and apical views (standard 
long-axis and two- and four-chamber images). Standard two-dimensional and colour 
Doppler data, triggered to the QRS complex were saved in cine loop format. LV 
volumes (end-systolic, end-diastolic) and LVEF were calculated from the conventional 
apical two- and four-chamber images, using the biplane Simpson's technique.12 
 
Evaluation of mitral and tricuspid regurgitation 
In patients with severe mitral and tricuspid regurgitation (grade ≥2) on TTE, additional 
TEE was performed within 5 days before surgery. The TTE and TEE were performed 
without general anesthesia to avoid underestimation of the severity of mitral and 
tricuspid regurgitation. The severity of mitral and tricuspid regurgitation was graded 
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semi-quantitatively from color-flow Doppler in the conventional parasternal long-axis 
and apical 4-chamber images. Mitral and tricuspid regurgitation were classified as: 
mild=1+ (jet area/atrial area <10%), moderate=2+ (jet area/atrial area 10-20%), 
moderately severe =3+ (jet area/atrial area 20-45%), and severe=4+ (jet area/atrial area 
>45%).13,14 The severity and precise mechanism of mitral regurgitation was confirmed 
from the TEE images. 
Immediately after surgery, TEE was repeated to assess residual mitral or tricuspid 
regurgitation, transmitral diastolic gradient (determined from continuous-wave 
Doppler), and length of coaptation of the mitral leaflets. Six months after surgery, TTE 
was performed to assess possible recurrence of mitral and tricuspid regurgitation. 
Continuous-wave Doppler examination was also performed to estimate pulmonary 
artery systolic pressure from the trans-tricuspid maximal regurgitant flow velocity. All 
TTE measurements were analyzed in random order by two independent observers 
without knowledge of the clinical status of the patient and the timing of the 
echocardiogram. 
 
Assessment of RV chamber size 
RV end-diastolic chamber size was assessed using three parameters, which were 
described previously by Foale et al.15 The first parameter is the diameter of the annulus 
of the tricuspid valve (TV ANN), defined as the point of attachment of the septal and 
posterior leaflets to the atrioventricular junction. The second measurement is the 
maximal dimension of the middle third of the RV, parallel to the tricuspid annulus (RV 
SAX). The last measurement is the major axis of the RV (RV LAX) and is defined as 
the distance between the RV apex to the mid-point of the tricuspid annulus. 
Inter- and intra-observer agreement for assessment of RV chamber size were 98% and 
96% for TV ANN, 90% and 92% for RV SAX, and 94% and 95% for RV LAX 
respectively. 
 
Tissue Doppler Imaging 
In addition to the conventional echocardiographic examination, tissue Doppler imaging 
was performed to assess LV dyssynchrony. For tissue Doppler imaging, color Doppler 
frame rates varied between 80 and 115 frames/s depending on the sector width of the 
range of interest; pulse repetition frequencies were between 500 Hz and 1 KHz, 
resulting in aliasing velocities between 16 and 32 cm/s. Tissue Doppler imaging 
parameters were measured from color images of three consecutive heart beats by offline 
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analysis. Data were analyzed using commercial software (Echopac 6.1, General Electric 
- Vingmed). 
To determine LV dyssynchrony, the sample volume was placed in the basal portions of 
the septum and the LV lateral wall; peak systolic velocities and time-to-peak systolic 
velocities were obtained and the delay in peak velocity between the septum and the LV 
lateral wall was calculated as an indicator of LV dyssynchrony (referred to as the septal-
to-lateral delay). 
Inter- and intra-observer agreement for assessment of the septal-to-lateral delay were 
90% and 96%, respectively.16 
 
Assessment of Functional Status 
Functional status was assessed according to the NYHA classification, quality-of-life 
score (using the Minnesota quality-of-life questionnaire) and 6-minute hall-walk test. In 
all patients, QRS duration was measured from the surface ECG using the widest QRS 
complex from the leads II, V1 and V6. The ECGs were recorded at a speed of 25 
mm/sec and were evaluated by two independent observers without knowledge of the 
patient’s clinical status. All parameters were assessed within 1 week before surgery and 
approximately 6 months post-surgery. 
 
Statistical Analysis 
Data are presented as mean ± SD, and compared using the paired or unpaired Student’s 
t-test when appropriate. For all tests a P-value <0.05 was considered statistically 
significant. 
 
 
RESULTS 
 
Twenty-one patients were evaluated: 12 patients (57%) had dyskinesia and 9 patients 
(43%) had akinesia. (Peri-)operative data and early operative complications (<30 days) 
are summarized in Table 2. Note that we only included a selected group of patients with 
complete echocardiographic follow-up at 6 months. Therefore, data regarding mortality 
are not relevant and clinical findings reflect only patients who survived 6 months 
follow-up. 
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Table 2. Surgical information, complications 
Variable N=21 
Additional valve procedures 
- RMA 
- TVA 
 
14 (67%) 
8 (38%) 
Number of distal anastomoses 3.1±0.9 
CPB, min 223±57 
AoX, min 131±38 
Early complications (<30 days) 
- SVT 
- VT 
- IABP 
- Reoperation for bleeding 
- Inotropy >24 hours 
 
1 (5%) 
1 (5%) 
3 (14%) 
1 (5%) 
12 (57%) 
ICU-duration, days 7±8 
Hospital stay, days 17±10 
AoX, aortic cross clamp time; CPB, cardiopulmonary bypass; IABP, intra-aortic balloon pump; ICU, 
intensive care unit; RMA, restrictive mitral annuloplasty; SVT, supraventricular arrhythmias; TVA, 
tricuspid valve annuloplasty; VT, ventricular tachycardia 
 
Clinical Parameters 
At 6-months follow-up a significant improvement in clinical status was observed. 
NYHA class improved significantly from 3.4±0.5 to 1.4±0.5 (P<0.001), the Minnesota 
quality-of-life score improved from 39±21 to 15±23 (P<0.001) and the 6-minute 
walking distance improved from 234±124 m to 416±106 m (P<0.001). QRS duration at 
baseline was 107±28 ms (range 80-202 ms) and remained unchanged (111±22 ms, 
range 90-172 ms, P=0.3481) at 6-months follow-up. 
 
Echocardiography 
Echocardiographic results at baseline and at 6-months follow-up are summarized in 
Table 3. 
 
Left ventricular dyssynchrony: At 6-months follow-up, tissue Doppler imaging 
demonstrated a significant reduction in septal-to-lateral delay from 61±41 ms to 12±12 
ms (P<0.001), indicating improved LV mechanical synchrony after surgery. 
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Left ventricular volume reduction: Significant LV volume reduction was shown at 6-
months follow-up. LV end-diastolic volume decreased from 248±78 ml to 152±50 ml 
(P<0.001), whereas LV end-systolic volume decreased from 186±77 ml to 101±50 ml 
(P<0.001). This resulted in an increase of the LVEF from 27±10 to 36±11% 
(P=0.0072). 
 
Right ventricular remodeling: At 6-months follow-up, significant reverse remodeling 
of the RV was demonstrated. All three parameters reflecting RV chamber size showed a 
significant decrease 6 months after surgery. The TV ANN showed a significant decrease 
from 30±7 mm to 27±6 mm (P=0.04), RV SAX decreased from 30±9 mm to 27±7 mm 
(P=0.03) and RV LAX showed a reduction from 90±7 mm to 79±10 mm (P<0.001). 
Moreover, after surgery, pulmonary artery pressure significantly decreased from 42±11 
mmHg to 28±10 mmHg (P=0.02). 
 
Table 3. Echocardiographic data 
 Baseline TTE 6- months follow-up TTE P-value 
LVEF, % 27±10 36±11 0.0072 
LVEDV, ml 248±78 152±50 <0.001 
LVESV, ml 186±77 101±50 <0.001 
Septal-to-lateral delay, ms 61±41 12±12 <0.001 
RV chamber size: 
- TV ANN, mm 
- RV SAX, mm 
- RV LAX, mm 
 
30±7 
30±9 
90±7 
 
27±6 
27±7 
79±10 
 
0.0430 
0.0326 
<0.001 
Pulmonary artery pressure, 
mmHg 
42±11 28±10 0.0157 
MR, grade 2.0±1.0 1.0±0.7 0.0013 
TR, grade 1.3±1.1 0.9±0.6 0.0018 
LVEF, left ventricular ejection fraction; LVEDV, left ventricular end-diastolic volume; LVESV, left 
ventricular end-systolic volume; RV, right ventricle; TV ANN, tricuspid valve annulus; RV SAX, right 
ventricular short axis; RV LAX, right ventricular long axis; MR, mitral regurgitation; TR, tricuspid 
regurgitation 
 
Mitral and tricuspid regurgitation: In 14 patients additional restrictive mitral 
annuloplasty (median ring size 24; range 24-28) was performed. In 9 (43%) of these 
patients, severe (grade 3 to 4+) mitral regurgitation was confirmed by TTE and TEE 
performed within 5 days before surgery. In the other 5 (24%) patients, grade 2+ mitral 
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regurgitation was observed during the TTE and TEE performed within 5 days before 
surgery. In these patients, provocative testing was performed in the operating room, 
resulting in grade 3 to 4+ mitral regurgitation in all patients. None of the patients had 
primary organic valvular disease. The mechanism underlying mitral regurgitation was 
systolic restrictive leaflet motion with annular dilatation, which resulted in coaptation 
failure (resulting in a central regurgitant jet). The patients who underwent mitral valve 
repair (n=14) had grade 2.8±0.7 mitral regurgitation on pre-operative TEE, which 
improved to grade 0.1±0.3 immediately after restrictive mitral annuloplasty. TTE after 6 
months showed no significant recurrence (grade 0.9±0.7). In these patients, pre-
operative TEE showed a mean length of coaptation of 0.23±0.06 cm, and 0.78±0.12 cm 
after restrictive mitral annuloplasty, with a mean transmitral diastolic gradient of 
3.1±1.5 mmHg. No systolic anterior movement of the anterior leaflet was observed in 
any patient. In the patients who did not receive additional mitral valve repair (n=7), 
mitral regurgitation was unchanged at 6-months follow-up (mitral regurgitation grade 
1.3±0.9 at baseline versus 1.1±0.8 at follow-up, P=0.604). In the group as a whole, 
mitral regurgitation was grade 2.0±1.0 at baseline, and 1.0±0.7 at 6-months follow-up 
(P=0.0013). 
In 8 patients additional tricuspid annuloplasty (median ring size 28; range 28-32) was 
performed for severe tricuspid regurgitation (pre-operative TEE: grade 2.5±0.5). The 
tricuspid regurgitation was successfully treated (post-operative TEE: grade 0.1±0.1). In 
the group as a whole, tricuspid regurgitation was grade 1.3±1.1 at baseline and 0.9±0.6 
at 6-months follow-up (P=0.0018). 
 
 
DISCUSSION 
 
The number of patients presenting with heart failure is increasing exponentially.17 In 
these patients, severe LV dilation and mitral/tricuspid regurgitation are frequently 
observed and conservative treatment of both complications is associated with a poor 
prognosis.18,19 
Therefore, surgical therapies (SVR and if indicated mitral and/or tricuspid annuloplasty) 
to correct these complications have evolved with acceptable survival rates. However, 
limited data is available about the effects on clinical status and LV and RV 
hemodynamics. In the current study, we analyzed clinical status and biventricular 
function in a group of patients with ischemic dilated cardiomyopathy undergoing SVR 
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and revascularization with, if needed, mitral and/or tricuspid valve repair before and 6 
months after surgery. In particular, we report the effects of this approach on LV volume, 
LV dyssynchrony, right ventricular (RV) reverse remodeling and RV functional 
parameters (severity of tricuspid regurgitation and pulmonary artery pressure). 
 
Clinical Status 
In the total group of patients, an improvement in heart failure symptoms was observed, 
illustrated by a significant reduction of NYHA class from 3.4±0.5 to 1.4±0.5, with all 
patients in NYHA class I or II at follow-up. Similar observations were reported by Di 
Donato et al. and Suma et al.20,21 In addition, more objective parameters of symptoms 
were also evaluated in the present study, including quality-of-life score and 6-minute 
walking distance, which improved in parallel to the improvement in NYHA class. 
 
Echocardiographic Evidence of Remodeling 
LV function: Besides the improvement in clinical status, previous studies demonstrated 
improvement in LVEF and LV volume reduction after SVR. Maxey et al. showed an 
acute increase in LVEF from 22±3 to 33±1% in 56 patients who underwent SVR 
combined with CABG.22 Qin et al. reported an increase in LVEF from 27±9 to 36±11% 
at 6-months follow-up in patients who underwent SVR combined with mitral valve 
repair.23 A similar increase in LVEF (from 27±10 to 36±11%, P<0.001) was noted in 
the current study. The improvement in LVEF was associated with the decrease in LV 
volume, with a mean reduction of 39% in LV end-diastolic volume and 46% in LV end-
systolic volume. Qin et al. showed a comparable reduction in patients undergoing SVR 
and mitral valve repair; the LV end-diastolic volume decreased from 235±87 ml at 
baseline to 156±73 ml at discharge, whereas the LV end-systolic volume decreased 
from 175±80 ml at baseline to 104±63 ml at discharge.23 At 6-months follow-up, 
however, LV volume reduction was not fully maintained and re-dilatation occurred with 
a final LV end-diastolic and LV end-systolic volume of 177±94 ml (NS vs. baseline) 
and 114±66 ml (NS vs. baseline) respectively. The re-dilatation was most outspoken in 
patients with recurrent mitral regurgitation, indicating that effective mitral valve repair 
is warranted in these patients to prevent re-dilatation. In our series, successful mitral 
valve repair without significant recurrence of mitral regurgitation was performed 
resulting in significant reduction in LV volumes at 6-months follow-up. Recently, Fujii 
et al. demonstrated that LV volume reduction may even be maintained at 3-years 
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follow-up; in 14 patients undergoing SVR, LV end-systolic volume was significantly 
reduced from 165±74 ml at baseline to 94±70 ml at 3-year follow-up.24 Also, 
Yamaguchi et al. demonstrated a long-term reduction in LV volumes at 5-year follow-
up after successful SVR with mitral valve repair.25 These preliminary results suggest a 
long-term benefit from SVR and mitral annuloplasty, but additional studies with larger 
patient populations are needed to confirm these findings. Previous studies indicate an 
acute volume reduction after SVR in a range between 33% to 40%, which suggests that 
the 39% volume reduction found in our study at 6 moths follow-up is achieved largely 
immediate after surgery.7,8,23,24 
RV function: The results in the current study illustrate that our surgical approach in 
patients with ischemic dilated cardiomyopathy is associated with a significant reduction 
in pulmonary artery pressure, with reduction in severity of tricuspid regurgitation and 
reverse RV remodeling. Currently, no other data are available regarding the effect of 
SVR and mitral and or tricuspid annuloplasty on RV function in patients with heart 
failure. One could hypothesize that successful mitral valve repair may lead to a 
reduction in pulmonary artery pressure with a recovery in RV function.26 Similarly, 
tricuspid annuloplasty would be expected to improve RV function.27 However, in our 
series we could not demonstrate significantly different effects on RV function between 
the patients who did or did not receive mitral and/or tricuspid annuloplasty. However, 
the number of patients in the subgroups is too small for adequate statistical analysis. 
The improvement in RV function is clinically important, since decreased RV function 
and RV dilatation have been shown to negatively affect hemodynamics, resulting in 
deterioration in heart failure symptoms with a worse prognosis.28,29 
 
LV Dyssynchrony  
LV dyssynchrony appears to be an important co-determinant of LV dysfunction in 
patients with heart failure.30,31 Recently, Di Donato et al. showed an acute reduction of 
LV mechanical dyssynchrony after SVR assessed by using centerline analysis of LV 
angiographic data.7 Similarly, Schreuder et al. showed that the reduction in LV 
dyssynchrony after SVR induced acute improvements in contractile status, energy 
efficiency, and LV relaxation.8 In the current study, a significant reduction in LV 
dyssynchrony at 6 months after surgery was shown using tissue Doppler imaging. 
Recent data suggested that LV dyssynchrony was associated with a worse outcome, 
whereas LV resynchronization was associated with a better long-term prognosis.32,33 
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Additional studies on LV dyssynchrony and subsequent resynchronization in patients 
undergoing SVR are needed to determine the clinical value of LV resynchronization. 
 
Limitations of the study 
In this study, we evaluated the hemodynamic and clinical status in a group of patients 
after SVR with, if indicated, mitral and/or tricuspid annuloplasty, who survived 6 
months follow-up. Therefore, this study did not provide data regarding clinical outcome 
in terms of mortality and morbidity. Another limitation of this study is the lack of acute 
data and therefore we cannot compare mid-term effects of SVR with effects 
immediately after surgery. 
The effects of additional valve procedures on biventricular function could not be 
established as the number of patients in this study was too small and treatment was not 
randomized. 
 
In conclusion, SVR with, if indicated, additional mitral and/or tricuspid annuloplasty 
resulted in significant improvement of clinical status and heart failure symptoms at 6 
months follow-up, combined with an improvement in LV function, reduction in LV 
volume, and a reduction in LV dyssynchrony with minimal residual mitral regurgitation. 
In addition, a decrease in pulmonary artery pressure, RV reverse remodeling and 
reduced tricuspid regurgitation was observed. 
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ABSTRACT 
 
Background. Previous studies have demonstrated that surgical ventricular restoration 
(SVR) has acute beneficial effects on mechanical dyssynchrony and left ventricular 
(LV) systolic function. However, chronic effects on systolic and diastolic function are 
largely unknown. 
Methods. We studied 8 patients with ischemic dilated cardiomyopathy who underwent 
SVR, restrictive mitral annuloplasty and coronary artery bypass grafting. In all patients, 
invasive hemodynamic measurements by the conductance catheter were performed 
before and six months after surgery. In addition, NYHA classification, six-minute walk-
test, Minnesota Living with Heart failure questionnaire were assessed at the same time-
points. 
Results. At six months follow-up, all patients were alive and clinically improved 
significantly (NYHA from 3.6±0.5 to 1.5±0.5, Minnesota-score from 45±23 to 16±16, 
and six-minute walking distance from 300±133 to 442±89 m). Hemodynamic data 
showed significantly improved LV ejection fraction (from 31±8 to 40±14%), LV 
reverse remodeling (end-diastolic volume from 214±57 to 173±46 mL, end-systolic 
volume from 146±46 to 100±41 mL), and significantly improved intrinsic systolic 
function (end-systolic elastance from 0.98±0.31 to 1.51±0.82 mmHg/mL). In addition, 
mechanical efficiency significantly improved (0.40±0.12 to 0.55±0.13) with significant 
reduction of mechanical dyssynchrony (30±4 to 26±3%). However, parameters of 
diastolic function were unchanged six months after surgery (end-diastolic pressure: 
20±9 to 18±7 mmHg; dP/dtMIN: -1149±233 to –1189±307 mmHg/s; tau: 80±14 to 81±17 
ms; chamber stiffness constant: 0.097±0.037 to 0.104±0.037 mmHg/mL). 
Conclusion. Surgical ventricular restoration leads to clinical improvement with 
sustained LV reverse remodeling, improved global and intrinsic systolic function and 
unchanged diastolic function. The improved clinical status after six months may be 
related to improved mechanical efficiency, intrinsic systolic function and reduced 
mechanical dyssynchrony. 
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INTRODUCTION 
 
Chronic heart failure is one of the leading causes of morbidity and mortality in the 
Western world.1 In the majority of cases, the etiology in these patients is ischemic heart 
disease. More specific in patients after anteroseptal infarction, left ventricular (LV) 
aneurysm is a frequently observed complication. It leads to ineffective wall motion 
during the cardiac cycle and LV geometric shape changes resulting in inefficient LV 
pump function and adverse effects on remote myocardium.2 These changes will increase 
the systolic workload in the remote myocardium, which may contribute to progressive 
heart failure.3 Despite optimal medical treatment, patients with LV aneurysm often 
remain symptomatic and surgery may be indicated. Surgical ventricular restoration 
(SVR) by endoventricular circular patch plasty is increasingly performed in these 
patients. This technique can exclude akinetic or dyskinetic portions of the anterior wall 
and septum, reshapes the LV by the use of a patch to re-establishes the ventricular wall 
continuity.4 Long-term studies have been demonstrated that SVR is safe and highly 
effective in the treatment of ischemic cardiomyopathy with reduction of end-systolic 
volume and favorable five-year outcome.5 
Currently, little is known about the mechanisms of SVR on long-term LV systolic and 
diastolic function. Recent hemodynamic studies have demonstrated that SVR acutely 
reduces LV mechanical dyssynchrony with acute improvement of intrinsic LV systolic 
function.6,7 In these studies, no data is available about the acute effects on diastolic 
function while some studies suggest that SVR may induce diastolic dysfunction.8,9 
Furthermore, limited data are available regarding chronic hemodynamic effects of SVR 
on LV function. Therefore, the purpose of this study is to evaluate these effects by use 
of invasive hemodynamic measurements derived by the conductance catheter before and 
six months after surgery. 
 
 
METHODS 
 
Patients 
In this study we included 8 patients with ischemic dilated cardiomyopathy (NYHA class 
III/IV, LVEF < 35%) who underwent SVR. All patients underwent restrictive mitral 
annuloplasty for at least moderate to severe mitral regurgitation (grade ≥ 2) and all 
underwent additional CABG. All patients received stable medical therapy for chronic 
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heart failure, including diuretics (n=7), spironolactone (n=5), β-blockers (n=6), and 
ACE inhibitors (n=6). All patients gave informed consent and procedures were 
conducted in accordance with institutional guidelines. Patient characteristics are 
summarized in table 1. 
 
Table 1. Patient characteristics 
  
Number of patients (n) 8 
Male / Female 6/2 
Age (years) 62±7 
NYHA class 3.6± 0.5 
LVEF (%) 27±8 
Angina (n) 5 
Mean stenosed coronary arteries 2.3±0.9 
Duration of symptoms (median, months) 8 (2-14) 
Post-MI time (median, months) 3 (8-144) 
NYHA: New York Heart Association, MI: myocardial infarction 
 
Study protocol 
All patients underwent routine right and left heart catheterization at baseline (i.e. pre-
surgery) and six months after surgery, including thermodilution cardiac output, left 
ventriculography, and coronary angiography. In addition, a conductance catheter was 
placed in the LV via the femoral artery, and a temporary pacing lead was positioned in 
the right atrium.  
Hemodynamic measurements. The conductance catheter enables on-line measurement 
of multiple segmental volume slices perpendicular to the LV long axis. We used 7F 
combined pressure-conductance catheters with 1-cm interelectrode spacing (CD 
Leycom, Zoetermeer, The Netherlands). The catheter was connected to a Cardiac 
Function Lab (CD Leycom) for on-line display and acquisition (sample frequency 
250Hz) of segmental and total LV volumes, LV pressure and ECG. Total LV volume 
(VLV) is obtained as the instantaneous sum of the segmental volumes. VLV was 
calibrated using thermodilution and hypertonic saline dilution as previously described.10 
Right atrial pacing was performed at 80 beats/min. All measurements were repeated 
during re-catheterization at least six months after surgery. 
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Clinical evaluation. Evaluation of clinical status included assessment of NYHA 
functional class, quality-of-life score (using the Minnesota quality-of-life questionnaire) 
and six-minute hall-walk test. 
Echocardiography. In patients with moderate to severe mitral regurgitation (grade ≥2) 
on transthoracic echocardiography (TTE), additional transesophageal echocardiography 
(TEE) was performed within 5 days before surgery. The TTE and TEE were performed 
without general anesthesia to avoid underestimation of the severity of mitral 
regurgitation. The severity of mitral regurgitation was graded semi-quantitatively from 
color-flow Doppler in the conventional parasternal long-axis and apical 4-chamber 
images.11,12 When the severity of mitral regurgitation was less than 3+, a loading test (as 
described previously13,14) was performed during anesthesia just before surgery. During 
these provocative tests, the severity of mitral regurgitation is followed, and patients who 
deteriorate to grade 3 or 4+ mitral regurgitation underwent restrictive mitral 
annuloplasty. Immediately after surgery, TEE was repeated to assess residual mitral 
regurgitation, transmitral diastolic gradient (determined from continuous-wave 
Doppler), and length of coaptation of the mitral leaflets (ideally ≥ 8 mm). Six months 
after surgery, TTE was performed to assess the severity of mitral regurgitation. All TTE 
measurements were analyzed in random order by two independent observers without 
knowledge of the clinical status of the patient and the timing of the echocardiogram. 
 
Surgical procedures 
SVR was performed by the endoventricular circular patch plasty as previously described 
by Dor.4,15 Briefly, the left ventricle was opened through the infarcted area. An 
endocardial encircling suture (Fontan Stitch) was placed at the transitional zone 
between scarred and normal tissue. A balloon containing 55mL/m2 body surface area 
saline was introduced into the LV and the Fontan stitch was tightened to approximate 
the ventricular wall to the balloon. An oval dacron patch was tailored and used to close 
the residual orifice. The excluded scar tissue was closed over the patch to ensure 
hemostasis. Care was taken to eliminate all septal scar and to delineate a new LV apex 
with the goal to restore the normal elliptical shape. After completion of the LV 
restoration, a stringent restrictive mitral annuloplasty (2 sizes smaller than measured) 
was performed in these patients via an atrial transseptal approach using a Carpentier 
Edwards Physio ring (Edwards Lifesciences, USA). 
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Data-analysis 
LV function was quantified by cardiac output (CO), LV ejection fraction (LVEF) and 
stroke volume (SV), end-diastolic and end-systolic volume (EDV, ESV), end-systolic 
and end-diastolic pressure (ESP, EDP), maximal and minimal rate of LV pressure 
change (dP/dtMAX, dP/dtMIN). The time constant of relaxation (τ) was determined using 
phase-plot analysis.16 Stroke work (SW) was calculated as the area of the pressure-
volume loop. Mechanical efficiency (ME) was calculated as the ratio of external stroke 
work and pressure-volume area (PVA) as a measure of total mechanical work: 
ME=SW/PVA17. LV end-systolic elastance (Ees) was estimated by ESP/ESV as 
relatively load-independent indexes of systolic function. LV end-diastolic chamber 
stiffness (CS) was estimated by EDP/EDV to characterize passive late diastolic 
function. Nonuniform LV performance was determined from the segmental LV 
conductance signals and quantified by calculating the percentage of time within the 
cardiac cycle that a specific segment is dyssynchronous (i.e. opposite in phase with the 
global LV volume signal). Overall LV dyssynchrony (DYS) was determined as the 
mean of the segmental dyssynchronies. In addition, we calculated the internal flow 
fraction (IFF), which quantifies the ineffective shifting of blood volume within the LV 
due to nonuniform contraction and filling18. 
 
Statistics 
Pre- and post data were compared with paired t-tests. Statistical significance was 
assumed at p < 0.05. All data are presented as the mean value ± SD. 
 
 
RESULTS 
 
There were no peri-operative or hospital deaths and all patients were alive at six months 
follow-up. After surgery, two patients needed intra-aortic balloon pump to wean from 
cardiopulmonary bypass and six patients needed inotropic support (dobutamine > 2 
μg/kg/min) more than 24 hours postoperatively. Immediate after surgery, 
transesophageal echocardiography was performed and showed restored leaflet 
coaptation with no residual mitral regurgitation. Surgical details are summarized in 
table 2. 
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Table 2. Surgical data 
  
CPB (minutes) 228±46 
Aox (minutes) 155±29 
Number of distal anastomosis 3±1 
Ring size 25± 1 
Pre-operative TEE  
-MR-grade   
-AML (cm) 
-MA   (cm) 
-MA/AML-ratio 
-Coaptation 
 
2.5± 0.9 
2.88± 0.11 
3.81± 0.64 
1.32± 0.22 
0.21±0.07 
Post-operative TEE  
-MR-grade  
-Coaptation (cm) 
-MV-gradient (mmHg) 
 
0.1±0.4 
0.78±0.13 
2.57±1.02 
ICU-stay (days) 5±2 
Hospital stay (days) 16±5 
CPB, Cardiopulmonary bypass; AoX, Aortic cross clamping time; TEE, Transesophageal 
echocardiography; MR, Mitral regurgitation; AML, Anterior mitral leaflet; MA, Mitral annulus MV, 
Mitral valve; ICU: Intensive care unit 
 
Clinical and hemodynamic data. Clinical parameters as NYHA functional class, 
quality-of-life score (using the Minnesota quality-of-life questionnaire) and 6-minute 
hall-walk test significantly improved from baseline to six months follow-up (Table 3). 
QRS duration was unchanged and mitral valve repair was successful in all cases with no 
recurrence of mitral regurgitation at six months follow-up.  
The chronic effects of surgery on LV function are summarized in detail in table 3. 
LVEF improved significantly, whereas EDV and ESV were significantly reduced at six 
months follow-up, indicating substantial reversed remodeling. Stroke volume was 
unchanged at six months follow-up. Improved intrinsic systolic function was evidenced 
by the significant increase in the end-systolic elastance (Ees). End-diastolic pressure, 
active relaxation (τ), dP/dtMIN, and CS, all parameters of diastolic function, were 
unchanged, indicating unchanged LV diastolic function six months after SVR. 
Furthermore, at six month follow-up, mechanical dyssynchrony was reduced as shown 
by significantly reduced DYS, whereas IFF showed a clear tendency to be reduced. 
Mechanical efficiency was significantly improved at six months follow-up, resulting 
from a significant increase of SW in combination with a significant decrease of PVA. 
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Table 3. Clinical and hemodynamic data 
Parameter Baseline 6 months follow-up P-value 
NYHA class 3.6±0.5 1.5±0.5 <0.001 
QoL-test 45±23 16±16 0.028 
6-minute HWT (m) 300±133 442±89 0.003 
QRS-duration (ms) 103± 19 109± 15 0.348 
MR-TTE (grade) 2.1±0.7 0.4±0.5 0.001 
HR (bpm) 80±2 83±2 0.059 
SV (mL) 64±17 65±12 0.619 
CO (L/min) 5±1 5±1 0.270 
ESV (mL) 146±46 100±41 0.014 
EDV (mL) 214±57 173±46 0.034 
EF (%) 31±8 40±14 0.032 
ESP (mmHg) 133±33 124±28 0.319 
EDP (mmHg) 20±9 18±8 0.435 
dPdtMax (mmHg/s) 1270±254 1283±240 0.906 
dPdtMin (mmHg/s) -1149±233 -1189±307 0.577 
SW (mmHg.mL) 5971±1749 6878±1266 0.062 
Tau (ms) 80±15 81±18 0.966 
Ees (mmHg/mL) 0.98±0.31 1.51±0.82 0.049 
CS (1/mmHg) 0.097±0.037 0.104±0.037 0.667 
ME 0.40±0.12 0.55±0.13 0.020 
PVA (mmHg.mL) 16000±5160 13047±3407 0.044 
DYS (%) 30±5 26±3 0.058 
IFF (%) 61±25 41±19 0.169 
NYHA, New York Heart Association; QoL, Quality of life; HWT, Hall walk test; MR-TTE, Mitral 
regurgitation on transthoracic echocardiography; HR, Heart rate; CO, Cardiac output; ESV,End-systolic 
volume; EDV, End-diastolic volume; EF; Ejection fraction; ESP, End systolic pressure; EDP, End-
diastolic pressure; SW, Stroke work; Ees, End-systolic elastance; CS, Chamber stiffness ;ME, 
Mechanical efficiency; DYS, Dyssynchrony; IFF, Internal flow fraction 
 
 
DISCUSSION 
 
SVR by endoventricular circular patch plasty has been applied in patients with ischemic 
dilated cardiomyopathy complicated by an apicoseptal LV aneurysm. The short-term 
effects of this procedure on LV function are beneficial and consists of acute LV volume 
reduction with a decrease of mechanical dyssynchrony and improved LV systolic 
Long-term hemodynamic effects of SVR 
 187
function.6,19 The purpose of the present study was to quantify chronic hemodynamic 
effects of SVR and in particular the effects on diastolic function. 
The results of this study demonstrate that SVR leads to clinical improvement with 
improved LV hemodynamics. At six months follow-up, sustained LV reverse 
remodeling and improved global and intrinsic systolic function were observed. 
Furthermore, mechanical dyssynchrony was significantly reduced with significantly 
improved mechanical efficiency of the LV. Parameters of early (dP/dtmin, tau) and late 
diastolic function (EDP, CS) were unchanged six months after surgery, indicating that 
volume reduction and patch insertion did not compromise LV diastolic function. 
 
LV reverse remodeling. Our results demonstrated a 20% and 31% reduction of EDV 
and ESV respectively at six months follow-up. The observed decrease in EDV and ESV 
is consistent with the findings of Qin et al. showing similar reductions of EDV (25%) 
and ESV (35%) at six months follow-up in 30 patients who underwent SVR and mitral 
valve repair.20 
Somewhat larger reductions in LV volumes were reported in studies by Schreuder et al. 
and Di Donato et al.6,7 These larger reductions may be due to a more extensive surgical 
volume reduction related to larger pre-operative LV volumes. Alternatively, these 
differences may reflect redilation, because ours and Qin's studies were done at six 
months follow-up, whereas the studies by Schreuder and Di Donato were performed 
acutely after surgery. Findings of a later study by Di Donato et al., showing a reduction 
in EDV and ESV of 31% and 44% respectively at 12 months follow-up, may suggest 
some redilation at late follow-up.21 
A possible explanation for redilation in the study of Di Donato is the high recurrence of 
mitral regurgitation (38%) at 12 months follow-up. Qin et al. emphasized the 
importance of effective mitral valve repair in SVR patients as a pronounced redilation 
was occurred in patients with recurrence of mitral regurgitation.20 However, in our study 
no recurrence of mitral regurgitation occurred after six months follow-up. Therefore, it 
may be suggested that the smaller volume reduction at six months in our study may be 
result from less extensive resection in the acute phase due to smaller pre-operative LV 
volumes. Long-term sustained volume reduction has been confirmed by a recent study 
by Fujii et al. reporting 33% reduction in EDV after isolated SVR at 23 days, which was 
unchanged at 32 months follow-up.22 
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Systolic function. Our data confirm previous findings regarding improved LVEF, 
unchanged SV and reduced LV volumes after SVR.23,24 However, to our best 
knowledge, the present study is the first study with invasive hemodynamic 
measurements before and six months after SVR. At six months follow-up, a significant 
increase in Ees (from 0.98±0.31 mmHg/mL to 1.51±0.82 mmHg/mL) was observed in 
our study, indicating improved long-term intrinsic systolic function. Furthermore, 
mechanical efficiency was significantly improved with a significant reduction in 
mechanical dyssynchrony. These results are in line with previous findings by Schreuder 
et al. reporting a significant acute increase in Ees (from 1.2±0.6 mmHg/mL to 2.2±1.0 
mmHg/mL), reduced mechanical dyssynchrony and improved LV mechanical 
efficiency.7 Similarly, Tanoue et al. reported a similar significant increase in Ees (from 
1.15±0.6 mmHg/mL to 1.86±0.84 mmHg/mL) and improvement of ventricular 
efficiency derived by LV angiography 3 to 4 weeks postoperatively.25 However, these 
previous findings merely reflect acute changes of SVR on LV systolic function. Our 
study demonstrated that the increase in Ees is sustained after six months follow-up. 
Therefore, the improvement of intrinsic systolic function immediate after SVR is 
sustained on the long-term. These chronic effects are possibly due to positive acute 
effects on the remote myocardium by reduction of mechanical dyssynchrony, 
improvement of mechanical efficiency and reduction in LV wall stress. Schreuder et al. 
found that changes in Ees are inversely related to parameters of mechanical 
dyssynchrony and energy efficiency. Presumably, the chronic beneficial effects on Ees 
found in our study are mainly related to acute beneficial effects. 
 
Diastolic function. In this study, both early and late diastolic function were unchanged 
at six months follow-up. This is an important finding as endoventricular circular patch 
plasty may induce diastolic filling abnormalities with a restrictive pattern.9 
Previous acute studies reported altered early diastolic function after SVR with improved 
active relaxation (τ).6,7 These acute effects may be related to direct effects of 
revascularization26,27 and effects of cardiopulmonary bypass.28,29 Schreuder et al.7 found 
an increase in EDP (from 9.4±3 to 13.8±3 mmHg) after SVR, however these changes 
may be due to effects of postoperative edema.30 Di Donato et al. recently demonstrated 
that EDP was unchanged (from 20±12 to 17±8 mmHg) 10 days after SVR. These 
findings are in line with ours as EDP was unchanged (from 20±9 to 18±8 mmHg) after 
SVR at six months follow-up. In addition, diastolic chamber stiffness was unchanged 
after six months follow-up, indicating that volume reduction and insertion of patch 
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plasty does not increase diastolic chamber stiffness. These data imply that SVR does not 
alter diastolic function six months after surgery. 
 
In conclusion, surgical ventricular restoration leads to clinical improvement with 
sustained LV reverse remodeling, improved global and intrinsic systolic function and 
unchanged diastolic function. The improved clinical status after six months may be 
related to improved mechanical efficiency, intrinsic systolic function and reduced 
mechanical dyssynchrony. 
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SHORT INTRODUCTION 
 
The number of patients with chronic heart failure is rapidly increasing as a result of an 
aging population and advanced medical therapy leading to a substantial number of 
patients who survive a myocardial infarction. Despite improvement of pharmacological 
treatment, drug-refractory end-stage heart failure is a challenging problem. Although 
successful, cardiac transplantation is limited and consequently alternative invasive 
therapies have been developed. Currently, most widely applied are cardiac 
resynchronization therapy (CRT), surgical ventricular restoration (SVR) and restrictive 
mitral annuloplasty (RMA). Despite promising clinical results of these therapies, the 
working mechanisms are still partly unknown. In this thesis, we investigated the acute 
and chronic hemodynamic effects of these therapies in patients with end-stage heart 
failure. Quantification of these effects may provide further insight in the working 
mechanisms of these therapies and may help to explain clinical improvement in heart 
failure patients treated with these therapies. 
 
Chapter 2. In this chapter we evaluated the application of the conductance catheter 
technique in the operating room. Peri-operative quantification of systolic and diastolic 
load independent left ventricular (LV) function by pressure-volume relations is 
advantageous since loading conditions are varying during cardiac surgery induced by 
anesthesia, cardiopulmonary bypass (CPB) and the surgical procedure itself. In 8 
patients undergoing elective CABG, complete hemodynamic data was derived within 15 
minutes before and after CPB without any complications. Load-dependent and load-
independent indices of systolic function were unchanged after CPB. However, diastolic 
function changed significantly after CPB with a significant increase of end-diastolic 
pressure and the diastolic chamber stiffness constant. Active relaxation, quantified by 
the active relaxation time constant (tau), decreased significantly. We conclude that the 
conductance catheter method provides detailed data on peri-operative LV function. 
Therefore, this method may be used to evaluate the acute effects of new surgical 
procedures and the data acquired in the group of elective CABG-patients may serve as 
reference data. 
 
Chapter 3. In this chapter new parameters of LV mechanical dyssynchrony in patients 
with chronic heart failure were introduced, which were derived from online segmental 
conductance catheter signals obtained during diagnostic cardiac catheterization. We 
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determined cardiac function and LV mechanical dyssynchrony in heart failure patients 
with intraventricular conduction delay and a group of patients with coronary artery 
disease and relatively preserved LV function. The heart failure patients showed 
depressed systolic and diastolic function. However, the most marked hemodynamic 
differences between the groups were found for mechanical dyssynchrony indicating a 
high sensitivity and specificity of the new indices. Comparison of conductance catheter 
derived indices of mechanical dyssynchrony with septal-to-lateral dyssynchrony derived 
by tissue-Doppler velocity imaging showed highly significant correlations. We 
concluded that the proposed indices provide additional, new and quantitative 
information on temporal and spatial aspects of mechanical dyssynchrony in patients 
with heart failure. They may refine diagnosis of cardiac dysfunction and evaluation of 
interventions. 
 
Chapter 4. In this chapter, the baseline and chronotropic effects of normothermic 
CABG with intermittent antegrade warm blood cardioplegia on LV function were 
quantified. This on-pump approach has been applied in all heart failure patients who 
underwent SVR and/or RMA in this thesis and thus quantification of these effects in a 
control group was warranted. Our findings indicate that on-pump normothermic CABG 
with intermittent antegrade warm blood cardioplegia preserves systolic function, 
increases diastolic stiffness, and improves systolic and diastolic chronotropic responses. 
Normalization of the chronotropic responses after CPB is likely due to the effects of 
successful revascularization and subsequent relief of ischemia. The baseline effects on 
LV function reported in this chapter are used as reference data to interpret baseline 
effects on LV function after SVR and RMA in patients with heart failure. 
 
Chapter 5. In this study we quantified the acute effects of RMA on LV systolic and 
diastolic function by pressure-volume analysis using the conductance catheter. In 10 
patients with end-stage heart failure and concomitant severe mitral regurgitation, 
stringent RMA (two sizes under) effectively restored mitral valve competence (leaflet 
coaptation 8.0±0.2mm) without inducing significant acute changes in LV systolic or 
diastolic function. This study shows that undersizing the mitral annulus has no adverse 
effects on intrinsic systolic and diastolic LV function, and this procedure can be safely 
applied in patients with severe heart failure. 
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Chapter 6. In this chapter, we described the acute effects of SVR on LV systolic and 
diastolic function in patients with ischemic dilated cardiomyopathy. The results show 
that SVR achieves normalization of LV volumes, improves systolic function and 
decreases LV wall stress and mechanical dyssynchrony. At the expense of a higher 
diastolic pressure resulting from altered diastolic properties, cardiac pump function 
indexed by stroke work and cardiac output was not importantly altered while the 
pressure-volume area was significantly reduced after SVR. Therefore, mechanical 
efficiency was significantly improved, presumably resulting from reduced wall stress 
and reduced mechanical dyssynchrony. Interestingly, the diastolic chamber stiffness 
constant was not more altered after SVR than after the surgical procedures in the other 
groups, suggesting that this effect was importantly related to procedure-induced 
myocardial edema and may be partially transient. 
 
Chapter 7. This chapter gives an overview of the potential applications of pressure-
volume measurements by the conductance catheter during cardiac catheterization. This 
review showed that, in the context of CRT, pressure-volume measurements by 
conductance catheter have been mainly applied to study the basic mechanisms of 
dyssynchronous and resynchronized cardiac contraction. In this field important new 
insights were obtained from pressure-volume measurements. There are certainly 
possibilities and distinct advantages in the field of patient selection but this application 
will remain limited by the invasive character of the conductance method. Currently, 
ongoing studies apply pressure-volume measurements to optimize CRT in individual 
patients and evaluate the chronic hemodynamic effects of CRT. The possibility to assess 
cardiac function and mechanical dyssynchrony during implantation and the possibility 
to study the immediate effects of changes in lead position, AV and VV-delay, in an on-
line and quantitative fashion makes this a promising tool to optimize CRT. Load-
independent quantitative parameters of systolic and diastolic function derived from 
pressure-volume relations should provide more insight in the working mechanisms of 
chronic CRT. 
 
Chapter 8. In this chapter the chronic effects of CRT on LV hemodynamics were 
reported. Acute hemodynamic improvements of CRT have been studied previously, but 
detailed invasive studies showing hemodynamic consequences of chronic CRT are not 
available. We demonstrated that hemodynamic improvements previously shown in 
acute studies are maintained mid-term. In addition, ventricular-arterial coupling, 
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mechanical efficiency, and chronotropic responses are improved after 6 months CRT. 
These findings may help to explain the improved functional status and exercise 
tolerance in heart failure patients treated with cardiac resynchronization. 
 
Chapter 9. In this chapter clinical efficacy was evaluated 6 months after surgery in a 
cohort of patients with end-stage heart failure who underwent combined SVR and 
RMA, isolated SVR or isolated RMA. Clinical parameters, including NYHA 
classification, Minnesota Quality of Life questionnaire, and 6-minute walking distance, 
were assessed at baseline and 6 months after surgery. Mortality at 6 months was 12% 
and was associated with highly significant improvements in clinical parameters. We 
concluded that surgical treatment of end-stage heart failure by SVR and RMA seems 
relatively safe with a clear clinical benefit at 6-months follow-up. 
 
Chapter 10. In this chapter, a comprehensive analysis of SVR and if indicated mitral 
and/or tricuspid annuloplasty on mid-term hemodynamic and clinical status was 
performed. In a selected group of 21 patients who had complete echocardiographic 
follow-up including tissue Doppler imaging at 6 months, clinical and echocardiographic 
parameters were assessed. In particular, the effects of this surgical approach on LV 
volumes, LV dyssynchrony, right ventricular (RV) reverse remodeling and RV 
functional parameters (severity of tricuspid regurgitation and pulmonary artery 
pressure) were studied. It was demonstrated that this approach resulted in significant 
improvements of clinical status and heart failure symptoms, combined with a reduction 
in LV volume and LV dyssynchrony with minimal residual mitral regurgitation. In 
addition, a decrease in pulmonary artery pressure, RV reverse remodeling and reduced 
tricuspid regurgitation was observed. Therefore, this approach proved to have beneficial 
mid-term effects in terms of clinical and hemodynamic status. 
 
Chapter 11. In this chapter, chronic effects of SVR on pressure-volume relations were 
evaluated. Hemodynamic data showed significantly improved LVEF, sustained LV 
volume reduction and significantly improved intrinsic systolic function. In addition, 
mechanical efficiency significantly improved with significant reduction of mechanical 
dyssynchrony. Interestingly, parameters of diastolic function remain unchanged 6 
months after surgery. From these results, we conclude that SVR leads to improved LV 
systolic function with unchanged diastolic function at 6 months follow-up. The 
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improved LV systolic function after 6 months may be related to reduced LV mechanical 
dyssynchrony and improved LV efficiency. 
 
 
CONCLUSIONS 
 
This thesis demonstrates the feasibility and value of LV pressure-volume measurements 
by conductance catheter during cardiac surgery. Besides assessment of load-dependent 
and load-independent parameters of systolic and diastolic LV function, the conductance 
catheter can quantify LV mechanical dyssynchrony, which is an important determinant 
of cardiac (dys)function and a new sensitive parameter in patients with chronic heart 
failure. 
Prior to our studies in heart failure patients, we evaluated our methodology in patients 
with relatively normal LV function who underwent elective normothermic CABG. Like 
the heart failure patients, these patients were operated during intermittent antegrade 
warm blood cardioplegia. Our peri-operative measurements showed no significant 
changes in LV systolic function. However, diastolic chamber stiffness significantly 
increased, while active relaxation (tau) improved. These effects are probably related to 
effects of cardiopulmonary bypass, cardioplegic arrest, and the revascularization. In 
general, such effects should be taken into consideration when evaluating peri-operative 
hemodynamic measurements in patients with heart failure who undergo surgery with the 
same on-pump approach. 
With regard to surgical therapies, we focused on SVR and RMA in patients with end-
stage heart failure. Earlier studies have suggested that correction of mitral regurgitation 
may decrease LV systolic function in the acute phase. In addition, with regard to 
diastolic function, mitral valve repair by RMA might potentially impair filling. These 
concerns have caused hesitation to apply these procedures in patients with advanced 
heart failure. However, we have demonstrated by pressure-volume analysis that RMA 
did not affect systolic and diastolic function in the acute phase. Interestingly, our results 
show a clear tendency for a reduced mechanical dyssynchrony after RMA. These 
findings support the use of this approach even in patients with severely depressed LV 
function in view of beneficial long-term results. 
SVR is increasingly applied in patients with ischemic dilated cardiomyopathy and 
anteroseptal dyskinesia or akinesia. However, limited data are currently available about 
the acute and chronic effects of this therapy on LV function. The present thesis provides 
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measurements of LV systolic and diastolic function and dyssynchrony by use of 
pressure-volume relationships. In addition, mid-term (6 months) effects of SVR on 
clinical status and biventricular function were provided by clinical parameters (6-min 
walk test, Minnesota Living with Heart Failure questionnaire, NYHA classification) and 
echocardiography including tissue Doppler imaging. SVR resulted in significant acute 
improvement of systolic function, significant acute reduction of LV mechanical 
dyssynchrony, and significant reduction of LV wall stress. At the expense of a higher 
diastolic pressure resulting from altered diastolic properties, cardiac pump function 
indexed by stroke work and cardiac output was not importantly altered while the 
pressure-volume area was significantly reduced after SVR. Therefore, mechanical 
efficiency was significantly improved, presumably resulting from reduced LV wall 
stress and reduced mechanical dyssynchrony. The changes in diastolic stiffness were 
relatively limited and were comparable with the changes in patients with preserved LV 
function who underwent elective CABG suggesting that this effect was importantly 
related to procedure-induced myocardial edema and may be partially transient. 
These acute beneficial effects on systolic function are largely maintained chronically 
with no significant effects on diastolic function at mid-term follow-up. The pressure-
volume data at 6 months follow-up showed significantly improved LVEF, sustained LV 
volume reduction and significantly improved intrinsic systolic function. In addition, 
mechanical efficiency was improved with a reduction of mechanical dyssynchrony. 
Clinical and echocardiographic data at 6 months follow-up showed improvement of 
clinical status and a significant LV volume reduction and reduced LV dyssynchrony. In 
addition, RV reverse remodeling after SVR and, if indicated, mitral or tricuspid 
annuloplasty was noted with reduction in tricuspid regurgitation and pulmonary artery 
pressure. These data indicate that SVR improves LV global and intrinsic systolic 
function by reducing mechanical dyssynchrony and LV wall stress without inducing 
diastolic dysfunction. In addition, SVR leads to additional beneficial effects at mid-term 
follow-up such as reduced pulmonary artery pressure and RV reverse remodeling. The 
beneficial hemodynamic effects described in this thesis can explain the improved 
clinical status and survival of patients after SVR at long-term follow-up. 
A third important new technique to treat patients with end-stage heart failure is CRT, 
which is highly effective in patients with left bundle-branch block and severe heart 
failure. Previous studies showed long-term clinical benefit, improved LV function and 
reverse LV remodeling. Acute hemodynamic effects, previously described, consist of 
increased LV ejection fraction and stroke volume, accompanied by increased systolic 
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pressure, dP/dtMAX, and stroke work, reduced mechanical dyssynchrony and reduced 
diastolic pressure. In the present thesis, we obtained invasive hemodynamics by 
pressure-volume loops at baseline and after 6 months of CRT and showed that these 
improvements are still present at 6 months follow-up. Moreover, our results show 
improved ventricular-arterial coupling and improved mechanical efficiency, which 
constitute a more optimal energetic condition. In addition, we demonstrated improved 
responses to increased heart rate, which may partly explain the enhanced exercise 
capacity of patients treated with CRT. However, despite conversion to a more 
physiological chronotropic response, the capacity to increase cardiac output remains 
limited. The latter presumably is partly due to an abnormal relaxation reflected by a 
relatively long isovolumic relaxation time (tau), which did not improve after CRT. 
These effects of CRT help to explain the improved functional status and exercise 
tolerance in heart failure patients treated with CRT. 
 
In summary, recently several new therapies were introduced to treat patients with end-
stage heart failure. These therapies, SVR, RMA and CRT have all demonstrated to have 
clinical benefit. In this thesis, we documented the acute and chronic effects of these 
therapies on LV function by pressure-volume analysis. Our findings provide insight in 
the underlying mechanisms and help to explain improved functional status achieved 
with these therapies. 
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Samenvatting en conclusies 
 
KORTE INLEIDING 
 
Het aantal patiënten met chronisch eindstadium hartfalen neemt snel toe als gevolg van 
de vergrijzing en de verbeterde medische behandeling van het acute myocardinfarct. 
Ondanks verbeterde medicamenteuze therapie blijft een substantieel deel van deze 
groep patiënten symptomatisch. Harttransplantatie, hoewel succesvol, blijft beperkt tot 
een kleine groep patiënten. Hierdoor zijn de afgelopen jaren een aantal alternatieve 
behandelingen ontwikkeld en toegepast, waaronder cardiale resynchronisatie therapie 
(CRT), aneurysmectomie volgens Dor (Dor procedure) en chirurgische mitralisklep-
reparatie door middel van een restrictieve mitralisklep annuloplastiek (RMA). Ondanks 
de veelbelovende klinische resultaten van deze behandelingen zijn de 
werkingsmechanismen nog grotendeels onbekend. In dit proefschrift worden de acute 
en chronische hemodynamische en cardiovasculaire effecten van deze behandelingen 
gekwantificeerd o.a. door middel van ventriculaire drukvolume analyse met behulp van 
de conductantiecatheter. Het kwantificeren van deze effecten kan meer inzicht 
verschaffen in de werkingsmechanismen van deze interventies en daarmee de klinische 
verbetering, die doorgaans optreedt na de behandeling in patiënten met chronisch 
eindstadium hartfalen, wellicht verklaren. Bovendien geeft het mogelijk 
aangrijpingspunten voor het verder verbeteren van deze therapieën. 
 
Hoofdstuk 2. In dit hoofdstuk beschrijven we de toepassing van de 
conductantiecatheter in de operatiekamer. Met deze techniek kunnen acute effecten van 
hartchirurgische behandelingen worden gekwantificeerd. Met name het meten van 
parameters van intrinsieke systolische en diastolische linker kamerfunctie tijdens 
hartoperaties is belangrijk, omdat tijdens deze operaties belastingscondities van het hart 
sterk kunnen variëren als gevolg van de anesthesie, cardiopulmonale bypass (CPB) en 
de chirurgische interventie zelf. Om de toepassing van deze meettechniek te testen en 
acute effecten van een controlegroep patiënten met normale hartfunctie te verkrijgen, 
zijn metingen verricht in 8 patiënten die een electieve CABG ondergingen. Complete 
hemodynamische gegevens zijn verkregen binnen 15 minuten voor en na CPB. Hierbij 
traden geen complicaties op. Uit de resultaten blijkt dat zowel de 
belastingsonafhankelijke als de belastingsafhankelijke parameters van systolische 
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functie onveranderd bleven na CPB. De parameters van diastolische functie waren 
echter wel veranderd na CPB, waarbij de einddiastolische druk en de diastolische 
kamerstijfheidsconstante significant waren toegenomen. Actieve relaxatie, 
gekwantificeerd door de relaxatie constante tau, verbeterde significant na CPB. 
De resultaten in dit hoofdstuk laten zien dat de conductantiecatheter waardevolle 
informatie kan verschaffen over peri-operatieve linker kamerfunctie en dat deze 
methode kan worden toegepast om de acute effecten van nieuwe chirurgische 
procedures te kwantificeren. De gegevens in dit hoofdstuk zullen verderop in dit 
proefschrift worden gebruikt ter vergelijking met de acute hemodynamische effecten 
van chirurgische behandelingen in patiënten met ernstig hartfalen. 
 
Hoofdstuk 3. In dit hoofdstuk worden nieuwe parameters van mechanische 
dissynchronie van de linker hartkamer bij patiënten met chronisch hartfalen 
geïntroduceerd, die gemeten kunnen worden met behulp van segmentale 
volumesignalen van de conductantiecatheter. Tijdens diagnostische hartcatheterisaties 
werden conductantiemetingen verricht waarbij de hartfunctie en mechanische 
dissynchronie werd gemeten in een groep patiënten met chronisch hartfalen. Deze 
metingen werden vergeleken met metingen in een groep patiënten met coronairlijden en 
een relatief normale linker kamerfunctie. De patiënten met hartfalen hadden een sterk 
verminderde systolische en diastolische linker kamerfunctie. De duidelijkste verschillen 
tussen de beide groepen werden echter gevonden in de parameters van mechanische 
dissynchronie. Vergelijking van deze nieuwe parameters met echografische parameters 
van mechanische dissynchronie waaronder septal-to-lateral delay liet een sterke 
significante correlatie zien. Hieruit werd geconcludeerd dat deze nieuwe parameters 
verkregen met de conductantiecatheter nieuwe additionele en kwantitatieve informatie 
kunnen geven over temporele en ruimtelijke aspecten van mechanische dissynchronie 
bij patiënten met hartfalen. Deze parameters geven meer inzicht in linker 
kamerdysfunctie bij patiënten met hartfalen. Ook kan het effect van interventies op deze 
parameters inzicht verschaffen in de werkingsmechanismen van nieuwe behandelingen 
voor hartfalen. 
 
Hoofdstuk 4. In dit hoofdstuk worden de acute effecten besproken van normotherme 
CABG met intermitterend antegrade warm bloed cardioplegie op de linker 
kamerfunctie. Naast de effecten op de hartfunctie bij een frequentie van 80 slagen per 
minuut, worden ook de effecten op de hartfunctie tijdens hogere hartfrequenties 
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(chronotrope respons) besproken. Aangezien dezelfde on-pump benadering wordt 
toegepast bij patiënten met hartfalen die een Dor procedure en/of een RMA ondergaan 
in de volgende hoofdstukken van dit proefschrift, is kwantificatie van de effecten van 
deze benadering allereerst zinvol in een controle groep. De bevindingen in deze controle 
groep laten zien dat on-pump normotherme CABG met intermitterend antegrade warm 
bloed cardioplegie geen systematisch effect heeft op de systolische linker kamerfunctie 
maar wel op de diastolische linker kamerfunctie. De diastolische linker kamerstijfheid 
neemt toe en de actieve relaxatie verbeterd. Bovendien verbetert zowel de systolische 
als diastolische chronotrope respons na CPB. De verbetering van actieve relaxatie en de 
normalisatie van de chronotrope respons is waarschijnlijk het gevolg van de succesvolle 
revascularisatie. 
 
Hoofdstuk 5. In dit hoofdstuk beschrijven we de acute effecten van chirurgische 
mitralisklep reparatie door middel van RMA op de systolische en diastolische linker 
kamerfunctie door middel van drukvolume relaties verkregen met de 
conductantiecatheter. De resultaten verkregen bij 10 patiënten met eindstadium 
hartfalen laten zien dat RMA door middel van het inbrengen van een undersized ring, 
d.w.z. twee maten kleinere ring dan de maat die werd gemeten, de coaptatie van de 
mitralisklep kan herstellen (8.0±0.2 mm). Hierbij werd de ernstige mitralis-
insufficiëntie opgeheven en de metingen met de conductantiecatheter lieten geen 
veranderingen zien in de systolische en diastolische linker kamerfunctie na CPB. Dit 
toont aan dat RMA in patiënten met een verminderde linker kamerfunctie geen nadelige 
effecten heeft op de intrinsieke diastolische en systolische linker kamerfunctie en dat 
deze chirurgische techniek veilig kan worden toegepast bij deze groep ernstig zieke 
patiënten 
 
Hoofdstuk 6. In dit hoofdstuk worden de acute effecten op de systolische en 
diastolische linker kamerfunctie beschreven van de Dor procedure, uitgevoerd bij 
patiënten met ischemische, gedilateerde cardiomyopathie met een anteroseptaal 
aneurysma. De gegevens laten zien dat de Dor procedure resulteert in normalisatie van 
de linker kamervolumina met een verbetering in systolische functie, een afname van de 
linker kamerwandspanning en mechanische dissynchronie. Ten koste van een hogere 
einddiastolische druk als gevolg van veranderende diastolische eigenschappen na de 
operatie blijft de cardiale pompfunctie weergegeven door de slagarbeid (oppervlakte 
van de drukvolume lus) en de cardiale output vrijwel onveranderd. Daarnaast neemt de 
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mechanische efficiëntie significant toe na de Dor procedure, waarschijnlijk als gevolg 
van een vermindering van de wandspanning en mechanische dissynchronie van de 
linker kamer. De diastolische kamerstijfheidsconstante neemt echter toe alhoewel deze 
toename vergelijkbaar is met die in de controlegroep (zie hoofdstuk 4,5). 
 
Hoofdstuk 7. Dit hoofdstuk geeft een overzicht van de mogelijke toepassingen van de 
conductantiecatheter tijdens hartcatheterisaties. Het laat zien dat drukvolume relaties 
kunnen worden toegepast in de context van CRT om de basale mechanismen van 
dissynchrone en geresynchroniseerde cardiale contractie te bestuderen. Op dit gebied 
zijn dan ook belangrijke nieuwe inzichten verkregen met drukvolume metingen. Deze 
meettechniek biedt o.a. voordelen op het gebied van patiëntselectie, al blijft de 
toepassing van de techniek relatief beperkt vanwege het invasieve karakter van de 
conductantiecatheter. Er zijn diverse studies uitgevoerd die drukvolume analyse 
toepassen om CRT te optimaliseren in individuele patiënten en de hemodynamische 
effecten van CRT te evalueren. De mogelijkheid om de hartfunctie en mechanische 
dissynchronie te kwantificeren gedurende implantatie van een biventriculaire pacemaker 
en de mogelijkheid om direct de effecten van de positie van de pacemakerdraad, de AV 
en VV timing  te kunnen meten, maakt deze techniek aantrekkelijk om CRT te 
optimaliseren. Belastingsonafhankelijke kwantitatieve parameters van systolische en 
diastolische functie verkregen door middel van drukvolume relaties kan meer inzicht 
verschaffen in de werkingsmechanismen van CRT op de intrinsieke hartfunctie. 
 
Hoofdstuk 8. In dit hoofdstuk worden de chronische effecten van CRT op de linker 
kamerfunctie beschreven. Acute hemodynamische verbeteringen van CRT zijn reeds 
bekend, maar gedetailleerde invasieve metingen van hemodynamische effecten op lange 
termijn zijn nog niet beschikbaar. De resultaten in dit hoofdstuk laten zien dat de acute 
gunstige effecten van CRT op de linker kamerfunctie ook op lange termijn aanwezig 
blijven. Daarnaast verbetert de ventriculaire-arteriële koppeling, vermindert de 
mechanische dissynchronie en is er sprake van een verbetering in de chronotrope 
respons na 6 maanden CRT. Deze bevindingen verklaren mede de verbetering van 
klinische parameters en de toename van de inspanningstolerantie in patiënten met 
hartfalen die worden behandeld met CRT. 
 
Hoofdstuk 9. In dit hoofdstuk worden klinische parameters gebruikt om het effect van 
de gecombineerde Dor/RMA procedure, de geïsoleerde Dor procedure en de geïsoleerde 
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RMA te evalueren in een cohort patiënten met hartfalen. Klinische parameters, inclusief 
NYHA classificatie, de kwaliteit-van-leven-test en de 6 minuten looptest zijn bepaald 
vóór en 6 maanden na de operatie. De mortaliteit na 6 maanden was in deze selecte 
groep patiënten 12% en de klinische parameters verbeterde significant na 6 maanden. 
Hieruit werd geconcludeerd dat de chirurgische behandeling van eindstadium hartfalen 
door middel van de Dor procedure en/of de RMA relatief veilig is met een duidelijk 
klinische verbetering na 6 maanden. 
 
Hoofdstuk 10. In dit hoofdstuk wordt een uitvoerige analyse verricht van de effecten 
van de Dor procedure en, indien geïndiceerd, RMA en/of tricuspidalisklepplastiek op de 
hemodynamische en klinische status van patiënten met eindstadium hartfalen. In een 
selecte groep patiënten met een complete echocardiografische follow-up, inclusief 
tissue-Doppler imaging, werden vóór en na 6 maanden klinische en echocardiografische 
parameters bepaald. Echocardiografische parameters die werden bepaald waren: het 
linker kamervolume, linker kamerdissynchronie, rechter kamerdimensies, de ernst van 
de tricuspidalis insufficiëntie en de pulmonale arteriële druk. Na 6 maanden werd een 
significante verbetering in klinische conditie van de patiënt gevonden, gecombineerd 
met een reductie in linker kamervolume en dissynchronie met een minimale residuele 
mitralis/tricuspidalis insufficiëntie. Bovendien werd een significante reductie in het 
volume van de rechter kamer gezien met een afname van de pulmonale arteriële druk. 
Deze gegevens tonen aan dat deze chirurgische benadering positieve klinische en 
hemodynamische effecten heeft op de middellange termijn. 
 
Hoofdstuk 11. In dit hoofdstuk worden de chronische hemodynamische effecten van de 
Dor procedure geëvalueerd. De drukvolume relaties, gemeten tijdens hartcatheterisaties, 
tonen een verbetering in linker kamerejectiefractie, een reductie van linker 
kamervolume en een significante verbetering van de intrinsieke systolische linker 
kamerfunctie. Daarnaast neemt de mechanische efficiëntie significant toe na 6 maanden 
met een reductie van de linker kamerdissynchronie. Een belangrijk gegeven uit dit 
hoofdstuk vormen de onveranderende parameters van de diastolische functie na 6 
maanden vergeleken met de parameters voor de operatie. Hieruit kunnen we 
concluderen dat de Dor procedure leidt tot een verbetering in globale en intrinsieke 
systolische linker kamerfunctie waarbij de diastolische functie na 6 maanden 
onveranderd blijft. De verbetering in systolische functie na 6 maanden is mogelijk 
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gerelateerd aan de reductie van linker kamerdissynchronie en de verbetering in linker 
kamerefficiëntie. 
 
 
CONCLUSIES 
 
In dit proefschrift wordt de haalbaarheid en het belang van drukvolume metingen tijdens 
hartchirurgische en cardiologische interventies aangetoond. Naast het verkrijgen van 
belastingsafhankelijke en belastingsonafhankelijke parameters van systolische en 
diastolische linker kamerfunctie, kan de conductantiecatheter parameters van 
mechanische dissynchronie bepalen. Deze parameters zijn sensitief en bepalen mede de 
mate van cardiale dysfunctie bij patiënten met chronisch hartfalen. 
Voorafgaand aan onze studies in hartfalen patiënten, hebben we de conductantiecatheter 
methode geëvalueerd in patiënten met een relatief normale linker kamerfunctie die een 
electieve normotherme CABG ondergingen. Evenals bij de hartfalen patiënten, werden 
deze patiënten geopereerd met intermitterend antegrade warm bloed cardioplegie. Onze 
peri-operatieve metingen toonden geen significante veranderingen in systolische linker 
kamerfunctie. De diastolische linker kamerstijfheid in deze patiënten nam echter 
significant toe, terwijl de actieve relaxatie constante (tau) significant verbeterde. Deze 
effecten zijn hoogst waarschijnlijk het gevolg van de cardiopulmonale bypass, de 
cardioplegie en de revascularisatie. In het algemeen, moeten deze effecten in 
beschouwing worden genomen wanneer peri-operatieve metingen worden 
geïnterpreteerd van patiënten met hartfalen die worden geopereerd onder dezelfde 
omstandigheden. 
In dit proefschrift hebben we onder andere de effecten chirurgische behandelingen zoals 
de Dor procedure en de RMA onderzocht. Op basis van vroegere studies bestaan 
aanwijzingen dat RMA in de acute fase na de operatie de linker kamerfunctie in 
patiënten met hartfalen verder kan verslechteren. Daarnaast zou RMA mogelijk een 
nadelig effect hebben op de diastolische vullingsfase. Deze vermoedens hebben geleid 
tot twijfel of deze operatie wel moet worden toegepast bij patiënten met hartfalen. In dit 
proefschrift wordt met drukvolume relaties echter aangetoond dat chirurgische 
mitralisklep-reparatie door middel van RMA (met een twee maten kleinere ring dan de 
ringmaat die werd gemeten) geen nadelig effect heeft op de intrinsieke systolische en 
diastolische linker kamerfunctie in patiënten met hartfalen. Daarnaast was er een trend 
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tot reductie van de linker kamerdissynchronie. Deze bevindingen ondersteunen het 
gebruik van RMA zelfs in patiënten met een sterk verminderde linker kamerfunctie. 
Naast de RMA wordt ook de Dor procedure in toenemende mate toegepast bij patiënten 
met eindstadium hartfalen. Deze techniek wordt toegepast in patiënten met ischemisch 
gedilateerde cardiomyopathie met anteroseptale dyskinesie of akinesie. Er zijn 
momenteel nog weinig gegevens beschikbaar over de acute en chronische effecten van 
deze techniek op de linker kamerfunctie bij patiënten met hartfalen. In dit proefschrift 
worden met behulp van drukvolume relaties de acute en chronische effecten op de 
systolische en diastolische linker kamerfunctie en op de mechanische dissynchronie 
beschreven. Daarnaast worden de effecten van de Dor procedure na 6 maanden op de 
klinische status van de patiënt (6 minuten looptest, kwaliteit van leven test en NYHA 
classificatie), de biventriculaire functie en linker kamerdissynchronie, met behulp van 
echocardiografie en tissue Doppler imaging bestudeerd. De acute effecten van de Dor 
procedure, zoals beschreven in dit proefschrift, bestaan uit een verbetering in globale en 
intrinsieke systolische functie, een reductie van linker kamerdissynchronie en een 
significante afname van de linker kamerwandspanning. Ondanks veranderende 
diastolische eigenschappen (verhoogde einddiastolische druk en een toegenomen linker 
kamerstijfheidsconstante) na de operatie blijft de pompfunctie (cardiale output en 
slagarbeid) onveranderd. De pressure-volume area was significant verminderd na de 
Dor procedure hetgeen uiteindelijk leidt tot een verbetering in mechanische efficiëntie 
van de linker kamer. Dit effect is waarschijnlijk het gevolg van een reductie van linker 
kamerwandspanning en een reductie van mechanische dissynchronie. De toename in 
diastolische linker kamerstijfheid neemt toe na de Dor procedure, deze toename is 
echter vergelijkbaar met de toename in de controle CABG patiënten en waarschijnlijk 
het gevolg van tijdelijk oedeem dat ontstaat na de operatie. De positieve effecten op de 
systolische linker kamerfunctie, gemeten met drukvolume relaties, zijn na 6 maanden 
nog steeds aanwezig. Opmerkelijk is dat de diastolische functie na 6 maanden 
onveranderd is ten opzichte van voor de operatie. Kennelijk is de toename in linker 
kamerstijfheid, die direct na de operatie aanwezig is, tijdelijk van aard. De drukvolume 
gegevens na 6 maanden laten een significante verbetering zien in linker 
kamerejectiefractie, een significante reductie van het linker kamervolume en een 
significante verbetering in intrinsieke systolische functie. Daarnaast neemt de linker 
kamerefficiëntie toe met een reductie in mechanische dissynchronie. Ook de klinische 
parameters verbeterden 6 maanden na de Dor procedure. Daarnaast treedt reverse 
remodeling op van de rechter kamer en vindt een significante reductie plaats van de 
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pulmonale arteriële druk na de operatie. Deze resultaten tonen aan dat de Dor 
procedure, indien noodzakelijk met een tricuspidalisklepplastiek of een 
mitralisklepplastiek, de globale en intrinsieke systolische linker kamerfunctie verbetert 
door een reductie in mechanische dissynchronie en linker kamerwandspanning, zonder 
verandering in diastolische linker kamerfunctie. Bovendien treedt reverse remodeling 
op van de rechter kamer met een afname van de pulmonale arteriële druk. Al deze 
verbeteringen in functie verklaren mede de gunstige klinische lange termijn resultaten 
na de Dor procedure. 
Een derde belangrijke behandelingstechniek voor patiënten met eindstadium hartfalen is 
CRT dat effectief is gebleken bij patiënten met een ernstig hartfalen en een linker 
bundeltak blok. Eerdere studies laten gunstige lange termijn effecten zien met een 
verbetering in overleving en symptomen en een verbetering in linker kamerfunctie met 
reverse remodeling van de linker kamer. De reeds bekende acute effecten na CRT zoals 
toename in ejectiefractie, slagvolume, systolische druk, dP/dtmax en slagarbeid, en 
reductie in mechanische dissynchronie en diastolische druk zijn volgens de resultaten 
van dit proefschrift nog steeds aanwezig na 6 maanden behandeling met CRT. 
Bovendien laten deze resultaten een verbetering in ventriculaire-arteriële koppeling en 
een verbetering in mechanische efficiëntie zien. Verder laten deze resultaten een 
verbetering in chronotrope response zien, dat mogelijk de verbetering in 
inspanningstolerantie na CRT in deze patiënten mede verklaart. Ondanks conversie naar 
een meer fysiologische chronotrope response werd echter een beperkte toename gezien 
van de cardiale output na toename van de hartfrequentie. Dit is mogelijk het gevolg van 
een abnormale relaxatie door de vertraagde isovolumetrische relaxatie die niet 
verbeterde na CRT. Deze hemodynamische verbeteringen na CRT verklaren voor een 
deel de toename van de inspanningstolerantie in hartfalen patiënten die worden 
behandeld met CRT. 
In dit proefschrift zijn de acute en chronische hemodynamische effecten van de Dor 
procedure, RMA en CRT onderzocht met behulp van ventriculaire drukvolume analyse 
met de conductantiecatheter. De klinische effecten van deze behandelingen bij patiënten 
met hartfalen zijn over het algemeen gunstig. De bevindingen in dit proefschrift geven 
inzicht in de onderliggende werkingsmechanismen en kunnen de klinische 
verbeteringen in deze patiënten mede verklaren. 
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